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an de Mathias 
Der Deutsche hat für den Komplex des Daseins eines wirklichen Wesens das 
Wort Gestalt. Er abstrahiert bei diesem Ausdruck, von dem Beweglichen, er nimmt 
an, dass ein Zusammengehöriges festgestellt, abgeschlossen und in seinem Charakter 
fixiert sei. Betrachten wir aber alle Gestalten, besonders die organischen, so finden 
wir, dass nirgend ein Bestehendes, nirgend ein Ruhendes, ein Abgeschlossenes 
vorkommt, sondem dass vielmehr alles in einer steten Bewegung schwanke. Daher 
unsere Sprache das Wort Bildung sowohi von dem Hervorgebrachten, als von dem 
Hervorgebrachtwerdenden gehörig genug zu brachen pflegt. 
Wollen wir also Morphologie einleiten, so dürfen wir nicht von Gestalt 
sprechen; sondern, wenn wir das Wort gebrauchen, uns allenfalls dabei nur die Idee, 
den Begriff oder in der Erfahrung nur für den Augenblick Festgehaltenes denken. 
J. W. v. Goethe, Morphologie (1807) 
For the whole existential complexity of the actual phenomenon German has 
the word Gestalt ('shape', 'form', character'). The expression enables one to abstract 
from fluidity, to assume that something that belongs together is thereby identified, 
detached, and fixed in its character. But if we actually contemplate all the forms 
(Gestalten) around us, especially the organic ones, nowhere do we find anything 
stable, at rest, or detached; rather, we find that everything is in constant flux. For that 
reason, the German language uses the word Bildung ('form', 'formation', 'shaping', 
'constitution') to designate, appropriately enough, both the product and the process. 
Translation by R. H. Stephenson; Goethes Conception of Knowledge and Science, 
Edinburgh University Press, © 1995. 
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Abstract 
This thesis describes the application of Fourier transform ion cyclotron 
resonance mass spectrometry (FT-ICR MS) to the study of small proteins and 
peptides and their structures. Experiments were carried out using two instruments, a 
3.0 Tesla FT-ICR mass spectrometer and a 9.4 Tesla FT-ICR mass spectrometer. 
Ions were produced via electrospray ionisation and fragmented in the ICR cell by 
either sustained off-resonance irradiation collisionally activated dissociation (SORI 
CAD) or electron capture dissociation (ECD). The latter technique has attracted 
considerable interest recently. It is an electronically mediated dissociation technique 
that provides complementary information to vibrational excitation techniques (e.g. 
SORT CAD). More importantly, ECD has been shown to be a powerful tool for the 
identification and localisation of post-translational modifications, such as 
glycosilations and phosphorylations. 
Two unique features of FT-ICR mass spectrometry are high mass resolution 
and mass accuracy. These features have been exploited in a novel approach to the 
study of metal exchange reactions in metallo-proteins using stable isotope labelling. 
The system chosen, Zn.4-SmtA, is a cyanobacterial metallothionein (MT). 
Deconvoluted ESI-FT-ICR spectra for Zn4-SmtA containing Zn isotopes in natural 
abundance as well as enriched with 93% 67  Zn show that the Zn4 cluster of SmtA, in 
contrast to the structurally-analogous cluster of mammalian MT, contains a 
kinetically-inert Zn site, a feature which can be related to its secondary and tertiary 
structure, and which is of potential importance to its biological function. 
The main body of this work is a systematic study of the dissociation, via 
ECD, of doubly protonated peptides, such as luteinising hormone releasing hormone 
(LHRH), bradykinin and bombesin. The most common fragments reported in the 
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literature occur from cleavage of the N-C,, backbone bond, yielding c' (N-terminal ) 
and z (C-terminal) fragments. One striking observation in the spectra of the peptides 
studied is the presence of prominent radical c fragments (labelled herein c) and 
even-electron z fragments (labelled z'). A study of the correlation between the 
relative abundance of each of the fragment ions as a function of the amino acid 
sequence for each of the peptides is shown. 
These experimental studies have been complemented by molecular 
mechanics modelling, using the Amber force field, to correlate with putative gas-
phase structures for these doubly protonated peptides. Here, a hypothesis is put 
forward that the relative ECD fragmentation pattern is related to the gas-phase 
structure of the peptide ion prior to electron capture, and in particular that hydrogen 
bonding of the protonated site to the backbone enhances backbone cleavage at that 
site (referred to as 'ECD/structure correlation'). The relative ECD fragmentation 
pattern for bombesin and four LHRH variants are compared to their modelled gas-
structures. A detailed study of the LHRH variants with sequences pEHWSYGLRPG-
OH {1} and pEHWSYGLRPG-NH2 {2}, and bombesin {3}, showed good 
agreement between the relative ECD fragment abundances and predicted Amber 
structures for { 1 } and f  }, but not for {2}. This may imply that the postulated model 
is not a full description of the ECD process. 
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1.1 Peptide and protein mass spectrometry - the big picture 
In the past few years a milestone in genetics has been achieved with the 
deciphering of the human genome [1]. However the rewards from this achievement 
in terms of understanding cellular biology and obtaining medical breakthroughs may 
take many more years to materialise. While the genetic map of an organism may be 
viewed as an instruction book on how proteins should be expressed by a cell, the 
system is highly complex and dynamic. For the 30 thousand genes that are thought to 
exist for the human species, there may be as many as I million proteins if one 
includes their modifications (e.g. post-translational modifications) that can regulate 
the biological activity of a protein [2]. Since proteins, contrary to deoxyribonucleic 
acid (DNA), cannot be amplified (i.e. multiplied) analytical techniques are required 
that are sensitive enough to study biological systems. Hence, the study of proteins, 
which is also termed proteomics, is a more difficult project than genomics (i.e. study 
of genes) [3]. 
Mass spectrometry is one of the most sensitive analytical techniques available 
that gives qualitative and (with careful analysis) quantitative information for 
complex protein mixtures [4,5]. The common feature for mass spectrometric 
techniques is that molecules are transferred into the gas-phase as ions where they can 
be manipulated by electrostatic and/or magnetic fields to determine their mass-to-
charge ratio (m/z). In the incipient days, mass spectrometry was applied to volatile 
compounds which can be easily transferred into the gas-phase by heating and which 
can then be ionised with electron ionisation (El) [6]. Desorption techniques with fast 
energy deposition onto the sample enabled mass spectrometry to be applied to non-
volatile compounds. These 'energy-sudden' methods include field desorption (FD) 
[7], plasma desorption (PD) [8], secondary ion mass spectrometry (SIMS) [9], fast 
atom bombardment (FAB) [10] and laser desorption (LD) [11]. However, for 
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macromolecules, such as proteins, more energy is required to transfer the molecule 
into the gas-phase than energy needed to break up the molecule. 
Two ionisation techniques have enabled macromolecules to be studied by 
mass spectrometry. In matrix-assisted laser desorption ionisation (MALDI) [12] the 
laser photons heat a matrix which aids transfer of the analyte into the gas-phase as 
ions. Koichi Tanaka was first to extend this technique to biomolecules [13], for 
which he was awarded the Nobel Prize in Chemistry in 2002. In electrospray 
ionisation (ESI) in the presence of an electrostatic field a Taylor cusp is formed 
which causes formation of droplets, from which ions pass into the gas-phase (a more 
detailed account of ESI will be given in section 1.3.2). John B. Fenn also shared the 
Nobel Prize in Chemistry in 2002 for his contribution in developing electrospray 
ionisation for biological mass spectrometry [14]. 
A biological sample (e.g. cell extract) may contain tens of thousands of 
proteins, the abundances of which may vary by a factor of 106  [15]. Hence 
sophisticated separation techniques are required to reduce the complexity of the 
sample prior to mass spectrometric analysis. The cutting-edge technology for protein 
separation is two-dimensional polyacrylamide gel electrophoresis (21) PAGE), where 
proteins are supported on a polymer and separated in one dimension based on their 
masses by the application of an electric field gradient [16,17]. Proteins are separated 
in the second dimension based on their isoelectric point (i.e. pH where protein is 
neutral). The isolated proteins are cut into peptide fragments by an enzyme (e.g. 
trypsin), which is technically known as enzymatic digestion of proteins. 
Mass spectrometry assists protein identification by two main approaches. In 
the 'peptide- mass mapping' (or 'peptide-mass fingerprint') approach [18,19] the 
enzymatic peptide fragments are mass analysed and these masses are compared to 
theoretical mass spectra predicted from databases that contain the genetic sequence 
information. lonisation of peptides by MALDI coupled with time-of-flight (TOF) 
mass analysis has been shown to be readily amenable to automated analysis [20,21]. 
The second approach to protein identification consists of peptide ion mass isolation 
(MSMS) and fragmentation in a mass spectrometer for the purpose of obtaining the 
primary structure (i.e. sequence) of the peptide [22,23]. These peptide sequences are 
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scanned against known protein sequences contained in databases in order to establish 
the identity of the protein. While this approach provides more reliable identification 
of proteins, the implementation of automated peptide fragmentation in a mass 
spectrometer is more technically challenging than the 'peptide-mass mapping' 
approach. 
A limitation of 2D PAGE (two-dimensional polyacrylamide gel 
electrophoresis) is its insensitivity for many of the lower abundance proteins (i.e. < 
1,000 copies per cell) [15]. Recent advances in improving the sensitivity of protein 
identification by 2D PAGE include the use of affinity tags (e.g. antibodies) to purify 
protein samples [24,25]. Since 2D PAGE is a labour-intensive and expensive 
technique several research groups are developing approaches to separate protein 
mixtures by chromatographic techniques on-line to mass spectrometric analysis [26] 
and fragmentation in the mass spectrometer [27,28]. The role of mass spectrometry 
inproteomics and current challenges have been reviewed in the literature [5,15,29]. 
1.2 	Contribution of this work 
This work presents a new approach to study the kinetic metal exchange in 
metalloproteins using metal isotope exchange for the whole cyanobacterial 
metallothionein Zn4-SmtA (see Chapter 5) [Blindauer Claudia, 2003 #72]. One of the 
Zn metal sites appears to be inert to exchange, which is linked to the tertiary 
conformation of the protein and may be of biological significance. The high 
resolving power and mass accuracy of Fourier transform ion cyclotron resonance 
mass spectrometry (FT-ICR MS) are essential to establish the amount of Zn that has 
exchanged. 
The main body of this work involves the study of a relatively novel peptide 
fragmentation technique, electron capture dissociation (ECD) [30], which is a 
promising tool to identify and localise post-translational modifications [31-34] and 
has so far only been demonstrated on FT-ICR MS instruments. The equipment used 
in this work and the approach used to produce reliable ECD mass spectra is shown in 
Chapter 2. Systematic studies of ECD on model polypeptide ions are discussed in 
mechanistic terms in Chapter 3. Some of these peptides are modelled using the 
Amber mechanical force field [35,36] to determine if there is a correlation between 
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the modelled gas-phase structures and the ECD fragmentation pattern (Chapter 4). 
The role of a peptide fragmentation technique is to provide primary structure 
information (i.e. sequence) of a peptide in order to identify it; ECD may also reveal 
secondary structure information of polypeptides. Chapter 6 hints at further 
mechanistic studies of ECD with synthetic peptides and gives a summary of the 
present work on ECD. 
Thus, FT-ICR MS is ideally suited for structural elucidation of biologically 
relevant molecules, and of peptides and proteins in particular. Further, the high 
resolution and mass accuracy as well as ion trapping abilities of FT-ICR MS enable 
more interesting biological problems to be studied, which cannot be studied with any 
other mass spectrometric technique. 
1.3 Fourier Transform Ion Cyclotron Resonance Mass 
Spectrometry 
1.3.1 History and developments 
A Fourier transform ion cyclotron resonance mass spectrometer (FT-ICR 
MS) works on the premise that ions in the presence of a uniform magnetic field 
describe a circular motion in the perpendicular plane to the magnetic field direction, 
named the cyclotron motion (see section 1.3.2 for cyclotron theory). The cyclotron 
frequency of each ion, which is dependent on its mass-to-charge ratio (m/z), is 
measured as an induced current on the detection plates in a detection cell. 
Cyclotron motion was first observed by Lawrence and Livingstone in 1932 
[37]. The first mass spectrometer to make use of the ICR principle was the 
omegatron [38,39], which was constructed in 1949. In the omegatron and the ICR 
mass spectrometers developed thereafter [40-42] the magnetic field is scanned to 
generate mass spectra. In the 1970's two fundamental modifications to ICR gave rise 
to the field of FT-ICR MS. The first was the idea by McIver to trap ions using an 
electric field combined with a magnetic field [43]; the second improvement was the 
introduction of the Fourier Transform algorithm by Marshall and Comisarow [44]. 
The former improvement enabled ions to be trapped in three dimensions and 
therefore allow the measurement of ions for longer periods of time, whereas the latter 
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improvement made it possible to detect ions of different mass-to-charge ratios at the 
same time and de-convolute their cyclotron frequencies. In FT-ICR MS, as opposed 
to ICR MS, the magnetic field strength is held constant. The advent of 
superconductive magnets in the 1980's increased the achievable mass resolution and 
extended the upper mass limit. 
Whereas the first ICR mass spectrometers used internal electron ionisation 
(El) to forin ions [37], nowadays the ionisation is generally performed external to the 
magnetic field. External ionisation has a number of advantages over internal 
ionisation, including easier sample introduction and easier changeover from one 
ionisation technique to another. Some ionisation techniques, and in particular 
electrospray ionisation (ESI), which is operated at atmospheric pressure, are in fact 
incompatible with the low pressure present in the detection cell during ion detection 
(< 10 mbar). In order to bridge the pressure difference between the ionisation 
source and the detection cell, multiple pumping stages are required (differential 
pumping). ESI was first interfaced with FT-ICR in 1986 [45]. Since then other 
ionisation techniques which are important to the study of biological molecules have 
been interfaced with the technique, including matrix assisted laser desorption 
ionisation (MALDI) [46] and smaller volume ESI techniques: nano ESI [47] and 
micro ESI [48]. ESI works well in conjunction with FT-ICR, since the most abundant 
charge states in the mass spectra of proteins are generally observed between m/z 500 
to 2500, which is a m/z range where high mass resolving power is readily achievable. 
Furthermore, the ion population generated by ESI is very reproducible and 
controllable in contrast to MALDI, thereby making the external calibration of spectra 
much more accurate. 
The advantages of FT-ICR compared to other mass analysers are its ultra-
high mass-resolving power (106),  high mass accuracy (<ppm), good sensitivity, non-
destructive detection, long ion trapping times (minutes to hours) and tandem mass 
spectral (MS/MS) capabilities in time. Mass resolutions in excess of 1 million have 
been reported [49], and protein concentrations at the attomole (1018  mol) level have 
been detected [50]. Belov et al. have even achieved sub-attomole detection limits by 
using an ion funnel [51], which increases the overall ionisation efficiency of 
electrospray. Some methodological advances, such as stored waveform inverse 
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Fourier transform (SWIFT) [52] have made FT-ICR much more performant with 
respect to tandem mass spectrometry (MSMS). 
Many instrument development improvements have been proposed, such as 
using a dual-trap design, where one detection cell accumulates ions prior to 
introducing the ions into the actual detection cell [53]. This approach makes 
quadrupolar excitation axialisation (QEA) much easier to operate. QEA has been 
shown to be effective at reaxialising the ions to the centre of the trap, which 
increases the mass accuracy of the measurement and increases the number of peaks 
observed in the spectrum [54-56]. Since FT-ICR has fairly long duty cycles 
(seconds), such a dual-trap would also minimise sample loss when interfacing FT-
ICR with a chromatographic run. The long duty cycle of FT-ICR is in fact one of the 
major drawbacks of the technique with respect to chromatographic separation 
techniques. Nevertheless, FT-ICR has already been successfully interfaced with 
chromatographic separation techniques, such as capillary electrophoresis (CE) ESI to 
detect endogenous levels of hemoglobin from cell lysates [57]. A historical 
perspective of FT-ICR MS developments is given by Alan Marshall in his 
'milestones in FT-ICR MS development' review paper [58]. 
1.3.2 Fundamentals of FT-ICR MS 
The principles of FT-ICR MS have been reviewed abundantly in the literature 
[59-62]. In the presence of a uniform magnetic field ions undergo a circular motion 
in the plane perpendicular to the direction of the magnetic field, which is called the 
cyclotron motion. The fundamental reason for the cyclotron motion is the Lorentz 
force (depicted in orange in Figure 1.1), which acts on a positive ion, as shown in 
Figure 1.1. It should be noted that for negative ions the Lorentz force acts in the 




Figure 1.1 Diagrammatic representation the cyclotron motion, showing the Lorentz 
force (qv x B) acting on a positive ion, where v is the velocity vector of the ion, B is 
the magnetic field vector and q is the charge of ion. 
The unperturbed angular cyclotron frequency o (Equation 1.1) (radians s) 
is dependent on the magnetic field strength B0 (Tesla) and the inverse of the mass-to-





Figure 1.2 shows the diagram of a cubic ICR cell taken from Marshall and 
co-workers [621. The directions for this cell are defined such that the magnetic field 
direction is co-axial with the z direction. This means that the Lorentz force contains 
the ions radially (xy plane) and in order to trap ions in 3 dimensions, i.e. also in the 






Figure 1.2 Cubic ICR cell, B showing direction of magnetic field [62]. 
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The effect of the electric field generated by the trapping plates is to give rise 
to other ion motions besides the cyclotron motion: the trapping motion (angular 
frequency WT - Equation 1.2) in the z direction and the magnetron motion (angular 
frequency w,, - Equation 1.3), which takes place in the xy plane. The combined 
trajectory of these motions is similar to a spiral, to and from each trapping plate. A 
visual representation of the fundamental motions in the ICR cell is given in section 
1.3.3.1 (Figures 1.3, 1.4 and 1.5). It has been shown that the frequencies of these 
motions are given by the following equations: 
CO 	
/ qaV 






where VT is the trapping plate potential (V), a is the length of the cell (cm) 
and a is a term representing the geometry of the cell. Magnetron motion, which takes 
place in the xy plane in opposite direction of the cyclotron motion, causes a reduction 
in the observed cyclotron frequency, resulting in the reduced angular cyclotron 
frequency w+ (Equation 1.4). The reduced cyclotron frequency is also known as the 
observed cyclotron frequency, since it is the measured frequency in FT-ICR MS. 
Equation 1.4 
In contrast to the cyclotron frequency the magnetron frequency is virtually 
mass-to-charge independent. At normal mass-to-charge ratios (m/z) the magnitude of 
the magnetron frequency (100's Hz) is much lower than the cyclotron frequency 
(10's kHz), however at high values of m/z (> 10) the cyclotron frequency 
approaches the magnetron frequency. The magnetron frequency is proportional to the 
trapping plate voltages VT, thus it is desirable to employ low trapping voltages. 
When the ions are trapped in the detection cell they are positioned close to 
the centre of the trap (in the xy plane) and the cyclotron motions of ions of a 
particular m/z are not in phase with one another. In order to detect ions in the form of 
an induced current on the detection plates, the cyclotron radii of the ions need to be 
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increased. This is effected by employing a radiofrequency (rf) dipolar excitation1 on 
opposing excitation plates of the same frequency as the cyclotron frequency of the 
ions. Equation 1.5 shows the expression for the post-excitation radius rexc (cm) for a 
dipolar excitation. r, is dependent on the length of excitation t (s), the distance 
between the excitation plates d (cm) and the peak-to-peak voltage V (V), and 
inversely proportional to the magnetic field strength B0 Importantly, rexc is 
independent of m/z. 
vp _p  c 
= 	
[62] 	Equation 1.5 
2dB0  
Another reason for employing a dipolar excitation is that ions of a particular 
m/z need to be brought into phase with one another, so that they can be detected as a 
coherent ion packet on the detection plates. As shown in Figure 1.2, the detection 
plates are electrically connected and hence the movement of ions between these two 
plates causes the appearance of induced current (or image current) between the 
plates. The amplitude of this current is dependent on the charge moving between the 
two detection plates, according to Earnshaw's theorem [62]. In practical terms this 
means that the amplitude of the detected current is dependent on the charge and 
number of ions of a particular m/z. The amplitude of the induced current is also 
dependent on the distance of the charge to the detection plates, however, since the 
post-excitation radius is independent of m/z, it is the same for all ions. This feature 
makes FT-ICR a quantitative technique. 
In order to excite ions of different m/z, a sweep rf dipolar excitation is applied 
on the excitation plates. The resulting complex induced current signal on the 
detection plates encodes the frequencies of all ions that are excited. A Fourier 
Transform of this signal gives the individual frequency components of the induced 
current signal. An easily accessible tutorial for the operation of FT-ICR MS has been 
published by Amster [64]. 
In a dipolar excitation at any moment in time the voltage on one excitation plate is 1800  out of phase 
with the voltage on the other excitation plate. If the dipolar excitation frequency is identical to the 
cyclotron frequency, then the ion is accelerated (i.e. cyclotron radius increases) due to resonant 
absorption (see section 1.3.3.2, Figure 1.7). 
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The induced current signal on the detection plates is referred to as the time-
domain ICR signal [62]. The amplitude of the time-domain ICR signal (which is also 
termed free induced decay or transient) decays exponentially as a result of loss of 
coherence of the ion packet due to collisions with background gas. The time-domain 
ICR signal is digitised using an analog-to-digital converter and then Fourier 
transformed into a frequency domain spectrum. The digitisation rate needs to be at 
least twice as large as the largest cyclotron frequency to be measured (lowest m/z) 
according to the Nyquist criterion; the Nyquist criterion states that at least 2 points in 
a sine (or cosine) wave period have to be known in order to unambiguously 
determine its frequency. The frequency domain spectrum is converted into a mass-to-
charge spectrum using the fundamental cyclotron frequency equation (Equation 1.1). 
The mass resolution in FT-ICR MS is defined as the full width of the spectral 
peak at half-maximum peak height (FWHM), which is referred to as A050% in the 
frequency domain and Am50% in the mass domain. Generally, the mass resolving 
power w/Aw50% (= -m/Am50%) is more widely used as a measure of peak resolution in 
FT-ICR MS. In the low-pressure limit (i.e. ICR time-domain signal persists 
undamped during acquisition period) the mass resolving power is proportional to the 
cyclotron frequency of the ion and the length of the acquisition time. This implies 
that lower m/z ions, having higher cyclotron frequencies, also have higher peak 
resolutions than higher m/z species (for the same transient length). Although the peak 
width Aw50% remains constant with increasing m/z the cyclotron frequency varies 
inversely with m/z, which means that the mass resolving power varies inversely with 
m/z [62]. Longer acquisition times also result in higher peak resolution. This explains 
the requirement for an ultra-high vacuum in the detection cell in order to minimise 
collisions with background gas. 
While mass resolution is important, mass accuracy is arguably an even more 
important requirement in mass spectrometry. To obtain very accurate mass data (i.e. 
<ppm), the data needs to be calibrated against standard known m/z. The calibration 
takes into account cyclotron frequency shifts due to the magnetron frequency and 
space-charge effects between ions. To maximise mass accuracy low trapping 
voltages should be employed (< 1V) and not too many ions should be introduced into 
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the detection cell to minimise space-charge effects. The mass accuracy expression is 
given by: 
mass accuracy = (mexp - mtheor)/mtheor x 106 (in ppm) 	Equation 1.6 
Ledford et al. proposed the following equation to calibrate the mass spectra, 
which is generally used in FT-ICR [65]. 
M  B 
—=--+--- 	 Equation 1.7 
q (0~ co,  
where A and B are constants which are derived from FT-ICR measured frequencies 
of standards of known m/z. 
Coalescence of peaks that are very close in mass is a feature often observed 
in FT-ICR MS, even if the apparent mass resolving power should be high enough to 
resolve every peak. It was found that employing very low trapping potentials (e.g. 
0.2 V) is the best approach to minimise peak coalescence [66], since it results in a 
reduction of space-charge effects. 
In practice, the largest limitation to high resolution and mass accuracy are 
space charge-effects between ions (in the low pressure limit). The highest mass that 
has effectively been unit mass resolved is 112 kDa [67], however for molecules 
above 50 kDa it is difficult to generate high mass resolving power (i.e. > 10) spectra 
due to the very large number of isotopic peaks present [68]. 
1.3.3 Simulation of ion motion in the ICR cell 
Given the complexity of an ICR cell, which comprises electrostatic and 
magnetic trapping of the ions, as well as radiofrequency (rf) fields for dipolar and 
quadrupolar excitation of the ions, it would be of great benefit to be able to visualise 
the trajectory of the ions in the ICR cell in order to gain an intuitive understanding. 
SIMION2 is an ion optics simulation program (developed by David Dahl working at 
the Idaho National Engineering Laboratory (Idaho, USA)) that allows the 




optics and visualisation of the ion motions [69]. A review of the development of the 
SIMION program from a historical perspective has been given by David Dahl [70]. 
This review includes the present version of SIMION (version 7.0) that was used in 
these simulations and explains many of the concepts that can only be briefly 
explained here. 
A brief explanation of the theory underlying the SIMION program is given in 
Appendix 1, as well as a description of the open—ended ICR cell which was designed 
by Dr. Michael Easterling. This section is primarily concerned with giving a brief 
description of ion motions in the ICR cell. 
The shown simulations are all for a positive ion of m/z 1000 (mass = 1000 
amu, charge = +1.6x10 9 C) and a magnetic field strength of 4.7 T. The trapping 
plate voltage is +1 V unless otherwise specified. 
1.3.3.1 Fundamental motions in the ICR cell 
Figure 1.3 shows a cut-open cell with the trajectory of a positive ion of m/z of 
1000. The spiral-like trajectory is a superposition of the cyclotron and trapping 
motions. The Lorentz force due to the magnetic field constrains the ion in two 
dimensions (xy). The voltages on the trapping plates cause a potential energy well in 
the centre of the cell (see Figure 1.4), which enables trapping of the ions in the z 
direction (i.e. axis of magnetic field). 
Figure 1.3 Ion trajectory simulation in an ICR cell for 4.7 T magnetic field strength 
showing cyclotron motion (in xy direction) and trapping motion (in z direction). Ion 
m/z = 1000, trapping plate voltages = +1 V, cyclotron kinetic energy 5 eV. 
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Figure 1.4 Potential energy view of Figure 1.3 for xz plane. The trapping frequency 
depends on the trapping plate voltages (see Equation 1.2). 
The magnetron motion also occurs in the xy plane, but since its frequency is 
much lower (i.e. 100's Hz) it cannot be seen in Figure 1.3. By employing much 
higher trapping plate voltages (e.g. 500 V) than would normally be employed in FT-
ICR and placing the ion off-centre in the xy direction, the magnetron motion can be 
visualised (see Figure 1.5). 









Figure 1.5 Ion trajectory simulation showing magnetron (red colour code) and 
cyclotron (blue colour code) motions (cross-section of cell in xy direction). Magnetic 
field direction B is out of plane of paper. 
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1.3.3.2 Bipolar excitation 
When applying a dipolar excitation on the excitation plates of the same 
frequency as the cyclotron frequency of the ion (on-resonance excitation), the 
cyclotron radius of the ion increases linearly with time (see Figure 1.6). 
Figure 1.6 Ion trajectory for on-resonance dipolar excitation. xy cross-section of 
cell. vp_p 20 V, excitation time = 300 ts. Excitation (red colour code) and post-
excitation radius (green colour code). Initial cyclotron kinetic energy = 5 eV, post-
excitation cyclotron kinetic energy 580 eV. 
If, conversely, an off-resonance dipolar excitation pulse is applied, the ion 
goes through cycles of increases and decreases of the cyclotron radius (see Figure 
1.7). The cyclotron radius increases when the excitation and cyclotron phases are in 
resonance, but decreases when both are out of phase. 
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Figure 1.7 Ion trajectory for off-resonance dipolar excitation. VP _P 	40V, off- 
resonance = +2000 Hz. 
For a 2000 Hz off-set of the excitation frequency, the cyclotron and excitation 
phases are in resonance every 500[is. This implies that the cyclotron radius will 
increase to a maximum value after 250 ts of excitation. Off-resonance dipolar 
excitation is used in sustained off-resonance irradiation collisionally activated 
dissociation (SORI CAD) [71]. In SORI CAD the pressure in the ICR cell is raised 
by pulsing a gas (e.g. Ar). The increase in the number of collisions manifests itself in 
an increase in the internal energy of ions. The maximum collision energy to the ion 
can be adjusted by changing the excitation frequency off-set, length of excitation and 
the peak-to-peak voltage of excitation. SORI CAD will be discussed again in the 
section concerned with polypeptide fragmentation (section 1.4). 
1.4 	Protein and polypeptide structure 
1.4.1 Primary structure 
The basic building blocks of peptides or proteins are the amino acid. There 
are 20 different cc-amino acids encoded by DNA. These amino acids have a chiral 
carbon centre (Figure 1.8), apart from glycine, and are therefore optically active. All 
naturally occurring amino acids are L stereoisomers, apart from a very few 
exceptions. Table A2.1 (Appendix 2) summarises the 20 amino acids found in nature 
and their residue masses (i.e. mass of -NH-CHR-CO-, where R is side-chain). 
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In a protein amino acids are chemically bound by an amide/peptide bond. 
Molecules of less than 20 amino acids are generally referred to as polypeptides, 
whereas larger entities are called proteins. By convention, one always starts reading 
the primary structure (i.e. sequence) of a protein from the free amine site (named the 
N-terminus) and proceeds to the carboxylic acid group (named the C-terminus). The 
primary structure of a protein is the fundamental property by which it is identified. 
H2N_* 
OH 
Figure 1.8 General structure for cc-amino acid, where C*  denotes the chiral carbon. 
1.4.2 Differences in solution and gas-phase structures 
In solution protein folding is driven by the difference between the 
intramolecular interactions and the protein-solvent interactions. Both of these 
interactions have large values, whereas their difference is fairly small. This makes 
the task of modelling such systems extremely difficult. This challenge is commonly 
referred to as the protein folding problem. By removing the solvent, it is possible to 
study the intramolecular interactions separately and then add solvent molecules one 
at a time to study the effect of solvation [72]. 
The secondary structure of proteins [73] (e.g. a-helix, 13-sheet)3 and higher 
structures (tertiary folding, multiple protein assemblies) determine biological 
activity. How well the gas-phase structure mirrors the solution phase structure is a 
matter of debate. Differences in gas-phase and solution phase structures arise due to 
the fact that in solution the basic sites are generally located on the outside of the 
protein, in order to maximise protein-solvent interaction, whereas in the gas-phase 
the basic sites are generally involved in back solvation and hence located inside the 
structure. However, due to overall conformational constraints (i.e. large energy 
For simple introduction course, see http.. 	p .. 	c.J.Lc .. 	ccc..itm and 
16 
barriers between conformations), such a complete re-arrangement may not be 
possible and hence the solution phase structure could be 'frozen' into the gas-phase. 
This may especially apply to ionisation techniques that give little energy to the 
molecule in the ionisation process, such as electrospray ionisation. 
1.4.3 Electrospray ionisation 
Electrospray ionisation (ESI) is a soft ionisation technique that allows even 
non-covalent interactions to be conserved into the gas-phase [74]. The exact 
mechanism in ESI as to how ions pass from droplets into the gas-phase is still 
controversial. Dole et al. [75,76] suggested that solvent evaporation from the droplet 
causes a series of Coulomb explosions as the Rayleigh limit is reached resulting in 
ever smaller droplets and ending in the formation of free molecular ions (this is 
referred to as the charged residue model). Conversely, Iribane and Thompson [77] 
proposed that ions could directly desorb from the droplet surface into the gas-phase; 
multiple Coulombic explosions of droplets give rise to very small droplets with very 
high charge densities and hence the resulting electrostatic field at the droplet surface 
could transfer ions directly into the gas-phase (this is referred to as the ion 
evaporation model). Fenn used the ion evaporation model to explain the typically 
'bell-shaped' charge state distribution that is often observed for larger molecules, 
such as proteins [78]; since the number of charges on an ion is probably related to the 
number of charges available at the droplet surface at the time of evaporation, ions 
with lower charge states are formed earlier in the evaporation process than ions with 
higher charge states. Nevertheless, for much larger molecules Nohmi and Fenn have 
shown that the charge residue model can explain ion formation [79]. 
Recently Beauchamp and co-workers studied the droplet evaporation and 
discharge dynamics for electrosprayed droplets in a beautiful experiment involving 
Doppler interferometry to determine the droplet size and mobility in a constant field 
to determine the charge [80]. They inferred from these experiments that droplet 
instability occurs near the Rayleigh limit of charge resulting in discharge losses of 
15-40% of the total charge (depending on the solvent used) and only small mass 
losses. 
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1.4.4 Solution and gas-phase basicity 
Whereas acid-base functionality in solution is defined by pKa values4, in the 
gas-phase this concept is expressed by the gas-phase basicity or proton affinity (see 
Table A2.2, Appendix 2). The gas-phase basicity and proton affinity are defined as - 
AG and -AH of the reaction [M+H] 	MH [81]. Polar solvents (e.g. water) 
stabilise protonated bases in solution relative to protonated bases in the gas-phase 
due to favourable charge-dipole moment interactions (i.e. electrostatic interactions) 
[82]. This effect is more pronounced for ammonia than for imidazole, which explains 
why lysine is a much stronger base than histidine in solution (i.e. pKaiys jne > 
pKa!i jstdj ie), whereas the order of basicity is reversed in the gas-phase (i.e. GBli istidine > 
GBiys i ne) (see Table A2.2, Appendix 2). Hence, the order of basicity in solution and 
the gas-phase are not equivalent. Water also has a high dielectric constant5  (CH20 = 
80) which favours stabilisation of charges on amino acids that are not stabilised in 
the gas-phase [82]. 
The gas-phase basicity is in general determined by two methods - the 
deprotonation and the kinetic methods. In the deprotonation method [83,84] the 
protonated amino acid is reacted with a neutral standard compound of known gas-
phase basicity to abstract the proton. If the gas-phase basicity of this standard is 
higher this will result in deprotonation of the amino acid, if it is lower no proton 
transfer will take place. Thus, the gas-phase basicity of the amino acid can be 
bracketed in between the known gas-phase basicities of two standards. 
In the kinetic method [84-86] a proton-bound dimer of the unknown and the 
standard compound is dissociated (e.g. by collision-induced dissociation). The proton 
is expected to be retained by the species with higher gas-phase basicity. The 
advantage of the kinetic method over the deprotonation method is that the activation 
barrier to proton transfer is lower and hence a more accurate determination of the 
gas-phase basicity can be achieved. 
The pKa value is defined as the pH value where [HA] = [K] for the acid-base reaction HA -* K + 
Ht 
The dielectric constant of a medium is unitless and is also known as the relative permittivity c = 
c/60, where c is the permittivity of the medium and 60 the permittivity of free space. 
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Much controversy has surrounded the gas-phase basicity of histidine, for 
which different values were determined by different workers [83,84] (which may be 
due to the use of different ionisation techniques). It is nowadays accepted that 
arginine has the highest gas-phase basicity, followed by histidine and lysine [87] (see 
Table A2.2, Appendix 2). While these accepted gas-phase basicities concern amino 
acids on their own, the gas-phase basicities of individual amino acids increase in 
larger peptides [84]. This is due to favourable intramolecular non-bonding 
interactions (see section 1.4.5) resulting in a stabilisation of charges [84], in analogy 
to water molecules stabilising charges in solution. 
1.4.5 Non-bonding interactions 
Non-bonding interactions (or intermolecular interactions) between molecules 
refer to through-space interactions between partial charges of polar molecules that do 
not involve covalent bonding. The repulsive part of these interactions prevents nuclei 
from collapsing into one another. The attractive contribution of non-bonding 
interactions determines three-dimensional folding of peptides and proteins. 
Intermolecular forces vary with respect to their typical potential stabilisation energies 
and the distance dependence of their interaction energies (see Table 1.1). 
An intermolecular interaction that deserves a special mention is hydrogen 
bonding [88-90] since it plays a particularly important role in the determination of 
protein structure, which in turn affects the biological function of proteins. A 
hydrogen bond is defined as the intermolecular interaction between A-H.. .B, where 
A, B are electronegative elements such as N, 0 or F. The typical interaction energy 
for a hydrogen bond is 20 kJ moF' [91], which is relatively large compared to other 
intermolecular interactions. However, the strength of a hydrogen bond varies 
significantly with the system studied. Tareste at al. have deduced the strength of a 
hydrogen bond between a polar group and water molecule to be 0.5 kcal moi' [92], 
which they determined from the adhesion energy between monolayers of lipids and 
water. Huang et al. have calculated typical hydrogen bond strengths of complexes of 
biological interest in the range of 5-30 kcal moi' using quantum chemical 
calculations [93]. 
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Distance Typical energy 
Interaction type dependence of Comment 
potential energy (kJ mor1) 
Ion-ion hr 250 Between ions 
Ion-dipole hr2 15 








Between all types 
(dispersion) of molecules 
Table 1.1 Typical stabilisation energies and distance dependencies of intermolecular 
interactions taken from [91]. 
In solution protein folding intermolecular hydrogen bonds between polar 
groups and water molecules are broken and replaced by intramolecular hydrogen 
bonds depending on the energy balance of these processes (difference between 
intramolecular interactions and the protein-solvent interactions, as mentioned 
before). Conversely, in the gas-phase (for fully de-hydrated peptide or protein ions) 
only intramolecular hydrogen bonding is present and hence the gas-phase protein 
folding problem is arguably easier to solve. 
1.4.6 Techniques to study gas-phase structure 
Relatively few techniques are available to study the structure of large ions in 
the gas-phase. The most common techniques include H/D exchange [94-96] (that 
gives information about surface availability of proteins), dissociation studies [97-99] 
(that give mainly primary structure information) and ion mobility [100,101] [102] 
(that gives information about the size of ions). Hydrogen bonding in the gas-phase 
has been probed by infrared spectroscopy, however, this has only been implemented 
on small molecular systems with very strong hydrogen bonding (e.g. BrHBf.Ar 
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clusters) [103]. An excellent review of recent advances in the gas-phase structure of 
peptides and proteins has been published by Jarrold [81]. 
1.4.7 Computational modelling 
Since the experimental techniques described above only give limited 
information about the gas-phase structure of ions, computational modelling of gas-
phase structures is essential. In ion mobility mass spectrometry the experimental 
cross-section of a peptide is compared to calculated cross-sections for modelled 
peptide gas-phase structures in order to identify a structure [81]. Since peptides are 
large entities by the standards of quantum chemical models and the calculations are 
therefore computationally expensive, molecular mechanical models are generally 
employed for this modelling work. 
1.5 Molecular mechanics 
Molecular mechanics models are based on Newtonian physics and are used to 
simulate structures by calculating the strain energy of the molecule. The strain 
energy Es is defined as the sum of the bond stretching, angle bending, torsion strain 
and non-bonding interaction energies (see Equation 1.9). These energies are 
dependent on the positions of the atoms. Each atom position represents a variable in 
a multi-dimensional potential energy surface (PES) and the task of the force field 
model is to determine potential energy minima. 
Es = Ebod stretching + Eangie bending + Etorsion  strain + Enon.bonding  interactions 	Equation 1.9 
The temperature of a model system defines the kinetic energy of the atoms.6 
The potential and kinetic energy of the system can interchange in analogy to a ball on 
an inclined plane, and hence these models are referred to as (Newtonian) mechanical 
force field models. When during a simulation kinetic energy is taken out of the 
system (i.e. decreasing temperature) the molecule is forced to move to a minimum on 
6 
The temperature expresses the kinetic energy (K.E.) of the atoms. K.E. = '/ m v2 = Nf  k T12, where 
m = mass of atom, v = velocity of atom, Nf  = degrees of freedom (Nf  = 3, for perfect gas), k = 
Boltzmann constant and T = temperature. 
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the PES. If this procedure is repeated a number of times different minima are found 
with different relative energies, which serve as potential candidate structures. 
Various force field models have been developed including CHARMm [104], 
GROMOS [105], MM2 [106], MM3 [107] and Amber [108,109]. The Amber force 
field has been developed particularly for biological molecules such as proteins and 
deoxyribonucleic acid (DNA). Further developments of Amber have tried to improve 
the procedure for calculating atomic point charges [36]. These atom-centred point-
charges are meant to accurately describe the electrostatic potential of the molecule at 
given multiples of the Van der Waals radii (1.4, 1.6, 1.8 and 2.0) in order to model 
non-bonding interactions (i.e. charge-charge, charge-dipole, dipole-dipole and 
dispersion interactions, as well as hydrogen bonding; see Table 1.1). Atomic charge 
fitting in Amber was derived using Gaussian 90 [110] and Gaussian 92 [111] using 
Hartree-Fock level theory and a 631G*  basis set. The restrained electrostatic 
potential (RESP) charge fitting procedure involves a least-squares fitting of the 
atomic point charges (as determined by Gaussian) in order to minimise higher than 
expected charges on 'buried' atoms (e.g. sp3 carbons) and to give the same charge to 
chemically equivalent atoms [112]. Atomic charges of the 20 naturally occurring 
amino acids with typical protonation sites that are observed in solution are included 
in the AMBER  suite of programs [36]. 
The strain energy (Es) expression used in Amber is shown in Equation 1.10; 
the parameters and variables used are listed in Table 1.2. In order for force field 
modelling to accurately simulate molecular structures, the correct parameterisation of 
the force field is of crucial importance (i.e. garbage in, garbage out). The bond 
stretching and angle bending interactions are described by Hooke's law (in analogy 
to a spring). The equilibrium bond distance req and equilibrium bond angle °eq  are 
often obtained from X-ray crystallography data. The dihedral angle 0 refers to the 
torsional rotation. Many of the force constants are obtained from quantum chemical 
calculations. The final term in this expression describes non-covalent interactions, 
such as the Van der Waals forces, hydrogen bonding and the electrostatic 
Note that AMBER refers to the software modelling package, whereas Amber refers to the 
mechanical force field used in this package. 
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interactions. The Van der Waals interaction is modelled using a Lennard-Jones 
potential with an attractive force proportional to R 6 (Rij = distance between atoms i 
and j) and a repulsive force proportional to R 12. The electrostatic interaction (i.e. 
charge-charge interaction) depends on the magnitude of the charges qj and qj and 
their distance R1 . 
Es = Etoiai = 	Kr  (r - r,,)' + I K9 (9— 9eq 2 + 
bonds 	 angles 
V 	[1+cos(n—y)]+ 







Kr  Bond distance force constant 
r Bond distance 
req Equilibrium bond distance 
K9 Bond angle force constant 
0 Bond angle 
°eq Equilibrium bond angle 
V11  Torsion force constant 
Torsion angle 
Phase angle 
Aij  Repulsion term 
B 1  Dispersion term 
Rii Distance between atom i and j 
qj Charge on atom i 
qj  Charge on atom j 
Permittivity of medium 
Table 1.2 Summary of terms used in Equation 1.10. 
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Since electrostatic interactions only decrease as a function of R' it is the 
longest range intermolecular interaction (see also Table 1.1) and when modelling 
gas-phase structures this is particularly true, given the higher permittivity of free 
space8. Dipole moments have to be taken into account when calculating the 
electrostatic interactions. An alignment of the peptide dipoles, such as occurs in a-
helices, results in a higher energy which is stabilised by hydrogen bonding between 
the amide oxygen (i.e. C=O) of one amino acid and the amide hydrogen (i.e. N-H) of 
another amino acid. Polyalanine (Alan) has one of the highest helical propensities 
(i.e. preference to form a-helices). Simulations by Vila et al. have shown that the 
propensity for Alan to form a-helices increases as the dielectric constant of the 
solvent is lowered [113], suggesting that the gas-phase is a suitable environment to 
study the secondary structure of peptides (i.e. folding motives such as a-helices or 
sheets). Modelling by Hudgins et al. on Ac-Ala-LysH and Ac-LysH-Ala,, revealed 
that the former adopts an a-helical gas-phase structure, whereas the latter gave a 
globular structure, which was confirmed by ion mobility measurements [114,115]. 
This shows that the accuracy of mechanical force fields has reached a stage where 
the secondary structure of gas-phase peptides can be predicted accurately. 
Nevertheless, it is important to realise the limitations of force field models; it 
is not possible to change the configuration of the molecule during modelling or take 
into account electronic effects. This means that transition states cannot be 
determined. Another consequence of ignoring electronic effects is that the common 
force fields do not take into account polarisability of molecules9. Marten et al. have 
argued that there is a poor correlation between hydrogen bonding interactions 
modelled by classical electrostatic interactions (as used in force fields) as compared 
to hydrogen bonding interactions derived from quantum chemical calculations [116]. 
The use of polarisable force fields should allow for a more rigorous treatment of 
8 
Dielectric constant of water is 80, which means that the permittivity of water is almost two orders of 
magnitude lower than for a vacuum. 
9 
Polarisability of a molecule refers to the induced dipole moment generated in a molecule due to an 
applied electrostatic field. 
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hydrogen bonding interactions [117]. Accurate modelling of hydrogen bonds 
[93,117] can only be achieved by high-level ab initio calculations (MP2) [118] which 
take into account electron correlation [119], electrostatic, induction and dispersion 
effects [120]. Such high-level calculations are not yet applicable to larger systems 
such as polypeptides, for which force field modelling is the most appropriate 
approach. A comparison of various force fields with quantum chemical methods to 
describe hydrogen bonding in DNA (deoxyribonuclic acid) by Hobza et al. has 
shown that the best performance was exhibited by the Amber force field [121]. 
Moreover, calculations by Meyer et al. [122] using the B3LYP type exchange and 
correlation functionals [123] hybrid density functional method (DFT) [124] and 
Amber on intermolecularly hydrogen-bonded nucleic acid tetrads showed good 
agreement for strongly bonded complexes, but poor agreement for weakly hydrogen-
bonded complexes. 
1.6 	Fragmentation of polypeptides 
1.6.1 Nomenclature of backbone fragmentation 
Fragmentation of polypeptides with the aim of determining primary structure 
information (i.e. sequence) plays an important part in protein identification [22]. This 
sequencing is achieved by electronically and/or vibrationally exciting the molecule in 
order to induce bond cleavage. Figure 1.9 shows the nomenclature for the peptide 
fragmentation pattern. Three distinct bonds in the backbone exist where cleavage 
could occur: the CaC bond, the peptide bond C-N and the NCa bond. Of these the 
peptide bond (or amide bond) is generally the weakest and in vibrational excitation 
techniques of which collisionally activated dissociation (CAD) [125] is one example, 
b and y fragments generally are most abundant. Conversely, in electron capture 
dissociation (ECD) [30] c and z fragments are generally the most abundant 
fragments. In order to contrast the different fragmentation mechanisms in vibrational 
excitation techniques and electron capture dissociation (ECD), the widely known 
mechanisms for both are introduced; vibrational excitation techniques - mobile 
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Figure 1.9 Nomenclature for polypeptide fragmentation based on Roepstorff and 
Fohlmarm [128], where n is the number of residues from the N-terminus and in is the 
number of residues from the C-terminus. 
1.6.2 Vibrational excitation 
1.6.2.1 Mobile proton model 
Fragmentation of peptides by vibrational excitation techniques, such as CAD 
[125], sustained off-resonance irradiation collisionally activated dissociation (SORI 
CAD) [71], surface-induced dissociation (SID) [129], infrared multi-photon 
dissociation (IRMPD) [130] or black-body infrared radiative dissociation (BIRD) 
[131] generally cause cleavage of the peptide bond, resulting in b and y fragment 
ions. The common feature in these techniques is that energy is transferred to the 
molecule in the form of collisions (CAD, SORI CAD, SD) or infrared absorption 
(IRMPD, BIRD), which causes the molecule to be in a vibrationally excited state 
prior to dissociation. McLafferty and co-workers refer to these techniques as the 
'heating' techniques and they suggested that as the energy in the molecule increases 
one of the weaker bonds in the molecule dissociates. This would explain the high 
cleavage on the N-terminal side of proline, since the strain on the peptide chain due 
to proline makes the N-terminal peptide bond of proline particularly weak. 
Wysocki and co-workers observed that the number of ionising protons 
relative to the number of basic residues in peptides where acidic residues are present 
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influences the fragmentation behaviour [132]. Conversely, when the number of 
ionising protons is higher than the number of arginine residues the cleavage is 
nonselective. This implies that the proton is involved in cleavage of the peptide bond 
and hence that 'charge directed' cleavage occurs. In order to test their hypothesis, 
they carried out fragmentation studies on model peptides using SID. SID works on 
the premise that an ion collides with an organic surface. In contrast to other 
fragmentation techniques, SD allows accurate deposition of energy onto the 
molecule with a narrow energy spread, since the kinetic energy of the ion can be 
specifically set. 
Wysocki and co-workers showed fragmentation efficiency curves for the 
model peptides RPPGFSPF and PPGFSPFR in the 1+ and 2+ charge states [126]. 
The onset of fragmentation for the 1+ charge state for both peptides is equivalent. 
The preferred site of protonation is unequivovally on the arginine side-chain, since 
the gas-phase basicity of that site is highest [87]. This observation led to the 
development of the mobile proton model, which states that the energy required to 
effect fragmentation depends on the location of the proton; i.e. it is dependent on 
how much energy is required to make the proton mobile. The doubly protonated 
form of RPPGFSPF shows an earlier onset of fragmentation than does the 
corresponding 2+ charge state of PPGFSPFR. This is due to the fact that the second 
most likely protonation site for PPGFSPFR is on the proline at the N-terminus, 
which is a more basic site and therefore binds the proton more strongly than any of 
the protonation sites in RPPGFSPF, apart from arginine. A correlation exists between 
the gas-phase basicity of the protonated site and the energy required for 
fragmentation. 
The fragmentation efficiency curves for the 2+ charge states of RRPPGFSPF 
and PPGFSPFRR show a similar onset energy of fragmentation. With respect to the 
mobile proton model, this implies that the proton is bound with the same 'tightness' 
in both cases, which basically means that both arginine side-chains are protonated. 
Given the closeness of the charge sites and ensuing Coulombic repulsion, one would 
expect the onset of fragmentation to be at a lower energy. The higher fragmentation 
onset for doubly protonated RRPPGFSPF (and PPGFSPFRR) relative to singly or 
doubly charged RPPGFSPF (or PPGFSPFR) can only be explained by the mobile 
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proton model and implies that Coulombic repulsion plays an insignificant role. 
Studies by Jockusch et al. [97] on the fragmentation of different charge states of 
bovine ubiquitin by BIRD also suggested higher activation energies for higher charge 
states, which runs contrary to the belief that Coulombic repulsion more readily gives 
rise to fragmentation. 
1.6.2.2 Structure of fragment ions 
The question as to where and how the proton initiates backbone cleavage is 
still controversial, especially with respect to the structure of the resulting b fragment 
ion. The proton could either move to the amide nitrogen or the carbonyl oxygen. 
Since the carbonyl oxygen is more basic, it would be logical to assume that this is 
where the proton attaches. Lehmann and co-workers have proposed that protonation 
of the backbone carbonyl would result in nucleophilic attack from the carbonyl 
oxygen N-terminal to the protonated carbonyl to give rise to an oxalozone b ion and 
a linear y fragment [133] (see Figure 1.10). This is consistent with the observation 
that b1 ions are generally not observed, unless the N-terminus is acylated or carries a 
side-chain to generate a cyclic b1 ion [134]. Further, the oxazolone structure is more 
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Figure 1.10 Reaction schematic for formation of oxazolone b ion and linear y ion 
following nucleophilic attack by N-terminal carbonyl oxygen [133]. 
Conversely, protonation at the amide nitrogen would lead to a lengthening of 
the C(0)-N bond [98,136] giving rise to an acylium b ion (see Figure 1.11). 
Haselmann et al. used electron capture dissociation on b2 ions, which gave an 
abundant loss of CO, which they associated with the acylium structure [137]. These 
results are in disagreement with ab initio calculations by Yalcin et al. [138] and Paizs 
et al. [139] which propose the oxazolone structure as the most energetically 
favourable structure for b ions. 
Figure 1.11 Structure of acylium b ion. 
The fact that cleavage C-terminal to the proline residue does generally not 
occur, Schlosser and Lehmann have taken as evidence that the oxazolone structure is 
more likely [133]. In this case, due to the cyclic structure of proline, the oxazolone 
structure cannot be formed (see Figure 1.12). 
+ 
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Figure 1.12 Reaction scheme showing that oxazolone cannot be formed due to the 
cyclic structure of proline. Adapted from [133]. 
The controversy surrounding the structure of b ions will probably not be 
resolved until a spectroscopic technique establishes its structure. The acylium 
structure was in fact the first one to be proposed [140] and it may be that both 
structures are possible, especially for larger fragments, where high level theory ab 
initio calculations are not yet possible. Paizs et al. evaluated the dissociation energy 
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required to cleave the peptide bond, based on the oxazolone structure, which they 
determined to be 74 kJ mol 1 (equivalent to 0.767 eV) [139]. This compares to onset 
fragmentation energies of 30-80 eV for the model peptides that Wysocki and co-
workers studied [98]. The total available energy in the molecule far exceeds the 
energy required to break a peptide bond and therefore more dissociation pathways 
may be possible. 
1.4.2.3 Relative fragmentation 
Theoretical studies of SID and multiple collision activation collisionally 
induced dissociation (MCA-CID) [141] on small polyalanine peptides by Laskin et 
at. showed that both fragmentation techniques gave different abundances of fragment 
ions [142]. Due to the slower heating of the molecule in MCA-CID higher activation 
energy pathways, which are dominant in SD, have to compete against stepwise ion 
activations. As a result, the higher activation fragmentation channels are less likely to 
occur and low-energy dissociation channels predominate. Energy-resolved 
fragmentation efficiency curves also show that the relative abundance of fragments 
changes as a function of the mean collision energy. 
Predicting the relative fragmentation behaviour in vibrational excitation 
techniques is therefore not a simple task, since it depends on a whole variety of 
parameters: secondary structure of the peptide [132], the availability of the mobile 
proton [98], the charge state of the precursor ion [98,143], the size of the ion [144], 
the excitation energy, the time-scale of excitation and the pre-excitation internal 
energy of the ion [142] (and hence also the ionisation technique). While certain 
enhanced cleavages are observed, such as on the N-terminal side proline and on the 
C-terminal side of aspartate and glutamate [145], the fragmentation in vibrational 
excitation techniques is in general too dynamic to be totally predictable. 
1.4.3 Electron capture dissociation 
1.4.3.1 Hot hydrogen re-arrangement mechanism 
The dissociation mechanism in electron capture dissociation (ECD) in 
contrast to the vibrational excitation techniques is believed to be non-ergodic [30]; 
i.e. dissociation occurs prior to energy randomisation in the molecule. This implies 
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that the dissociation occurs on a very fast time-scale (< ips). Evidence supporting the 
non-ergodic mechanism of ECD are the fact that the peptide backbone N-C is 
broken preferentially in favour of more labile side-chain groups [31-34] and that 
even non-covalent intermolecular bonding is conserved in the presence of ECD 
[146]. Ab initio calculations by Carpenter have shown that the whole recombination 
energy must be contained in a small molecular region in order to account for NCa 
bond cleavage, suggesting non-ergodic behaviour [127]. 
The capture of an electron by a peptide cation leads to a reduction of the 
charge by one to give rise to the reduced odd-electron species [M+nH] 1 ' (see 
Scheme 1). This implies that the charge of the protonated species needs to be at least 
2+ in order to detect a charged reduced species. 
[M+nH] + e -+ [M+nH] 1 	 Scheme 1.1 
The capture of an electron is an exothermic process which is dependent on 
the recombination energy (see Figure 1.13) [147]. The total energy released upon 
electron capture is approximated to be on the order of 4-7 eV, depending mainly on 
the proton affinity (PA) of [M+(n-1)H]', since the hydrogen atom affinity is 
generally small (< 1 eV). The energy gain is sufficient to cleave any bond in the 
molecule (typical bond strength 3-4 eV). 
+ H + e 
PA 	
IIE(H)=13.6eV 
[M+nH] + e 
RE 
[M+(n-1 )H]( 1 ) + ft 
[M+nH](h11!ilA/'HA 
Figure 1.13 Thermodynamic cycle of ECD, showing recombination energy (RE), 
proton affinity (PA), ionisation energy of H atom (LE) and hydrogen atom affinity 
(HA). Adapted from [147]. 
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McLafferty and co-workers postulated the hot hydrogen re-arrangement 
mechanism to explain how electron capture would give rise to backbone dissociation 
[127]. The mechanism works on the premise that a peptide cation captures a slow 
electron (<0.2 eV) at the site of protonation, giving rise to a 'hot hydrogen' H ( 6 
eV) [148]. This hydrogen radical can then be re-captured at a high hydrogen radical 
affinity site, such as a backbone carbonyl, to induce backbone alpha-cleavage (Figure 
1.14) [30]. As can be seen in Figure 1.14 the c fragment ion contains an additional H, 
which explains the fact that it is I Da higher in mass than predicted from the residue 
masses. Kjeldsen et al. suggested a new notation for these fragments, c' and z [149], 
which will be used throughout this thesis to avoid confusion. Another piece of 
evidence in favour of the hydrogen radical transfer is the loss of 1 Da from the 
reduced species, which can only be explained by the loss of a hydrogen radical 
(hydrogen atom desorption). The preferential cleavage in ECD of the NCa bond 
resulting in c' and f ions also explains why no ECD cleavage is observed on the N-
terminal side of proline. 
RA
0 	 OH 	
OH 
NCH 	 RNH 	 RNH + •CR 
Figure 1.14 Schematic showing hot hydrogen re-arrangement mechanism with 
subsequent radical backbone alpha-cleavage resulting in c' and z fragment ions. 
Additional H on c fragment marked in red (H) explaining the fact that c fragment 1 
Da higher in mass than predicted from residue masses of amino acids. Adapted from 
[127] and [149]. 
McLafferty and co-workers also observed high cleavage efficiencies of 
cysteine bridges (i.e. disulphide bridges) (see Scheme 1.2) [127]. Ab initio 
calculations gave higher hydrogen radical affinities for CH3SSCH3 than 
CH3CONHCH3, supporting the 'hot hydrogen' re-capture hypothesis. 
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R-S-S-R' + H' - R-S-H + SR' 
	
Scheme 1.2 
More minor fragment ions that are observed in ECD include a and y ions 
(see Figure 1.15), which can be rationalised by hydrogen atom transfer to an amide 
nitrogen atom. Incidentally, hydrogen atom transfer to a nitrogen atom on the 
backbone, instead of a carbonyl oxygen, has been put forward by Zubarev and co-
workers as a alternative mechanism to explain NCa bond cleavage [150]. 





R N 	 NH 	 R' + C 	+ 2HNCHR'- H 2 
H 
a 	 y 
Figure 1.15 Proposed reaction schematic for a and y ion formation in ECD [127]. 
Other unusual lower abundance fragments, such as c and z' have been been 
observed by a number of groups [32,127,148,151,152], and have been rationalised by 
hydrogen atom transfer to a C [148]. 
Another phenomenon in ECD are neutral losses from the reduced species that 
have been linked to cleavages of particular amino acid side-chains [153,154]. Such 
neutral losses can give information about the presence of certain amino acids, which 
is particularly useful in cases where the sequencing is incomplete. This information 
can also be useful when there is ambiguity about N or C-terminal fragments. 
A review of the understanding of the ECD mechanism has been given by 
Zubarev and co-workers [150] in a historical context of related fragmentation 
techniques such as dissociative recombination [155], neutralisation-reionisation 
[156] and electron impact excitation of ions from organics (EIEIO) [157]. Many of 
the assumptions made in the hot hydrogen re-arrangement mechanism are based on 
empirical evidence from observed fragments and ab initio calculations. However, no 
direct empirical evidence exists for the hot hydrogen re-arrangement mechanism, 
which may be difficult to obtain if the mechanism is as fast as assumed. 
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1.4.3.2 Other ECD mechanisms 
It is likely that other reaction pathways compete against the hot hydrogen re-
arrangement mechanism in ECD. The cleavage at disulphide bridges for example 
has also been rationalised by direct dissociative electron capture [127]. Hudgins et al. 
[158] have shown that fully deuterated peptides and sodiated peptides give rise to 
backbone cleavage upon electron capture. While this observation does not disprove 
the hot hydrogen re-arrangement mechanism, it opens up the possibility of other 
mechanisms. A comparison of doubly protonated versus doubly sodiated polyglycol 
ions showed less fragmentation for the sodiated species [159], which is consistent 
with a lower recombination energy for sodiated ions than for protonated ions. 
O'Connor and co-workers have shown that ECD for cyclic peptides gave rise 
to amino acid losses, which can only be explained by two backbone cleavages to 
have taken place upon one electron capture [160]. Two backbone cleavages are also 
thought to give rise to a' and y fragment ions (see Figure 1.15). It remains to be seen 
whether two (or more) backbone cleavages are a dominant process in ECD or 
whether this is a low abundance dissociation channel. 
The non-ergodic mechanism in ECD is subject of some controversy. Since an 
FT-ICR MS experiment is much too long (100's ms - s) to establish a kinetic profile 
of the reaction, ECD has been investigated by quantum mechanical molecular 
modelling. Uggerud and co-workers have shown using ab initio calculations for 
model pepides that a fast ECD mechanism (< 10-12  s) may apply for a minority of 
ions (10%), while the majority of ions are subject to a much slower mechanism 
(10 s) [161]. Their calculations also indicate that disulphide bond cleavage 
proceeds without an activation barrier in the presence of a hydrogen atom [161]. Ab 
initio calculations by Tureek and co-workers have also shown that N-C, bond 
cleavage may not have to be non-ergodic and their predicted unimolecular rate 
constant is -105 s_ I [162], which is in agreement with Uggerud and co-workers (see 
above). Further, electron location on the backbone carbonyl carbon (see Figure 1.14) 
causes a weakening of the NCa bond [162], which has also been confirmed by ab 
initio calculations by Konishi et al [163]. Calculations on protonated GlySer gave an 
estimated recombination energy of electron capture of 66.66 kcal mol' (278.91 KJ 
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mold , 2.89 eV) through Franck-Condon factor (i.e. no atomic movement), whereas 
the N-C bond cleavage transition state was estimated at merely 6.6 kcal moF' (27.61 
KJ moF', 0.286 eV) [163]. In comparison, a typical N-C bond energy in the ground 
state is approximately 300 kJ moL' ( 3 eV). 
In these ab initio calculations, hydrogen bonding between the protonated site 
(e.g. basic site on amino acid side-chain of arginine, histidine or lysine) and a 
backbone carbonyl oxygen is thought to play an important part in explaining the 
hydrogen atom transfer [163]. In fact, ab initio calculations by Tureek and co-
workers have predicted unimolecular rate constants for this transfer as high as 1012  s 
[164]. Although, their current belief is that the electron moves along the chain to 
the carbonyl carbon, whereas the proton is transferred separately from the protonated 
site to the backbone carbonyl oxygen [165]. This separate electron and proton 
transfer, resulting in effective hydrogen atom transfer, was first suggested by 
Siegbahn et al. [166]. 
While ab initio calculations may be able to explain the ECD mechanism in 
terms of an ergodic mechanism, all quantum mechanical calculations suffer from the 
limitation of calculating energy levels at ground electronic states. When the electron 
is initially captured, this may occur in a high-lying electronic Rydberg state, in 
analogy to dissociative recombination [167], which is the current view of McLafferty 
and co-workers. Nevertheless, how the electron relaxes from this Rydberg state to 
lower electronic states and how the electronic recombination energy is transferred 
into nuclear motion to induce backbone cleavage cannot be accurately modelled even 
by state-of-the-art quantum mechanical calculations. Hence, the controversy about 
mechanisms in ECD is likely to go on for some time. 
1.4.3.3 Other electron-mediated dissociation techniques 
By varying the kinetic energy of the electrons it is possible to explore other 
ion-electron reactions, which have been pioneered largely by Zubarev and co-
workers. The electron capture cross-section is maximised for low-energy electrons (< 
0.2 eV), but has a local maximum around 7 eV [149]. Such a kinetic energy regime 
for the electrons has been termed as 'hot electron' capture dissociation (HECD) 
[149]. Electron excitation dissociation (EED) [168] has been proposed for singly- 
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charged species and electron detachment dissociation (EDD) [169] has been applied 
to multiply deprotonated peptides (peptide anions). The applicability of these 
electron-mediated dissociation techniques for polypeptides, the required electron 
kinetic energy and their general fragmentation behaviour are summarised in Table 
1.3. Reactions of polypeptide ions with electrons in the gas-phase have also recently 
been reviewed by Zubarev [170]. 
Name Abbreviation Ions e kinetic Fragments energy (eV) 
Electron Capture 
Dissociation ECD 2+ <0.2 c' and z 
Hot Electron 
Capture Dissociation HECD 2+ 7-10 All fragments 
Electron Detachment a, a-, x, x-, c 
Dissociation EDD ~ 2- >20 and z 
Electron Excitation Fast and 
Dissociation EED 1+ slow 6 a,c
, and z 
Table 1.3 Table summarising electron-mediated dissociation techniques for 
polypeptides proposed by Zubarev and co-workers, adapted from [171]. 
1.4.3.4 ECD of proteins 
The 'top-down' approach of sequencing whole proteins has been proposed by 
McLafferty and co-workers as a more efficient way to identify proteins [172,173]. 
The common 'bottom-up' approach involves enzymatic digestion of the protein 
followed by mass spectrometric analysis [22]. The disadvantage with the 'bottom-up' 
approach is that one cannot be sure how large the whole protein was before 
digestion. If a peptide fragment carrying a post-translational modification is not 
detected in the enzymatic digest mass spectrum, this information is lost. Further, 
tandem mass spectrometry of whole proteins requires very little sample (< 1017 mol) 
[47] and is therefore very sensitive. 
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ECD of peptides generally gives different sequence information to vibrational 
excitation techniques, and hence both sequencing techniques can be highly 
complementary [151]. Given the fact that b and c fragmentation at the same residue 
gives fragments that are 17.03 Da different in mass, whereas y and z fragmentation 
at the same residue gives fragments that are 16.02 Da different in mass, it would thus 
be possible to get information on which fragments are N or C-terminal. This is of 
particular interest in de novo sequencing and hence this approach has been termed 
the 'golden complementary set' for sequencing [174]. 
The challenge for ECD to sequence proteins is that non-covalent interactions 
may hold the molecule together, thus yielding no sequence information. In order to 
break non-covalent interactions McLafferty and co-workers used vibrational 
excitation prior to ECD, which they termed 'in beam' or 'activated-ion' ECD (Al 
ECD) [175]. 
A very interesting application of ECD has recently been pursued by 
McLafferty and co-workers to investigate the folding of protein ions. Since more 
extensive non-covalent bonding in the molecule results in fewer ECD fragment ions, 
the temperature-dependent folding of protein ions can be studied [99,176]. The 
extent of hydrogen atom desorption has also been shown to be linked to how 'open' 
the gas-phase structure of the protein is [177]. Nevertheless, the higher hydrogen 
atom desorption for a higher charge state (13+ charge state as opposed to 7+ charge 
state for bovine ubiquitin, see [177]) could also be due to a higher recombination 
energy, due to a decreased proton affinity for the higher charge state, as argued by 
Zubarev [170]. Hence, these results may be open to multiple interpretation and more 
fundamental work needs to be carried out before using ECD as a tool to investigate 
gas-phase structure of ions. 
Breuker and McLafferty have recently observed ECD-type c and y fragments 
in electrospray ionisation spectra of cytochrome c. This protein carries a heme group 
with iron (III) and since no electrons were used to effect electron capture, the authors 
have postulated that an electron transfer takes place in the protein, resulting in ECD. 
Breuker and McLafferty have named this phenomenon 'native electron capture 
dissociation' (NECD) [178]. The relative yield of c and y fragments was found to 
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increase with increasing cytochrome c concentration and decreasing pH, which 
Breuker and McLafferty have rationalised by dimer formation and asymmetric 
charge partitioning between the dimer parts, as observed by Jurchen and Williams 
[179]. Breuker and McLafferty believe that the charge asymmetry on the dimer may 
be the driving force for the proposed electron transfer, resulting in NECD. 
1.4.3.5 Relative fragmentation 
ECD is believed to give more extensive sequence coverage than vibrational 
excitation techniques [148,180]. While higher cleavage efficiencies have been 
reported at the C-terminal side of tryptophan and lower cleavage at the N-terminal 
side of cysteine, the cleavage efficiencies in ECD have been found to be more 
homogeneous than for CAD [180]. Budnik et al. have proposed that ECD is a more 
'reducible' fragmentation technique, which means that the cleavage efficiency is 
related to the immediate chemical vicinity and not to the rest of the molecule [181]. 
In practical terms, this implies that the relative cleavage efficiency in ECD does not 
depend on the molecular size of the peptide, the charge state, the basicities of the 
protonated sites or the gas-phase conformation of the peptide (i.e. gas-phase 
structure). 
This assumption only holds true in the absence of hydrogen bonding. In fact, 
as mentioned before, ab initio calculations by Tureèek and co-workers have 
indicated that a one-step transfer of the hydrogen atom to a backbone carbonyl would 
be preferred over the two-step process (hydrogen atom desorption followed by re-
capture) as proposed by McLafferty [164]. The predicted rate constants for this one-
step process were as high as 1012 I• This implies that hydrogen bonding of the 
protonated site to particular backbone carbonyls would result in enhanced transfer. 
One of the primary aims of this thesis is to investigate the relative cleavage 
efficiency in ECD and to compare this to structures modelled using the Amber force 
field model. 
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Chapter 2 
Experimental set-up and preliminary 
results 
2.1 Introduction 
The elemental constituents of a Fourier transform ion cyclotron resonance 
mass spectrometer (FT-ICR MS) are a strong magnet, an ultra-high vacuum, an ICR 
cell and an advanced data processing station [1]. Magnetic fields have historically 
been widely used in mass spectrometry and every mass spectrometer needs an 
advanced data processing station. The features that make FT-ICR MS truly unique 
compared to other mass spectrometric techniques are the non-destructive detection 
and the very long ion trapping times that can be achieved (hours). 
Whereas historically ions were made inside the ICR cell mostly by electron 
ionisation (El) [2], nowadays the ionisation is generally performed external to the 
magnetic field. There are multiple advantages to external ion generation, including 
easier sample introduction, easier changeover between different ionisation techniques 
and the fact that the most popular ionisation methods these days, electrospray 
ionisation (ESI) [3] and matrix-assisted laser desorption ionisation (MALDI) [4,5], 
operate on pressures which are incompatible with those required in the ICR cell 
during excitationldetection. The difference in pressure (ESI - atmospheric pressure; 
intermediate pressure MALDI - 10-3 atm) constitutes an engineering challenge which 
has been overcome by the use of multiple pumping stages. 
In this Chapter the two FT-ICR MS instruments employed in this work are 
described. Preliminary electron capture dissociation (ECD) data obtained are 
presented, as well as the method used to optimise the parameters to carry out ECD on 
these instruments. An investigation of the electron kinetic energy distribution from a 
rhenium filament and an indirectly heated dispenser cathode is shown. The aim of 
this Chapter is to show how 'purer' ECD mass spectra (i.e. ECD spectra showing 
abundant peaks due to electron capture dissociation and minimising fragments from 
other fragmentation processes such as vibrational excitation) can be achieved. 'Pure' 
me 
ECD spectra are a prerequisite for mechanistic studies of ECD, which are discussed 
in Chapter 3. 
2.1.1 3 Tesla Apex II Bruker FT-ICR MS 








Figure 2.1 Diagram of Bruker Daltonics FT-ICR MS set-up.' 
pumping stages. 
Arrows indicate 
Figure 2.1 shows a diagram of the experimental set-up of the 3 Tesla 
passively shielded APEX II Bruker Daltonics (Billerica, MA, USA) FT-ICR MS 
instrument equipped with an electrospray ionisation source (Analytica, Branford, CT, 
USA). The ions are formed at atmospheric pressure, then pass through a heated glass 
capillary with both ends metallised. This capillary (length 180 mm, ID 0.3 mm) also 
limits the leak to atmosphere of the first roughing stage, where the pressure is 
measured to be 0 mbar. Ions are accumulated in a storage hexapole located in the 
source chamber (at a pressure of 5x 10-6  mbar), prior to pulsed transfer to the ICR 
detection cell (analyser stage). This is located in the homogeneous region of the 3 T 
super-conducting magnet and is at the ultra-high vacuum, measured to be < 10 10 
mbar in optimal conditions. 
In between the source chamber and the analyser stage is the transfer stage 
which is made up of electrostatic lenses. In this region the ions are accelerated to '-3 
'Diagram taken from Bruker Daltonics BioApex handbook. 
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3 Tesla magnet 
ESI source. 
keV and then focused using an Einzel lens [6]. The reason for focusing the ions is to 
overcome the magnetic mirror effect [7] which occurs in the fringing magnetic field 
and applies a force opposite to the direction of travel (z direction, see Figure 2.3). 
This effect is minimised when the ions enter the fringing field tangent to the 
magnetic field lines. Given the requirement for low trapping plate voltages (< 1V) in 
the ICR cell in order to achieve high resolution, the kinetic energy of the ions needs 
to be finely adjusted in order to be able to trap them. Other instrument manufacturers 
(e.g. lonSpec, Irvine, CA) use multipole ion guides to focus the ions in [8], which 
arguably allow simpler tuning of the ion transfer. 
Figure 2.2 Picture of 3 Tesla Bruker Daltonics FT-ICR instrument. 
- 	- 
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Figure 2.2 shows a picture of the 3 Tesla instrument showing the 
superconducting magnet (Magnex, Oxford, UK) and the vacuum cart equipped with 
the ESI source. A syringe pump (Cole Parmer, IL, USA) used for ESI can be seen in 
the centre of the image. The vacuum cart can be wheeled in and out of the magnet 
bore allowing access to the ICR cell. The vacuum pumps consisting of rotary vane 
pumps and turbomolecular pumps (Edwards, West Sussex, UK) are contained inside 
the cart. The vacuum pressure displays can be seen on the right-hand-side of the 
vacuum cart. 
Figure 2.3 Picture of ICR InfinityTM cell. 
The gold-plated ICR InfinityTM cell [9] is shown in Figure 2.3. Ions enter 
through the aperture of the trapping plate PV1; the second trapping plate PV2 is not 
visible on this picture. The cell dimensions are 60 x 60 mm (a ruler and a 5 pence 
coin are included in this picture to represent dimensions). By applying a DC voltage 
of the same sign as the ions (e.g. +1V for positive ions) the ions are trapped in the 
direction of the magnetic field B (z direction, see Figure 2.3). The Infinity TI  cell 
derives its name from the fact that its electrostatic trapping plates are segmented with 
the intention of tricking the ions into believing to be in an infinite cell. The ICR cell 
is mounted on a flange on the rear side of the instrument. 
52 
2.1.2 9.4 Tesla Bruker APEX III FT-ICR MS 
The 9.4 Tesla actively shielded APEX III FT-ICR MS is in many ways 
similar to the 3 Tesla instrument described above. Until recently 9.4 Tesla was the 
highest commercially available super-conducting magnet for FT-ICR, although a 
14.5 Tesla magnet has been installed at the National High Magnetic Field Laboratory 
(NHMFL, Tallahassee, FL, USA). 
This 9.4 T APEX III instrument (as opposed to the 3 T instrument) is 
equipped with an Apollo electrospray ionisation source (Bruker Daltonics, Billerica, 
MA, USA), which has superceded the Analytica ESI source. The Apollo source 
enables easier cleaning of the skimmer and glass capillary (length 180 mm, ID 0.2 
mm). Further, switching between syringe infusion ESI, nanospray and atmospheric 
pressure chemical ionisation (APCI) can be achieved on the same ion source by 
simply exchanging the inlet door. Another ionisation source that can be fitted onto 
this instrument is a Scout 100 MALDI source, which includes a storage hexapole 
where the MALDI generated ions are cooled and ions from multiple laser shots can 
be accumulated prior to transfer to the ICR cell [10]. 
Due to a limiting digitisation rate of 10 Mhz, the highest cyclotron frequency 
that can be detected is 5 MHz according to the Nyquist criterion (section 1.3.2, 
Chapter 1). For the 9.4 T magnet instrument this means that the lowest mass-to-
charge ratio (m/z) that can be detected is 28.5, which compares to a lowest m/z of 
9.5 on the 3 Tesla instrument. The highest m/z is theoretically unlimited, but since 
the mass resolution decreases linearly with m/z, even on a 9.4 T magnet ions of m/z> 
15,000 are impractical to mass analyse. 
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2.2 Pulse sequence 
The complex design of an FT-ICR instrument and the relatively long time 
scale of FT-ICR mass measurement (100's ms - seconds) allows for a sequential 
treatment of the events of the experiment. A screen-shot of the experimental 
sequence in the XmassTM  software for an ECD experiment is shown in Figure 2.4. A 
representative time-frame of a typical ECD experiment is shown in Figure 2.5, 
indicating the typical length of each event for the APEX III 9.4 T FT-ICR MS 







Figure 2.4 Experimental pulse sequence in XmassTM  software. 
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Figure 2.5 Schematic showing time frame of typical ECD experiment on APEX III 
9.4 T FT-ICR MS instrument. 
Empty ESI source/Empty ICR cell. After each detection pulse cycle any 
remaining ions are expelled in order to make way for a new batch of ions. To this 
effect, the trapping plates are set to +10 and —10 V respectively. The storage 
hexapole is purged of ions by applying a quench pulse; this is to prevent ion 
fragment products to form in the hexapole. 
Raise trap potential. The initial ICR trapping potential are set to typically 3V 
on the rear trapping plate (PV2) and 2V on the front trapping plate (PV1). These 
settings were shown to enable efficient trapping of ions and to be more robust from 
day-to-day variations in the electrostatic voltages in the ion transfer optics. 
Hexapole accumulation. Ions are accumulated in a storage hexapole for a 
duration of typically 600-1000 ms. This hexapole is suitable to store ions up to a m/z 
<5000. 
Ion Generation. Ions are extracted from the hexapole by a pulsed switching 
of the hexapole trapping plate voltage (e.g. + 20V for positive ions) to an extraction 
voltage (e.g. —10 V for positive ions) for a length of time (typically 1200-3000 ps). 
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Presumably, only 10% of the ions contained in the hexapole are extracted this way, 
due to the low electric field penetration of the trap/extract plate into the hexapole. 
Marshall and co-workers have used an octapole with DC rods which causes a 
constant voltage drop along the length of the multipole, thereby increasing their 
extraction efficiency from the octapole over 10-fold [11]. During the ion extraction 
time, the ion packet travels through the ion transfer optics and the fringing magnetic 
field into the ICR cell where trapping occurs. In order to facilitate trapping, a pulsed 
gas (e.g. argon, 106  mbar) can be applied to collisionally cool the z-direction 
velocity of the ions. The application of a cooling gas requires a pump-down delay 
(typically 1-5 seconds), which lengthens the experimental time frame of the 
experiment and is therefore not used. Alternatively, the Sidekick TM  trapping method 
[12] can be employed, which consists in deviating the ion path laterally (xy direction, 
see Figure 2.4) by applying a voltage gradient between two electrode plates at the 
entrance of the ICR cell (EV2a and EV2b). The effect of this Sidekick TM  is to 
decrease the z-direction velocity of the ions, effectively spreading out the ion beam 
into xy. Hence, Sidekick TM  trapping comes at the price of increasing the magnetron 
radius of the ions, which can adversely affect resolution and sensitivity. 
Isolation. An ion of interest can be mass isolated by applying a sweep 
isolation pulse on the excitation plates that does not include the frequency of the ions 
to be isolated. The isolation sweep generally starts at high frequency (i.e. low m/z) 
and then proceeds to low frequency at a defined frequency step (parameter XBB, 
normally set to 100), with a 'notch' at the frequency of the ions of interest (i.e. that 
should not be ejected). The dwell time for each frequency and the excitation 
amplitude define the shape of the excitation sweep, which can be visualised by doing 
a 'Wavedetect' experiment (simultaneous excitation and detection). The parameter 
'ejection safety belt' (parameter JBB, typically 2000 Hz) determines how close the 
ejection sweep gets to the cyclotron frequency of the ions of interest. At low values 
of JBB (< 1000 Hz) off-resonance excitation of the ions of interest can occur, 
causing these ions to be taken from the centre of the cell. 
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Lower trap potential. The trapping plate voltages are reduced to 1V on both 
plates in order to increase the mass resolution that can be achieved .2 
Fire ECD. Electron irradiation is effected by pulsing a bias voltage in order 
to cause spontaneous electron emission from the electron filament (3 T, APEX II) or 
the dispenser cathode (9.4 T, APEX III) (more detail see section 2.3.4). In order for 
electron capture dissociation (ECD) [13] to take place the ion cloud should be near 
the central axis of the ICR cell. This implies low values for Sidekick TM  trapping and 
'careful' isolation. Further, electron capture is maximised for low kinetic energy 
electrons (< 0.2 eV). A study of the electron kinetic energy distribution is shown in 
section 2.3.4. 
Excitation. When applying a radiofrequency (rf) voltage on both excitation 
plates (dipolar excitation) of the same frequency than the cyclotron frequency the 
cyclotron radius is enhanced to a detectable radius (see Chapter 1 for theory). By 
applying a frequency sweep, the cyclotron radii of all ions are excited. The excitation 
stage is in fact very similar to the isolation stage, only this time the ions are not 
excited beyond the cell geometry. 
Detection. As a result of the dipolar excitation, ions of a particular m/z 
cyclotron as a coherent ion packet, causing an induced current on the detection 
plates. Due to collisions of this ion packet with background gas de-phasing of the ion 
packet occurs, which results in an exponential decay of the time-domain ICR signal. 
In order to observe long transients long mean free paths are critical, which requires 
an ultra-high vacuum (< 10 mbar). 
The induced current signal is amplified and then digitised (using an analogue-
to-digital converter), which is Fourier transformed to deduce the individual 
frequencies that make up the time-domain ICR signal. The frequency spectrum is 
then converted to a mass-to-charge spectrum based on the fundamental equation for 
cyclotron frequency (see Equation 1.1, Chapter 1). Calibration of the mass spectra is 
2 
Note that for the APEX II 3 T FT-ICR MS instrument the trapping voltages were always lowered to 
< lv (typically 0.1 V) (more detail see section 2.3.2.2). 
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performed with the 'Ca12' procedure in the XmassTM  software, which is based on the 
equation developed by Ledford et al [14]. 
2.3 Preliminary results 
2.3.1 Peptide fragmentation 
As described in Chapter 1 (section 1.6), three distinct peptide backbone bonds 
exist where cleavage can occur: the Ca-C bond, the peptide bond C-N and the NCa 
bond (see Figure 1.9, Chapter 1). Of these the peptide bond is generally the weakest 
and in collisionally activated dissociation (CAD) [15], of which SORT CAD [16] is 
one example, b and y fragments are most abundant. Conversely, in electron capture 
dissociation c and z fragments are generally the most abundant fragments. Whereas 
cleavage in SORT CAD occurs due to a gradual increase in the vibrational energy 
levels in the molecule, the mechanism in ECD is believed to be non-ergodic (i.e. 
dissociation before energy randomisation). ECD experimental pulse sequences are 
configured to minimise other dissociation processes (such as vibrational excitation), 
with the intention of studying the mechanistic processes in ECD. Mechanistic aspects 
of ECD are discussed in Chapter 3. 
2.3.2 Electron capture dissociation with rhenium filament 
The polypeptides in this study were obtained from Sigma-Aldrich (unless 
specified otherwise) and were electrosprayed by syringe infusion (flow rates 80-120 
j.il/hr) at concentrations 10-100 1tM in H20/MeOH/CH3CQOH (49:49:2). In order to 
carry out ECD experiments one requires a source of electrons, which is generally an 
electron filament. Alternatively, a laser could be used to emit electrons from a metal 
plate through the photo-electric effect. Incidentally, the first time ECD was observed 
it was falsely ascribed to photo-fragmentation, when actually the 193 nm laser 
employed caused emission of electrons, thereby inducing ECD [17]. However, the 
current intensities from a filament are much higher and hence it is more convenient 
to use. Further, most commercial FT-ICR instruments are already equipped with an 
electron filament; our 3 Tesla instrument is fitted with a rhenium filament located at 
a distance of 13 cm from the rear trapping plate (see Figure 2.6). This filament is 
normally used for carrying out electron ionisation (El) inside the detection cell, 
z 
which is a good predictive tool to check that the excitation and detection work when 
trouble-shooting the instrument. Whereas El experiments are performed with 
electrons at relatively high kinetic energy (e.g. 70 eV), ECD requires the use of low-
energy electrons (i.e. < 1 eV). 
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Figure 2.6 Schematic diagram of electron filament, ICR cell and the Einzel lens 
elements FOCL2, PL9 and FOCL1. B0 indicates direction of magnetic field. Note 
that the electron gun and the ICR cell are located inside the strong magnetic field, 
whereas the Einzel lens elements are in the fringing field. 
The rhenium filament (ca. 5 mm x 0.038 x 0.51 mm Re ribbon, resistance 
0.09959 Ohm/cm) was operated at a current of 3 A, which is equivalent to a voltage 
drop of 2 V. When pulsing the filament to emit electrons a voltage U (range —0.48 to 
+0.65 V) was applied to one side of the filament. As a consequence of the potential 
drop across the filament, a voltage U (U = U + 2 V) was measured on the other 
side of the filament. The emitted electron beam passes through the central axis of the 
ICR cell. A more detailed account of the kinetic energy distribution of electrons 
emitted from this filament is given in section 2.3.3. 
2.3.2.1 Static trapping 
The initial set-up of the 3 Tesla instrument did not allow for the trapping 
voltages to be altered during the experiment. Hence these experiments were run at 
static trapping voltages of 0.5 V. Trapping voltages of 1 V or higher did not result in 
successful ECD experiments, whereas lower trapping voltages than 0.5 V do not 
permit trapping of the ions. Another prerequisite for ECD to occur, is that the ion 
cloud and the electron beam need to overlap, which is why no Sidekick TM  trapping 
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was employed in these experiments. No pulsed gas was employed to collisionally 
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Figure 2.7 ECD mass spectrum of substance P in the 2+ charge state. Electron 
irradiation time 1 s; 40 time-domain transients (512 kb) were co-added to generate 
this mass spectrum.3  
Electron irradiation of the mass isolated doubly protonated form [M+2H]2 of 
substance P (MW 1347.6, Sigma Aldrich) gave rise to the ECD mass spectrum 
shown in Figure 2.7. The capture of one electron without resulting fragmentation 
leads to the reduced odd electron species [M+2H] at a m/z double of the isolated 
precursor ion. Evidently, at least doubly protonated species are necessary to perform 
ECD experiments on, since otherwise no charged fragments can be observed in the 
mass spectrum. A series of c fragments is observed in this spectrum, which can be 
rationalised from the fact that the charge-carrying arginine residue is located at the 
N-terminus of the molecule. The lowest abundance c fragment is c8 , with a S/N ratio 
of 10. Two b ions are also present in this spectrum, suggesting that other activation 
mechanisms took place. As a result, this spectrum does not qualify as a 'pure' ECD 
spectrum. 
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An attempt was made to optimise the experimental parameters of electron 
injection to obtain better ECD. The bias of the filament voltage U, which is also 
applied to the repeller plate (see Figure 2.6), determines the kinetic energy of the 
electrons. Hence, fine tuning of U should lead to better electron capture. Figure 2.8 
shows the ECD fragment efficiency for the 2+ charge state of substance P as a 
function of the filament voltage U [18]. A third order polynomial function gave an 
adequate fit to this data set and the maximum c fragment abundance is determined to 
be at a value of U of 0.52 V. 
Filament voltage U-, V 
Figure 2.8 ECD fragment efficiency for substance P as a function of filament 
voltage U. The ECD fragment efficiency is calculated by adding the ECD fragment 
peaks c4 to c10 , and normalising with respect to the mass spectrum with the highest 
total abundance of c fragments. 
ECD of bee venom melittin (MW 2845.5, Sigma Aldrich) was also attempted 
with these very similar optimised parameters (U = +0.65 V). Electron irradiation of 
the most abundant charge state, 4+ [M+4H]4 , gave rise to the ECD mass spectrum 
in Figure 2.9. The conversion efficiency of the precursor ion [M+4H]4 to fragment 
ions is much reduced in this spectrum, compared to the ECD mass spectrum of 
substance P (Figure 2.7). According to Coulombic attraction of charges, the electron 
capture cross-section should increase by z2, z being the charge on the electron-
capturing cation, and hence one would expect better electron capture. However, the 
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the overlap between the ion cloud and the electron beam, which may not be the same 
in this experiment than for ECD of substance P. For larger species the number of 
fragmentation channels is greater and hence the S/N ratio for individual fragment 
peaks is reduced. A total of 17 fragment ions are observed in this spectrum, as well 
as typical neutral losses expected in ECD, such as hydrogen atom desorption, 
ammonia and arginine side-chain losses [19,20]. The mass resolution of the reduced 
species [M+4H]3 and the fragment peaks in this spectrum is 8000. Hence, the 
mass resolving power of the 3 Tesla instrument is adequate to unit mass resolve ECD 
fragment ions of polypeptides. ECD of the 4+ charge state of bovine insulin B chain 
(MW 3495.9, Sigma Aldrich) gave 13 (out of 29 possible) backbone cleavages [18]. 
However, irradiation times of 5 s needed to be employed and 200 time-domain 
transients were co-added, resulting in a total experimental time of 23 minutes. ECD 
of the 7+ charge state of bovine ubiquitin (MW 8564.9, Sigma Aldrich) only yielded 
very limited fragmentation even for 200 scans. This implies that this 3 Tesla FT-ICR 
MS is suitable for ECD of polypeptides of molecular weights up to 3.5 kDa, but not 







600 	800 	1000 m/z 1200 
	
1400 	1600 
Figure 2.9 ECD mass spectrum of melittin in the 4+ charge state. Electron 
irradiation time was 1.5 s and 100 time-domain transients (512 kb) were co-added to 
generate this spectrum. The insert shows an expansion of the reduced species 
[M+4H]3 . Asterisks denote artefact peaks. 
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2.3.2.2 Dynamic trapping 
A hardware upgrade to the 3 Tesla instrument permitted ramping of the 
trapping plate voltages during the experiment (ICC controller). Given the experience 
that lower trapping plate voltages resulted in better ECD mass spectra, the attempt 
was made to reduce the trapping plate voltages as low as possible. By slowly (100-
250 ms) ramping the trapping plate voltages from initially 3 V (PV2) and 2 V (PV1) 
the voltages for both trapping plates could be reduced to 0.1 V while still trapping a 
large number of ions. The mass isolation sweep was carried out after ramping down 
the voltages, followed by electron irradiation. Optimised parameters for U were 
again used in the range found to be optimised before. 
Figure 2.10 shows the ECD mass spectrum of the 2+ charge state of a variant 
of the luteinizing hormone releasing hormone (LHRH, MW 1312.5). A series of z 
fragments (z3 to z9 ) can be seen in this spectrum. This mass spectrum exemplifies 
the use of ECD as a tool for de novo sequencing [22]. The mass differences between 
the z fragment peaks accounts for 6 consecutive amino acids that are sequenced 
without even having to know the peptide sequence. The S/N ratio of the fragment 
peaks is high, supporting the assumption that lower trapping plate potentials during 
electron irradiation lead to better ECD spectra. Further, peaks due to other 
fragmentation processes, such as vibrational excitation, are minimised in this 
spectrum. This spectrum reflects a 'purer' form of an ECD spectrum, which could be 
used to study the mechanistic processes in ECD. 
The experimental parameters for the 3 Tesla instrument seem to be optimised 
well enough under these conditions to attempt more difficult problems. A study by 
Chan et al. [23] on their 4.7 Tesla FT-ICR instrument showed that they obtained 
good quality ECD spectra by short pulse (50 ms) electron irradiation and that 
employing a cooling gas improved the S/N ratio of the fragment ions. Such a strategy 
only worked on the 3 Tesla instrument in some isolated cases and hence it appears 
that different instruments may require different strategies of optimisation. 
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Figure 2.10 ECD mass spectrum of LHRH in the 2+ charge state. Electron 
irradiation time is 200 ms and 50 time-domain transients were co-added to generate 
this mass spectrum. 
The ECD mechanism, in contrast to the heating techniques (e.g. SORT CAD, 
IRMPD, BIRD), is believed to be non-ergodic. This means that backbone cleavage 
occurs before energy randomises in the molecule, whereas fragmentation in the 
heating techniques takes place when the molecule is highly vibrationally excited. 
One would therefore assume that ECD is less likely to lose weakly bound groups in 
the fragmentation process. Recently, interest has grown in ECD as a tool to identify 
and localise post-translational modifications [24-28]. Many of these modifications, 
and in particular glycosylations, are more weakly bound and could hence be lost in 
harsher fragmentation conditions. For N-glycosylations [29] a consensus sequence 
exists, which allows such sites to be predicted from the protein sequence; this does 
not apply to O-glycosylations, which makes them a more useful target for ECD. 
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Figure 2.11 shows the ECD mass spectrum of the doubly 0-glycosylated 
peptide fragment TAP254 (MW 2793.0). 0-glycosylations occur on threonine (T) 
and serine (S) residues. Here it was possible to identify and localise the glycosylation 
sites, since cleavage on either side of the modified threonine residues was achieved. 
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Figure 2.11 ECD mass spectrum of TAP25 carrying two GaINAc groups in the 3+ 
charge state. Electron irradiation time 1 s (100 scans). Insert shows addition of 
GaINAc group onto threonine residue and corresponding mass increase to peptide. 
A combination of ECD and IRMPD, as demonstrated by Hâkansson et al. 
[28], can be used to further elucidate the fine structure of the glycosylation. The 
power of the IRMPD laser can be tuned low enough to specifically break the bonds 
in the sugar group, without breaking backbone bonds. By using the IRMPD laser 
"TAP25 peptide derived from the human mucin MUd, was in vitro glycosylated with GaINAc-T3 
transferase. Sample obtained from the group of Prof R. Zubarev (Angstrom Laboratory, Uppsala 
University, Sweden) and originally made by H. Clausen (School of Dentistry, University of 
Copenhagen, Denmark). 
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slightly off-axis, it has been shown that IRMPD and ECD experiments can now be 
effected on the same ion population [28], which makes FT-ICR MS a very powerful 
technique to investigate post-translational modifications, and particularly 
glycosylations. 
2.3.3 Electron capture dissociation with dispenser cathode 
ECD experiments were attempted on the 9.4 Tesla APEX III instrument using 
the fitted rhenium filament, however, no successful spectra were obtained. The 
stronger magnetic field leads to a greater focusing of both the ion cloud and the 
electron beam. Hence, one would theoretically expect greater ease of ion 
cloud/electron beam overlap at lower magnetic fields. Similar strategies employed 
for the 3 Tesla instrument, such as lowering of trapping plate potentials to 0.1 V and 
even employing a pulsed gas (to cool or scatter the electron beam), did not result in 
successful ECD. It appears that when the electrons are 'born' on a particular field 
line, they are unlikely to move away from it. The greatest limitation of the filament 
set-up in performing ECD experiments is the very small diameter of the electron 
beam, which precludes efficient ion cloud/electron beam overlap. As McLafferty and 
co-workers have shown, by using a design of ICR cell consisting of an open-ended 
cylindrical cell with additional flat trapping plate electrodes, 'the nested cell 
geometry' [22], positive ions and electrons can be trapped at the same time. While 
this can result in better precursor ion to fragment ion conversion, the overall time 
scale for such experiments is very long (multiple electron irradiation and storage 
times resulting in single scan times of up to 90 s). 
Tsybin et al. [3 0] and Haselmann et al. [31] have used indirectly heated high-
surface dispenser cathodes that have larger emitting currents and higher electron 
beam diameters. They have reported irradiation times as low as 1 ms, which allow 
on-line liquid chromatography (LC) eluted peptides to be fragmented by ECD. 
A high-surface BaO coated dispenser cathode was installed on the 9.4 Tesla 
instrument. This has a diameter of 5 mm (HeatWave, Watsonville, CA, USA) (see 
Figure 2.12). This cathode was fitted in place of the rhenium filament (see Figure 
2.6). In normal operating conditions, a current of 1.8 A was applied and the grid 
voltage was maintained at 15.2 V during the experiment, both of which were applied 
Me 
GRill 
using an external power supply (ElektroAutomatik, Viersen, Germany) (see Figure 
2.13). This power supply was operated in current-limiting mode; for a current of 1.8 
A voltage drop of 5.2 V was applied across the filament in steady-state conditions. 
Vacuum sealable holder 
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Figure 2.12 Picture of the indirectly heated dispenser cathode. 
FExtemal Power Supply 	External Power Supply 	Break Out Box 
Figure 2.13 Schematic diagram of the dispenser cathode with connections. 
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One side of the filament is floated with the U voltage in the XmassTM 
software in order to pulse electron emission. This voltage is taken from the filament 
(-) voltage on the break out box. In the case of the cathode, ramping the trapping 
voltages to lower values before electron irradiation did not seem to have a significant 
effect on the efficiency of precursor to fragment ion conversion. 
An example ECD spectrum of substance P in the 2+ charge state is shown in 
Figure 2.14. Comparing this spectrum to the ECD spectrum obtained with the 
electron filament for static trapping potentials (Figure 2.7) one observes much better 
defined fragment peaks. Further, the most abundant fragment peaks are due only to 
the ECD process, which is critical in order to carry out mechanistic studies. Mass 
isolation, when performing electron irradiation with the rhenium filament, often had 
to be 'compromised' in order to maintain overlap between the ion cloud and the 
electron beam. Conversely, isolation of the 2+ charge state of substance P [M+2H]2 
is nearly perfect, with even the sodium adduct species ejected in the isolation sweep. 
The ratio of species that have captured an electron to remaining [M+2H]2 in Figure 
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Figure 2.14 ECD mass spectrum of substance P in the 2+ charge state. Electron 
irradiation was 20 ms and 30 time-domain transients (512 kb) were co-added to 
generate this mass spectrum. 
2.3.4 Characterisation of electron sources 
In order to characterise the electron filament and dispenser cathodes, 
measurements of the emitted electron currents were made. One side of the filament 
and the repeller plate are held at a voltage U. As a consequence of the potential drop 
across the filament, a voltage U is measured on the other side of the filament which 
is 2 V higher than U for the rhenium filament at a current of 3 A. The repeller plate 
is negatively biased relative to U, which causes pulsed emission of electrons from 
the filament. Some of the emitted electrons travel in the z-direction (axis of direction 
of magnetic field 130) through the ICR cell to the Einzel lens components (see Figure 
2.6). The emitted electron current was measured using a picoammeter (model 610C, 
Keithley Instruments, Munich, Germany) at the Einzel lens element closest to the 
ICR cell. No electron current could be detected on any of the other Einzel lens 
elements. Whereas the electron gun and the ICR cell are located inside the bore of 
the magnet (i.e. at 3 Tesla, respectively 9.4 Tesla field strength), the Einzel lens 
elements are placed in the fringing magnetic field. Electrons travel along a particular 
field line and in the fringing magnetic field the field lines diverge, causing the 
electrons to impact onto the Einzel lens element FOCL2. All voltages (electrodes in 
the 	ICR cell: trapping voltages, Sidekick TM  voltages, etc., and the Einzel lens 
elements) are set to 0 V (i.e. ground) to prevent interference with the electron path. 
2.3.4.1 Rhenium filament electron emission 
The emitted current intensity of the rhenium filament for a filament current of 
3 A as a function of the filament bias U was measured on FOCL2 as described 
above and the plot is shown in Figure 2.15. The current intensity plot has a sigmoidal 
shape and levels off at a current of 1400 nA. The best ECD spectra (i.e. highest 
abundance ECD fragments in those spectra) were obtained at a value of U = +0.5 V, 
which is the point where the current intensity starts increasing. The measured current 
at that filament voltage was 30 nA, which is equivalent to 2x101 ' electrons. This 
compares to a space-charge capacity of the 3 Tesla ICR trap of a few million 
charges, which demonstrates that many more electrons pass through the cell than 
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Figure 2.15 Intensity of emitted current detected on FOCL2 'FOCL2 as a function of 
the filament voltage U (filament current 3 A). Line shows best sigmoidal fit. 
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The question arises as to what kinetic energy (KB) the electrons need to have 
for efficient ECD to take place; ECD efficiency is defined as the conversion 
efficiency of precursor to fragment ions [22]. McLafferty and co-workers proposed a 
value of < 0.2 eV for low-energy electrons which would be involved in ECD. 
Measuring the KE distribution of emitted electrons from a filament is actually quite 
challenging, since it depends on the work function that the electrons need to 
overcome to enter the vacuum [32]; the work function of Re is 4.9 eV. In order to 
overcome this work function, the filament is heated by applying a current, which 
raises the energy available to electrons to escape the filament. The Re melting point 
is high (Tm = 3170 °C), which is why it is suitable for electron emission. Since 
thermionic emission from pure metals only occurs at temperatures > 2500 K, an 
electrostatic field is applied in the vicinity of the metal surface to lower the activation 
barrier [33]. Pulsing of the U voltage to a suitable value causes favourable 
conditions for electrons to be emitted from the filament. The mean KE distribution 
depends on the value of U that is applied. Nevertheless, we need not be concerned 
with the electron KE distribution at the filament since ECD occurs in the ICR cell. 
Hence, this is where the KB distribution must be known. 
This renders the measurement of electron KB distribution simpler, and in fact, 
the FT-ICR instrument itself can be used to make the measurements. To this effect 
the rear trapping plate (PV2) is employed as a retarding voltage. The voltages of the 
other electrodes in the ICR cell are maintained at 0 V, as well as the Einzel lens 
elements. At a sufficiently negative value of PV2 no electron current is measured on 
FOCL2, since the KB of even the most energetic electrons emitted from the filament 
cannot overcome the potential energy barrier. Evidently, this only refers to the z-
direction velocity of the electron; velocity of the electron in the xy plane would result 
in higher cyclotron or magnetron radii due to the focussing effect of the magnetic 
field. The retarding voltage where all electrons are stopped serves as the zero KB 
reference point. As the value of PV2 is then incrementally 'increased' (i.e. made 
more positive), the current detected on FOCL2 increases, until no more increase in 
current is detected. For a filament voltage U of-0.5 V, a voltage of-2.4 V retards 
the electrons and no current is observed. Since the static trapping ECD experiments 
are performed at voltages of +0.5 V, the resulting effective KB of these electrons 
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when entering the ICR cell is 2.9 eV [0.5-(-2.4)]. The measured current profiles on 
FOCL2 (as a function of PV2, shown in Figure 2.16) are differentiated and adjusted 
to +0.5 V trapping plate voltages employed in the static trapping ECD experiments to 
yield the retarding field analysis in Figure 2.17. This procedure is repeated for values 
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Figure 2.16 Rhenium filament emitted currents detected on FOCL2 (IFocL2)  as a 
function of the retarding voltage on PV2. (A) U = +1.5V, (B) LI = +0.5V and (C) U- 
= -0.5V. Red line indicates best sigmoidal fit. Note that 'FOCL2  scales are different for 
each emission curve. 
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Figure 2.17 Effective kinetic energy distributions at the rear trapping plate PV2 
(held at +0.5 V during static trapping ECD experiments) for different values of 
filament voltage U. The relative electron abundance is normalised with respect to the 
maximum electron current emitted at a particular value of U. The intensity of the 
relative electron abundance for U = + 1.5 V has been multiplied by a factor of 10 for 
clarity [18]. 
At a filament voltage U = -0.5 V the most abundant electrons have an 
effective KE of 1.3 eV, whereas at a filament voltage of U = +0.5 V, the most 
abundant electrons have an effective KE of 0.9 eV. The effective KE is lower for 
more positive values of U. The most abundant electrons in the effective KE 
distribution of U = +1.5 V is even lower, however, the number of electrons is very 
low as well. The effective KE distribution for U = +0.5 V contains more low-energy 
electrons than is the case for either of the other two values of U. Hence, it appears 
that a value of U = +0.5 is the best trade-off between obtaining low-energy electrons 
and sufficiently high electron currents to perform ECD. 
The most effective approach to obtain even lower energy electrons in the ICR 
cell with the current set-up is to use even lower trapping plate potentials. In the 
dynamic trapping ECD experiments, the trapping plate voltages were lowered to +0.1 
V. The retarding field data in Figure 2.16 was also analysed using a different 
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procedure, where the sigmoidal best fit lines in Figure 2.16 were differentiated; here 
the kinetic energy axis was corrected for trapping plate potentials of +0.1 V used 
during the dynamic trapping ECD experiments (see Figure 2.18). The advantage with 
differentiating the sigmoidal best fit line is that the electron KE distribution always 
has a Gaussian shape. Further, this procedure allows for a statistical evaluation of the 
mean kinetic energy of the distribution. Since only the mean KE can be determined 
with a degree of accuracy, whereas especially the low-energy tail of the distribution 
is not, differentiation of the sigmoidal fit line will be the method of choice for the 
remainder of this study. The mean KE of the electrons for U = -0.5 V is 0.919 (± 
0.006) eV, and in the case of U +0.5 V the mean KE of the electrons is 0.465 (± 
0.006) eV. Considerably better ECD spectra were obtained using the lower trapping 
voltages, which could thus be explained. Furthermore, the fact that no ECD was 
observed at trapping plate voltages of 1 V or higher is consistent with this view. 
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Figure 2.18 Effective kinetic energy distributions at the rear trapping plate PV2 
(held at +0.1 V during dynamic trapping ECD experiments) for different values of 
filament voltage U, as determined by differentiating sigmoidal best fit lines in Figure 
2.16. The relative electron abundance is normalised with respect to the maximum 
electron current emitted at a particular value of U. 
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Many experimentalists advocate the use of a pulsed gas prior to electron 
irradiation to decrease the mean KE distribution of the emitted electrons. A retarding 
field analysis was carried out to determine if the use of a pulsed gas could really 
collisionally cool the electrons. A pulsed gas of argon was applied in the ultra-high 
vacuum (UHV) region, which caused the pressure to increase from lxi 010  mbar to 
about 3x I 06  mbar, immediately prior to electron irradiation. An exact determination 
of the maximum pressure is difficult to ascertain, furthermore the pressure 
exponentially decreases and hence the pressure would not be stable over the length of 
electron irradiation (1 s). Once again a sigmoidal fit was performed on the plot of 
'FOCL2 vs PV2 (see Figure 2.19), and the best fit line was differentiated and the 
kinetic energy axis was corrected for trapping plate potentials of 0.1 V used during 
the ECD experiment (see Figure 2.20). 
PV2 voftage, V 
Figure 2.19 Rhenium filament emitted currents detected on FOCL2 (IIocL2)  as a 
function of the retarding voltage on PV2, when pulsing Ar as in UHV. (A) U = 
+0.5V, (B) U = OV and (C) U -0.5V. Red line indicates best sigmoidal fit. Note 









-0.5 	0.0 	0.5 	1.0 	1.5 	2.0 	2.5 
Electron kinetic energy, eV 
Figure 2.20 Rhenium filament effective electron kinetic energy at PV2 (for trapping 
voltages of 0.1 V), when employing a pulsed argon gas in the UHV. 
In Figure 2.20, the mean KE energy distribution for U = -0.5 V were 
measured at 0.562 (± 0.002) eV, which compares to 0.919 eV measured when no 
pulsed gas was applied (Figure 2.18). The electron KE distributions for U -0.5 V 
with and without a gas pulse are shown again in Figure 2.21, to demonstrate the 
effect of pulsing a gas. The maximum current was measured to be 810 nA (pulsed 
gas), compared to 1050 nA when no pulsed gas was used. This may suggest that loss 
of some electrons occurred or that the emission current was lower due to the higher 
pressure in the UHV chamber. The detected electron current on FOCL2 for U = +0.5 
V is much reduced when applying a gas pulse, which is probably due to more 
significant cooling for low KE electrons. Electrons with a negative effective KE at 
PV2 in Figure 2.20 would not be able to overcome the retarding field and would 
consequently not enter the cell. The width of the KE distribution for U = -0.5 V in 
Figure 2.20 is 0.75 eV, compared to 0.74 eV for U -0.5 V in Figure 2.18. Hence 
it appears that the use of a pulsed gas can decrease the mean KE of emitted electrons 
but does not narrow their KE distribution. 
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Figure 2.21 Rhenium filament effective electron kinetic energy at PV2 (for trapping 
voltages of +0.1 V) for U = -0.5V, with and without employing a pulsed argon gas 
in the UHV. 
As mentioned before, there are limitations to the accuracy of this retarding 
field analysis especially regarding the low-energy tail of the KE distribution. In this 
case positive values of PV2 yielded higher current readings on FOCL2 (IFOCL2),  in 
spite of the fact that the remaining electrodes were set to 0 V, and therefore no 
increase should have occurred at values of PV2 higher than 0 V. One of the 
assumptions made when doing a retarding field analysis is that the voltage applied on 
PV2 has no effect on the emitted electron current from the filament. This hypothesis 
is probably viable since PV2 and the filament are 13 cm away in space, whereas the 
repeller plate that creates the local bias for pulsed emission is only 1 cm away from 
the filament. Nevertheless, the fact that positive values of PV2 gave higher current 
readings than obtained for 0 V indicates that the retarding field analysis is not 
accurate at values close to 0 V, which is equivalent to the low-energy tail of the 
electron KE distribution. 
77 
2.3.4.2 Dispenser cathode electron emission 
According to the retarding field analysis, a large number of electrons can be 
generated with a conventional rhenium filament with sufficiently low KE to give rise 
to 'good' ECD. Nevertheless, the ECD efficiencies of spectra obtained with the 
filament are generally poor due to the limited overlap between the ion cloud and the 
electron beam. The emitting area on a filament is believed to be very small (<< 1 
mm 2)  [30], whereas the ion cloud is radially spread further. In contrast, the high-
surface dispenser cathode fitted on the 9.4 Tesla instrument has an emitting surface 
of 19.6 mm  (diameter 5 mm), which is much closer to the radial displacement of the 
ion cloud off the central axis in the ICR cell. The emitting surface is coated with BaO 
which has a reduced work function ( = 1.7 eV) [34], and hence a high number of 
electrons can be emitted at lower operating temperatures. The normal operating 
temperature of a filament is on the order of 2500 K, whereas the temperature of an 
oxide coated cathode is around 1200 K. Emission from the coated BaO surface 
occurs as a secondary electron emission process, due to electrons emitted from the 
heating filament impacting onto the BaO surface. 
The emitted current retarding field plots in Figure 2.22 show that for more 
negatively biased filament voltages U higher electron currents could be emitted. The 
maximum current emitted for a filament voltage U = -0.5 V was 27000 nA (i.e. 27 
jiA), which compares to 1400 nA for similar filament voltages when using the 
filament. The total number of electron emitted is almost 20 times larger than for a 
filament and this emission occurs over a much wider area. This compares to 
maximum reported electron currents for similar cathodes of 2 mA [30]. The lines in 
Figure 2.22 indicate the best sigmoidal fits, which were used to determine the 
effective KE of the electrons for trapping voltages of 1 V (as used in most cathode 









PV2 voltage, V 
Figure 2.22 Emitted currents detected on FOCI-2 (IFocL2)  as a function of the 
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Figure 2.23 Effective kinetic energy distributions at PV2 (= 1V) for different 
filament voltages U. 
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The effective kinetic energy distributions at PV2 in Figure 2.23 show a 
decrease of the mean KB as the filament voltage U becomes more positive, as could 
be expected. The KE spread at half-height for U = -0.5 V is 2.27 eV, which is higher 
than for the filament at that value of U- (0.74 eV, Figure 2.19). Generally, the KB 
spread measured in these retarding field experiments should be related to the 
Maxwell-Boltmann distribution, which in turn depends on the temperature of the 
emitting surface. The cathode is operated at a lower temperature than the filament 
(Tcat1 ode 1200 K, Ttjiarnent  2500 K), and hence the emitted electron KB spread for 
the cathode should be narrower than for the filament. When performing ECD the 
filament voltage setting in the range of U- -0.5 V to —1.5 V did not seem to have an 
effect on how good the precursor to parent ion conversion was. Given that the mean 
KB of the distributions in Figure 2.23 are elevated (U = -0.5 V: 4.39 eV; U = -1.0 
V: 4.73 eV; U = -1.5 V: 5.07 eV) and do not seem to contain many low-energy 
electrons, it is somehow odd that ECD took place at all in these conditions. Chan et 
al. have approximated the electron kinetic energy for efficient ECD for electrons 
made by their rhodium filament to be in the range of 3-6 eV [23]. However, they 
have merely taken the average filament potential (i.e. average of voltages applied on 
either side of filament) during electron emission as the measure of electron KE. They 
did not take into account the work function of the filament. Further, their estimate of 
the electron KB does not constitute a measurement of the electron KE in the ICR 
cell. 
In summary, the mean electron KB's as determined by this retarding field 
analysis for the rhenium filament seem to be in agreement with ECD efficiency 
measurements, which validates this approach to measure electron KB distributions. 
Nevertheless, for the dispenser cathode this retarding field analysis may not 
determine the 'real' KE spread of the electrons. This would also explain why the 
value of the trapping plate potentials seemed to have little effect on the ECD 
efficiency (trapping plate potentials at 3 V gave very similar ECD spectra to 1 V 
trapping voltages). In a retarding field analysis, the assumption is made that electrons 
in a beam behave as independent charged particles and that space-charge effects 
caused by electrons among one another are negligible. The emitted electron beam 
from this dispenser cathode may be 5 mm wide, and hence electrons located in the 
centre of that beam may not 'see' the retarding field voltage. This could be due to the 
fact that the retarding voltage is only capable of 'peeling away' some of the layers of 
the electron beam, while electrons in the centre of the beam are not subjected to the 
retarding field voltage. Therefore, electrons in the centre of the electron beam would 
able to overcome a retarding field voltage in excess of their KE. This is consistent 
with the observation that a current of 100-200 nA was detected for the maximum 
retarding field voltage of —10 V. These results seem to imply that a retarding field 
analysis using this instrument is not suitable to determine the KE distribution of 
electrons emitted from a dispenser cathode. 
2.3.5 Electron detachment dissociation 
Electron capture dissociation is only applicable to positively charged 
peptides. For many polypeptides containing acidic residues (e.g. Glu, Asp) and acidic 
functions (e.g. C-terminal carboxylic acid, sulfation, N-acetylation, phosphorylation) 
it is not possible to generate a doubly protonated species and hence ECD is not 
feasible. The truly complementary technique to ECD would be the capture of a 
positron by a peptide anion. Still, positron sources are not available to the wider 
research community. Electron detachment dissociation (EDD) has been proposed as 
an analogue technique to positron capture [35]. In EDD peptide anions are irradiated 
with electrons at higher kinetic energies (i.e. -21 eV), causing abstraction of one 
electron (i.e. oxidation) (see scheme 2.1). 
[M-nH] + e- - [MnH]l* + 2 & 	 Scheme 2.1 
The resulting electronically excited oxidised species [MnH]*  can 
fragment according to an 'electron'/'hole' recombination [35]. Similarly to ECD, the 
precursor ion needs to be doubly charged (at least), since the charge is reduced by 
one in the electron detachment process. 
Figure 2.24 shows the EDD mass spectrum of the doubly deprotonated 
species of a standard peptide. This spectrum was obtained by electron irradiation 
from the rhenium filament (1 s) at a filament voltage U of —20 V. The oxidised 
species [M-2H] can be seen in this spectrum, as well as a loss of 44 Da from [M- 
ROM 
2H]. The 44 Da neutral loss constitutes an abundant fragmentation channel, which 
has also been observed by Budnik et al., and which they have associated with the 
loss of CO2 according to scheme 2.2. 
R--COO- + e -> RCOO* +25 --> R + CO2 	Scheme 2.2 
The fragments in Figure 2.24 are mostly due to the cleavage of the CaC bond 
(a fragments and x5 fragment; see Figure 1.9 Chapter 1), which may be due to 
differences in the mechanism compared to ECD. All fragments include the 
phosphorylated tyrosine residue, indicating that it is the charge carrier. 
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Figure 2.24 EDD mass spectrum of Z charge state of peptide with sequence Ac-
DY(P03H2)VPML-NH2. Electron irradiation 1 s; 100 scans were accumulated. 
Asterisks indicate overtones and artefact peaks. 
Figure 2.25 shows the EDD mass spectrum of the 2 charge state of hirudin 
(sulphated). Apart from the CO2 neutral loss, another loss of 70 Da is observed, 
which has been associated with the loss of S03. Limited fragmentation is observed 
(x8 to x1 i).  The preferred cleavage of the Ca-C bond is again confirmed in this 
spectrum. 
The filament voltage U was observed to cause EDD if set to values of -20 V 
or higher (i.e. more negative). However, no fine tuning was required, and in fact, 
values of U = -30 or even —40 V, resulted in similar EDD spectra (not shown). It 
appears that in EDD the exact KE of the electrons plays less of a role, as long as the 
electrons have a minimum onset energy. 
The cross-section for electron/ion interaction in EDD is reduced respective to 
ECD, since both the electron and the anion are negatively charged. This also explains 
why EDD efficiency on average is lower than the corresponding ECD efficiency. 
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Figure 2.25 EDD mass spectrum of 2 charge state of hirudin (sulphated). Electron 
irradiation 3 5; 200 scans were accumulated. Asterisks indicate overtones and artefact 
peaks. 
2.4 Conclusions 
Preliminary ECD results using the electron filament indicate that relatively 
good ECD efficiency can be obtained by using a conventional rhenium filament by 
lowering the trapping plate potentials to very low values (0.1 V) prior to electron 
irradiation. A 'retarding field analysis' of electron emission suggests that low 
trapping plate voltages give a higher abundance of low-energy electrons, thereby 
improving ECD efficiency. Nevertheless, the very small diameter of the electron 
beam emitted from a filament limits the extent of overlap between the ion cloud and 
the electron beam. Mass isolation in the filament ECD experiments often had to be 
compromised, in order to achieve any ion cloud/electron beam overlap. 
Consequently, fragments due to other processes, such as vibrational excitation, are 
observed in these spectra. Conversely, in the dispenser cathode ECD experiments the 
abundance of fragments was found to be very high and the mass isolation did not 
have to be compromised due to the better electron beam/ion cloud overlap. 
Competing fragmentation processes to ECD can be minimised by using the dispenser 
cathodes and almost 'pure' ECD spectra can be obtained, which enables the study of 
mechanistic processes in ECD (which is shown in Chapter 3). The retarding field 
analysis was not able to determine the real kinetic energy distribution of emitted 
electrons from dispenser cathodes, probably due to the fact that only some of the 
outer electrons in the beam are affected by the retarding voltage. Hence, the values of 
the trapping voltages do not seem to play a role in controlling ECD efficiency when 
using dispenser cathodes. 
The study on EDD showed that preferential cleavage occurs at the CaC 
bond, as opposed to the NC,, bond in ECD. EDD could be a promising electron-
mediated sequencing technique for peptides where a 2+ charge state is not possible. 
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Mechanistic studies of electron 
capture dissociation 
3.1 Introduction 
Dissociation of peptides by mass spectrometry to determine the primary 
structure is generally effected by collisionally activated dissociation (CAD) [1]. 
Computer algorithms such as Sequest1 assist in the identification of peptide 
sequences [2-4], by comparing the experimental tandem mass spectrum to predicted 
tandem mass spectra for putative sequences. However, due to incomplete knowledge 
of the fragmentation patterns much of the information contained in the mass spectra 
is not predicted by these algorithms. Hence, Wysocki and co-workers have used SID 
(surface-induced dissociation) to carry out mechanistic studies in order to improve 
the prediction rate of automated sequence analysis by mass spectrometry [5-9]. As 
explained in Chapter 1, SD is a vibrational excitation technique that allows 
controlled deposition of energy onto the ion. An analysis of doubly protonated tryptic 
digest peptides dissociated by collisionally induced dissociation (CID) in an ion trap 
(3-dimensional Paul trap) [10] has also shown that preferential cleavage rules can be 
established. Electron capture dissociation is a relatively novel dissociation technique 
[11], which has only been successfully implemented on FT-ICR instruments, hence 
far fewer mechanistic studies have been undertaken [12,13]. 
This chapter highlights mechanistic aspects of ECD which can yield further 
primary sequence information: neutral side-chain losses and ease of H atom transfer. 
The ease of hydrogen atom transfer is assumed to be dependent on the ease of 
abstraction from the protonated site and ease of acceptance of the backbone carbonyl, 
resulting in backbone cleavage. Further, a 'reverse' backbone alpha-cleavage is 
proposed to be in competition with 'normal' alpha-cleavage. Simple polypeptides 
were chosen with predictable protonation sites, and by modifying one amino acid at a 
1 http://fields.scripps.edulsequestlindex.html 
time the effect on the fragmentation pattern can be observed. Results are discussed in 
terms of the non-ergodic mechanism in ECD and the proposed hot hydrogen re-
arrangement mechanism. These results will also be discussed in terms of the 
secondary structure of the peptide ion in more detail in Chapter 4. 
All ECD mass spectra shown in this Chapter were generated on the 9.4 Tesla 
APEX III instrument (Bruker Daltonics) using a dispenser cathode (for procedure see 
Chapter 2, section 2.2), unless specified otherwise. The peptides included in this 
study are summarised in Table 3.1. 
Abbreviation Description Peptide sequence 
[LHRH -HR]2 
Luteinizing hormone 
releasing hormone pEIIWSYGLRPG-OH 
[LHR1-1_RH]2 
F 
idem pER WSY WLI 1PG-OH 
[LHRHHH]2 
* 
idem pEl IWSYWLI IPG-OH 
[LHRH_RR]2 
* 
idem pER WSYWLR PG-OH 
[LHRHHR_NH2]2 # idem pEl IWSYGLRPG-NH2 
[LHRH(l)W]2 # idem pEt IWSYWL0G-NH2 
[LHRH_(d)W]2 # idem pEt I WSY(d)WL RPG-NH2 
[BOMB] LVII Bombesin pEQRLGNQWAVGI ILM-NH2 
IiBKJ2 Bradykinin RPPGFSPFR-OH 
[Ac_BK]2 N-acetylated bradykinin Ac-RPPGFSPFR-OH 
Table 3.1 Abbreviations used for doubly protonated peptide ions with corresponding 
sequences. For amino acid single letter code, see Table A2.2, Appendix 2. The most 
likely sites of protonation are the side-chains of the amino acids arginine and 
histidine which are red colour-coded .2  Note that pEI-IWSYGLRPG-NH2 refers to the 
mammalian form of LHRH.3 (' refers to peptides obtained from Sigma Aldrich, * 
refers to peptides made by Dr. Kim Haselmann from the University of Southern 
Denmark by solid phase synthesis). 
3.2 Neutral losses 
The losses of amino acid side-chains as a diagnostic tool for the presence of 
amino acids in peptides was first proposed by Cooper et al [14], in analogy to 
immonium ions in high-energy collision-activated dissociation (CAD) [15]. 
2 The gas-phase basicities of arginine (237 kcal mol') and histidine (223.7 kcal mor') are highest (see 
Table A2.2, Appendix 2). N-terminus protected in case of pyro-glutamic acid and therefore not a 
possible site of protonation. For [LHRH_HH]2 , side-chain of tryptophan {6} could be a competing 
site of protonation, as discussed in section 3.2. 
Note: pE refers to pyro-glutamic acid, which is made from N-terminal glutamic acid by cyclisation 
of the NH, terminus with glutamic acid side-chain through elimination of water. For structure, see 
Figure A2. 1, Appendix 2. 
Haselmann et al have named this region the (Ms —X) region (1 Da :!~ X :!~ 130 Da) 
[16]. Neutral losses are in general 1 Da in mass higher than the expected mass of the 
amino acid side-chains, implying hydrogen atom rearrangement and/or incorporation 
in the cleavage. Generally these losses are observed for basic amino acids such as 
arginine, histidine and lysine, which would also be expected to be protonated (see 
gas-phase basicities Table A2.2, Appendix 2). Since work has already been done on 
neutral losses [14,16] these will only be briefly discussed in this Chapter. The (Ms - 
X) regions for luteinizing hormone releasing hormone (LHRH) variants 
[LHRH_(d)W]2 (Figure 3.1), [LHRH_HR_NH2]2 (Figure 3.2) and [LHRH_HH]2 
(Figure 3.3) are shown in the following Figures. Neutral losses for [LHRH_HR]2 
(ECD mass spectrum in Figure 3.4) and [LHRH_  RR] 2 (ECD spectrum in Figure 
3.9), for which the (Ms —X) region is not specifically shown, will also be discussed. 
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Figure 3.1 (Ms —X) region for [LHRH_(d)W]2+. The peaks are labelled with mass 
losses, the proposed chemical formulae of the losses and colour-coded with the 
associated amino acid residues. (electron irradiation: 35 ms) 
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Figure 3.3 (M. —X) region for [LHRFI_HHJ2 . Unidentified peaks are labelled with 
a question mark (?). (electron irradiation: 35 ms). 
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The masses of the proposed fragment losses in Figures 3.1 to 3.3 are summarised in 
Table 3.2. For most experimentally observed losses and the masses of the predicted 
fragments there is reasonable agreement. 
Fragment formula Mass (Da) 
H(1) 1.008 
NH3 (2) 17.027 
H20(2) 18.011 









NH (2)  
==Ci 82.053 
H 	(4)  
NH2 
Y 101.095 
NH (2)  
H 
131.073 
Table 3.2 Masses of the predicted fragment losses in (M. —X) region. Structures of 
fragment ions first suggested by (1) [11], (2) [14], (3) this author and (4) [16]. 
Table 3.3 summarises the neutral losses observed in Figures 3.1 to 3.3. Each 
of these neutral losses is discussed with respect to its specificity and sensitivity for 
the presence of a particular amino acid or group. 
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Peptide sequence 17 18 43 59 82 101 131 
pEHWSY(d)WLRPG-NH2 Y N Y Y Y Y Y 
pEHWSYGLRPG-NH2 Y N Y Y Y Y Y 
pEHWSYWLHPG-OH N Y N Y Y N Y 
pEHWSYGLRPG-OH Y N Y N Y Y Y 
pER WSY WLRPG-OH Y Y N Y N N N 
Table 3.3 Summary of neutral losses for Figures 3.1 to 3.3, 3.4 and 3.9. 
1 Da loss. The hydrogen atom desorption, in contrast to the other neutral 
losses, cannot be associated with the presence of particular amino acids. 
Nevertheless, it can be a measure of how globular the structure of the peptide ion is 
[17]. Table 3.4 summarises the relative abundances of hydrogen atom desorption and 
the 'reduced' species [M+2H]. Hydrogen atom desorption is more pronounced for 
[LHRHHRNH2]2 , which may be due to more extended structures than for the 
other peptide ions. 
Peptide sequence [M+11f [M+2H] 
pEHWSY(d)WLRPG-NH2 75 % 25% 
pEHWSYGLRPG-OH 75% 25% 
pEHWSYGLRPG-NH2 85 % 15 % 
pEHWSYWLHPG-OH 45% 55 % 
pERWSYWLRPG-OH 40% 60% 
Table 3.4 Relative abundances of hydrogen atom desorption ([M+H]-) relative to 
reduced,  species ([M+2H]+. ). Abundances calculated by taking heavier isotope peak 
of [M+H] into account. 
17 Da loss. In spite of the fact that this loss is much more abundant in the 
case of amidated peptides, it is not specific to the presence of that group since it is 
also observed in the case of [LHRH HR]2 . The ammonia (NH3)  loss could also 
originate from the arginine side-chain and this loss may be isobaric with the loss of 
0H (17.0027 Da) when the mass accuracy is insufficient. 
18 Da loss. This loss is linked to water loss and is observed for the free acid 
C-terminal peptide. Nevertheless, this loss is of low abundance and therefore of 
lesser diagnostic value. 
43 Da loss. The 43 Da loss is generally a good indication for the presence of 
an arginine residue. The loss of the radical CH3N2 group from the arginine side- 
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chain, without incorporation of a hydrogen atom, seems to be specific to the LHRH 
peptides, Cooper et al. observed a 44 Da loss (see Table 3.2) for other arginine-
containing peptides they studied. 
59 Da loss. Due to the C-terminal amino acid being a glycine the 59 Da loss 
(loss of (CH2)2C=NH) is isobaric with the c9 fragment ion in the case of free acid C-
terminal peptides and therefore both cannot be distinguished. The 59 Da loss is not 
seen in the (M. —X) region of pEHWSYGLRPG-NH2 (Figure 3.2), despite the fact 
that an arginine residue is present. Instead, a 58 Da loss is seen in the (M. —X) region 
of pEHWSY(d)WLRPG-NH2 (Figure 3.1), which can be associated with the loss of 
CH4N3 from the arginine side-chain. This is in analogy to the 43 Da loss observed 
for LHRH peptides, for which no hydrogen atom incorporation into the neutral loss 
fragment occurs. The 58 Da loss seems to be specific for the presence of an arginine 
residue in LHRH peptides. 
82 Da loss. This loss is associated with the loss of the histidine side-chain. It 
is abundantly observed every time that histidine is present and is not observed when 
histidine is not present. Hence, this 82 Da loss constitutes a true positive and 
negative check for the presence of histidine in the amino acid sequence. 
Unfortunately, the relative loss of 82 Da is not increased for the two histidine-
containing LHRH peptide (i.e. pEHWSYWLHPG-OH) over any of the other 
peptides that only contain one histidine. While this loss is a qualitative indication for 
the presence of histidine, it does not seem to give a quantitative assessment of how 
many histidines are present. 
101 Da loss. The 101 Da loss, similarly to the 43 Da loss, is a good predictive 
tool for the presence of the arginine residue. Importantly, it does not give a false 
positive result in the case of pEHWSYWLHPG-OH (see Figure 3.3). This loss, in 
conjunction with the 43 Da loss (or 44 Da loss in other peptides than LHRH), can be 
used as a diagnostic tool for the presence of the arginine residue. 
131 Da loss. This loss gives a good indication for the presence of the 
tryptophan residue, since it cannot be confused with other neutral losses. However, 
for most of the studied peptides the abundance of the loss is quite low, which 
decreases its value as a predictive tool. The peptide pEHWSYWLHPG-OH (Figure 
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3.3) shows a very abundant 131 Da loss. In contrast to the other LHRH variants, this 
peptide has no arginine residue and hence the tryptophan side-chains are competing 
sites of protonation to the histidine side-chains .4  This would also explain why the 82 
Da loss due to the histidine side-chain is not more abundant for pEHWSYWLHPG-
OH. 
In summary, neutral losses in the (M. —X) region for the studied LHRH 
variants are shown to provide information for the presence of particular amino acids. 
This especially applies to the 82 Da loss linked to the loss of the histidine side-chain. 
The 43 and 101 Da losses are useful indicators for the presence of the arginine 
residue. Conversely, the 59 Da loss is slightly more ambiguous, especially due to the 
fact that for these peptides it can be confused with the c9 fragment ion and similar 
ambiguities may arise in other sequences. The 131 Da loss, while generally of low 
abundance, can serve as a good indication for the presence of tryptophan. Further, a 
high abundance of this loss could be due to protonation of the tryptophan side-chain. 
On the other hand, the 17 Da loss is not specific enough and the 18 Da loss is of low 
abundance. 
" The gas-phase basicity of tryptophan (216.1 kcal mol') is relatively close to the gas-phase basicity 
of histidine (223.7 kcal moF'). 
3.3 Ease of hydrogen atom transfer from protonated site 
As explained in Chapter 1, the hypothesis in the hot hydrogen re-
arrangement mechanism is that a slow electron (<0.2 eV) is initially captured at the 
protonated site (i.e. H). The ensuing hydrogen radical (H') is then transferred to a 
high affinity site for hydrogen atoms. The following study investigates the 
relationship between the gas-phase basicity of the protonated site and the ease of 
hydrogen atom transfer from that site. 
3.3.1 ECD of [LHRH_HR]2 
The ECD mass spectrum of [LHRH_HR]2 is shown in Figure 3.4. The most 
likely sites of protonation for this peptide ion are the side-chains of arginine and 
histidine, given their higher gas-phase basicities. The ECD process gives rise to the 
reduced species [M+2H]' and neutral losses, as discussed in section 3.2. Further, a 
series of z fragment ions (z3 to z9 ) can be seen in this spectrum as well as the c9 
fragment. All of these fragment ions include the arginine residue, which in terms of 
the hot hydrogen re-arrangement mechanism means that only electron capture at the 
histidine side-chain causes backbone cleavage. Considering that the gas-phase 
basicity of arginine is higher, this may rationalise why electron capture at that site is 
less likely to give rise to a 'mobile' hydrogen atom, in analogy to the mobile proton 
model proposed by Wysocki and co-workers [9]. Electron capture occurring on the 
arginine side-chain would then only result in the typical neutral losses associated 
with the arginine side-chain are observed (i.e. 43, 59 and 101 Da). 
The insert in Figure 3.4 shows the detailed peak structure of the labelled z5  
fragment ions. This peak is in fact made up of two different peaks. One peak 
corresponds to the mass calculated for the z5 ' fragment, however, the labelled z5 ' 
peak is not the 13C  isotope peak of Z5+*.  The mass difference between these peaks is 
1.00795 Da, corresponding to a hydrogen atom difference. Therefore, z5 ' is an even-
electron z fragment ion, which will be discussed in detail in section 3.4. The 
appearance of even-electron z fragments has been documented in the literature [18-
22], and the notation as proposed by Kjeldsen et at [23] is employed in this thesis. 
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Figure 3.4 ECD mass spectrum of [LHRH_HR]2 showing z and c fragment ions. 
(100 time-domain transients) Insert shows detail of z5 fragment ion. (electron 
irradiation 35 ms). 
3.3.2 ECD of [LHRH_RH]2 
To test the assumption that electron capture at the arginine side-chain gives 
rise to very inefficient backbone cleavage compared to electron capture at the 
histidine side-chain, electron irradiation was effected on [LHRH RH]2 . This peptide 
has reversed positions for the arginine and histidine residues compared to 
[LHRHHR]2 .5 The ECD mass spectrum of [LHRHRH]2 (see Figure 3.5) 
confirms that only charged ECD fragment ions are observed that also contain the 
arginine residue. 
The second site of protonation for [LHRH_RH]2 could be either on the 
histidine side-chain in position 8 or the tryptophan side-chain in position 6. 
[LHRH RH]2  also contains a tryptophan residue in position 6 instead of a glycine residue in the 
case of [LHRH HR]2 . This should, however, not affect the preferential protonation of the arginine 
side-chain. 
all 




Protonation of the tryptophan side-chain in position 3 is less likely due to Coulombic 
repulsion with the protonated arginine side-chain. Neutral side-chain losses for 
[LHRHRH]2 are very weak; an 82 Da loss, linked to the histidine side-chain, is at a 
signal-to-noise ratio = 3, but no 131 Da loss (associated with the tryptophan side-
chain) is seen. Since the gas-phase basicity of histidine is higher than for tryptophan 
and the distance between arginine and histidine (5 residues) is higher than for 
arginine to tryptophan in position 6 (3 residues), the histidine side-chain is likely to 
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Figure 3.5 ECD mass spectrum of [LHRH_RH]2 . (100 time-domain transients) 
Insert shows detail of C5+.  (electron irradiation 35 ms) Starred (*) peaks due to 
instrument artefacts. 
The c fragments in this mass spectrum also consist of two different types of 
fragments. The insert in Figure 3.5 shows the c5 ' fragment and a fragment which is 
1.017 Da lower in mass, corresponding to the mass of a hydrogen atom, labelled as 
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C5+*. Therefore, c5 is an odd-electron species, which will be discussed in section 
3.4. 
3.3.3 SORI CAD of [LHRH_HR12 
In contrast, collisionally activated dissociation (CAD) of [LHRHHR]2 
(Figure 3.6) does not result in a higher abundance of C versus N-terminal fragment 
ions. According to the mobile proton model one would expect the proton on the 
arginine side-chain to be more fixed than the proton on the histidine side-chain [9]. 
Hence, the proton from the histidine side-chain would be expected to preferentially 
induce backbone cleavage. The resulting b and y fragments are in competition as to 
which one carries the proton depending on their proton affinities, as suggested by 
Nold et al. [24]. For b ions to be abundantly observed in this case, the proton needs 
to preferentially remain with that fragment. The complementary y fragment would be 
charged in this case due to the proton on the arginine side-chain. If all the protons 
(from the histidine side-chain) that induce backbone cleavage remain with the b 
fragment, one should observe equal fragment abundances for complementary 
fragments. However, the N-terminal fragment abundances are higher in some cases 
+ 	+ 	+ 	+   (e.g. b2 vs. y8+,   b3 vs. y7 and b4 vs. Y6+).   This implies that either a proton is lost 
from some fragments (and hence they would not be observed), or that larger 
fragments further dissociate. The latter hypothesis is more likely, since smaller 
fragments are more abundant in the mass spectrum than larger fragments. 
Collisionally activated dissociation of these peptides does not seem to give 
information where the most basic amino acid in the peptide is located. 
Conversely, in ECD of these peptides all the fragment ions include the most 
basic amino acid. In terms of the hot hydrogen re-arrangement mechanism this could 
be explained by the relative ease of hydrogen atom abstraction from the protonated 
site. Thus, the ease of hydrogen atom transfer from the protonated site would be 
inversely linked to the gas-phase basicity of the protonated site. In analogy with the 
mobile proton model, the hydrogen atom on the arginine side-chain is more 
localised. 
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Figure 3.6 SORT CAD mass spectrum of [LHRH_HR]2 . (100 time-domain 
transients, hexapole accumulation = 0.5 s) 
3.3.4 ECD of [BOMB]2 
To test this assumption further, the peptide ion [BOMB]2+ was irradiated with 
electrons (see Figure 3.7). The most likely sites of protonation in the doubly charged 
peptide are the side-chains of arginine and histidine. Once again only ECD fragment 
ions are observed which include the arginine residue, thus confirming the hypothesis 
that electron capture at the histidine side-chain is more likely to result in backbone 
cleavage than capture at the arginine side-chain. This mass spectrum compares 
favourably to the ECD mass spectrum of [BOMB]2+ shown by Chan et al. [25], 























700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 
m/z 
Figure 3.7 ECD mass spectrum of [BOMB]2+.  (100 time-domain transients) 
(electron irradiation = 50 ms). 
3.3.5 ECD of [LHRH_HH]2 and [LHRH_RR]2 
If the relative gas-phase basicities of the protonated amino acids in a peptide 
with basic residues on either end of molecule determine whether one observes 
primarily N or C-terminal fragment ions, the presence of two amino acids of the 
same gas-phase basicity should result in an even amount of N or C-terminal fragment 
ions. The ECD mass spectra of [LHRHHH]2 (Figure 3.8) and [LHRH_RR]2 
(Figure 3.9) both show c and z fragments. For [LHRH_HH]2 the sites of protonation 
are more ambiguous as for any of the other peptides and hence the original sites of 
protonation could be on the histidine or tryptophan side-chains or even a mixture 
thereof. This means that a multitude of fragmentation channels are available. 
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Figure 3.8 ECD mass spectrum of [LHRHHH]2 . (100 time-domain transients) 
Insert shows detail of z5t (electron irradiation = 35 ms). 
The low ECD efficiency (i.e. precursor to fragment ions conversion) for 
[LHRHRR]2 (see Figure 3.9) could be due to the low efficiency of hydrogen atom 
transfer from the arginine side-chain to the backbone. Nevertheless, the ECD 
efficiency actually depends on a host of factors including ion cloud/electron beam 
overlap and the electron kinetic energy distribution and hence one needs to be careful 
when comparing different mass spectra. The experiment was repeated a number of 
times yielding no improvement in the precursor to fragment ion conversion. 
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Figure 3.9 ECD mass spectrum of [LHRH_RR]2 . (300 time-domain transients) 
Insert shows detail of z6 . (electron irradiation = 35 ms). 
3.3.6 ECD of [BK]2 
In order to establish whether electron capture at the arginine side-chain 
always gives rise to inefficient backbone cleavage in ECD, the peptide bradykinin 
[BK]2 was irradiated with electrons to give the mass spectrum in Figure 3.10. 
Figure 3.10 shows an efficient conversion of precursor to fragment ions. The 
N-terminal fragments in the spectrum are much more abundant than C-terminal 
fragments. These results are analogous to results shown by Tsybin et al [26] on a 
doubly protonated y fragment ion of a tryptic decapeptide from the signal recognition 
particle (SRP) of Saccharomyces cerevisae; ECD of the doubly protonated peptide 
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Figure 3.10 ECD mass spectrum of [BK]2 . (100 time-domain transients) Insert 
shows detail of c5 ' fragment. (electron irradiation = 35 ms). 
In the light of the previous discussion, this could be due to two (among other) 
reasons: either the arginine on the C-terminus is less basic and therefore electron 
capture at that site results in more efficient hydrogen atom transfer to the backbone 
explaining more extensive backbone cleavage, or another site of protonation is 
present in the molecule. Since the N-terminus in this molecule is unprotected, it is a 
possible site of protonation. In the case of [BK]2 this would suggest a Zwitterionic 
structure (Figure 3.11), where the N-terminus is protonated and the C-terminus is de-
protonated. This structure would explain why the N-terminal ECD fragments carry 
one proton, whereas the C-terminal fragments are neutral and therefore are not 
detected. The Zwitterionic structure of [BK]2 has also been proposed by Freitas and 
Marshall based on H/D exchange studies with D20 [27]. H/D exchange studies of 




bradykinin in an ion trap by Mao and Douglas have also indicated that [BK]2 can 
exist in the Zwitterionic form [28]. Ab mi/jo calculations have shown that the 
Zwitterionic structures of arginine and arginine aggregates in the gas-phase can be 
stable [29-31], although the conclusions for theoretical calculations on bradykinin are 
more ambiguous [32]. Conversely, a direct probe of neutral arginine in the gas-phase 
by infrared cavity ringdown laser absorption spectroscopy (IR-CRLAS) [33] 
indicated that arginine exists predominantly in the neutral configuration in the gas-
phase [34]. Since addition of water is known to stabilise Zwitterionic structures, the 
H/D exchange studies may in fact induce a Zwitterionic structure. 
H3N-RPP G1S F1R-O 
\ 'X 
/ e 
Figure 3.11 Schematic of electron capture at Zwitterionic bradykinin [BK]2 , where 
the side-chains of arginine (R) are protonated. 
3.3.7 ECD of IAc_BK12 
ECD of N-terminal protected bradykinin [Ac_BK]2 (see Figure 3.12) gives 
rise to a similar fragmentation pattern than for [BK]2 . In this case no free amine 
group is available at the N-terminus as a possible site of protonation. The two most 
likely sites of protonation are on the side-chains of the arginines. Nevertheless, the 
C-terminus may be deprotonated, while an extra proton is carried on another basic 
site (e.g. backbone carbonyl). The N-terminal arginine would be expected to have a 
higher gas-phase basicity than the C-terminal arginine residue in [BK]2 due to the 
free amine group on the N-terminus. 
Even if [BK]2 cannot adopt the Zwitterionic structure, the presence of the 
free amine group on the N-terminus confers a higher basicity to the N-terminal 
arginine residue over the C-terminal arginine residue. Replacement of the free amine 
group in [BK]2 with an acetylated N-terminus in [Ac_BK]2 results in a decrease of 
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the gas-phase basicity of the N-terminal arginine group, which manifests itself in 
Figure 3.12 in the form of a higher proportion of C-terminal fragments relative to 
Figure 3.10. It therefore appears that the relative abundance of N vs C-terminal ECD 
fragments can give information about the location and relative gas-phase basicities of 
the protonated amino acids in doubly protonated peptides. 
ECD of singly protonated acetylated bradykinin [Ac_BK] (sequence: Ac-
RPPGFSPFR) was attempted, but did not give rise to any (charged) fragments. A 
Zwitterionic structure of [Ac_BK] (i.e. deprotonated C-terminus and two protonated 
arginine side-chains) could yield charged c fragments if electron capture on the C- 
terminal arginine side-chain gives rise to backbone cleavage and the resulting 	and 
Zm fragments are able to break apart. Hence, this result shows that either electron 
capture on the arginine side-chain does not result in efficient backbone cleavage, 
and/or that the resulting fragments oppositely charged fragments are held together by 
Coulombic interactions. 
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Figure 3.12 ECD mass spectrum of [Ac_BK]2t (100 time-domain transients) Insert 
shows detail of c5 fragment. (electron irradiation = 35 ms) 
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3.3.8 Conclusions 
The observation that in the ECD mass spectra of [LHRH_HR]2+ 
[LHRHRH]2 and [BOMB]2 all charged ECD fragments include the arginine 
residue implies a correlation between the higher gas-phase basicity of that site and 
the fragmentation pattern. Various groups have shown that ECD of doubly 
protonated peptides preferentially gives rise to charged fragments that include an 
arginine residue [35] [36] [22] [25]. Hâkansson et al [22] have linked the higher gas-
phase basicity of arginine with the observation that charged fragments include this 
residue. 
One way to explain these results, in analogy to the mobile proton model [9] 
and in terms of the hot hydrogen re-arrangement mechanism [18], is that hydrogen 
atom transfer from the arginine side-chain to the backbone is less efficient than from 
a less basic site. This may also be due to the fact that the recombination energy of 
electron capture at a less basic site is higher than for a more basic site (see Figure 
1.13, Chapter 1). In support of this assumption, ions at higher internal energies have 
been shown to give rise to a higher proportion of charged fragments that do not 
include an arginine residue. Haselmarm et al. [36] have shown that pulsing a gas 
during electron irradiation resulted in a higher loss of labile groups and a higher 
proportion of charged fragment ions that do not include an arginine residue. 
Similarly, Tsybin et al. [26] have shown that infrared irradiation of ions prior to 
electron irradiation caused the appearance of fragment ions without an arginine 
residue, which were not observed for electron irradiation only. This shows that 
'proton mobility' and 'hydrogen atom mobility' in a peptide are related and that the 
relative ECD fragmentation pattern is related to the internal energy of the molecule. 
BCD of [LHRH_RR]2 appears to confirm the assumption that hydrogen 
atom transfer from the arginine side-chain is less efficient. In this light, the abundant 
ECD fragmentation of [Ac_BK]2 is surprising, but could be explained by 
deprotonation of the C-terminus and a protonation site elsewhere on backbone. As 
mentioned before, arginine may exist as a Zwitterion in the gas-phase [30]. 
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An alternative explanation for the observation that the most basic amino acid 
residue is preferentially included in the charged fragment is that the ECD mechanism 
takes place on a much slower time-scale and that backbone cleavage and proton 
transfer take place on similar time-scales. The time-scale of the ECD process cannot 
be measured directly. In fact, the time-scale of an ECD experiment in an FT-ICR 
instrument is very long (i.e. 100's ms) and hence it is not possible to establish 
whether the reaction is non-ergodic (i.e. <ps) or at a longer time-scale of ns, ts or 
even ms! Ab initio calculations by Uggerud and co-workers have indicated that ECD 
is a non-ergodic mechanism for a minority of peptide ions (- 10%), while for the 
majority of ions backbone cleavage occurs on a slower time-scale (-- 10 s) [37]. Ab 
initio calculations by Tureek have also shown that the mechanism may not have to 
be non-ergodic in order to account for the observed NCa backbone cleavage [38]. 
Further, Tureek and co-workers [39] have proposed that the electron and 
proton move separately, as first suggested by Siegbahn et al [40], effectively 
resulting in hydrogen atom transfer from the protonated site to the backbone 
carbonyl (see Chapter 1, section 1.6.3.2). A separate movement of the electron and 
proton could explain why proton transfer occurs mainly from the less basic site in the 
molecule (This idea will be re-visited in Chapter 6). 
McLafferty and co-workers believe that the ECD mechanism involves 
capture of an electron in a Rydberg state, in analogy to dissociative recombination 
[41], followed by fast intersystem crossing to result in non-ergodic fragmentation 
[42]. Neverthess, the molecule still somehow 'knows' where the most basic site in 
the molecule is. Charge delocalisation at the guanidine group is particularly favoured 
(thus explaining the high gas-phase basicity of that site), hence we can assume that 
charged fragments including the guanidine group should be energetically favoured to 
charged fragments that instead include a site of less favourable charge delocalisation 
(e.g. imidazole ring of histidine side-chain). This would imply that ECD 
preferentially results in fragments that are more energetically favourable. Since ions 
at higher internal energies give rise to fragments that are less energetically favoured, 
the ECD process appears to behave analogous to a thermodynamically driven 
reaction. This also implies that the cleavage pattern is not 'reducible' (i.e. cleavage 
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efficiency related to immediate chemical vicinity, not rest of molecule) [13], since 
the cleavage pattern clearly does depend on where the protonated sites are present. 
In spite of the ambiguity surrounding the mechanism in ECD, the fact that the 
charged ECD fragments in this study preferentially include the most basic amino 
acid gives ECD an advantage over vibrational excitation techniques: if the most basic 
amino acid is located at one of the termini one would expect predominantly N or C-
terminal fragment ions for doubly protonated peptides. This renders de novo 
sequencing much easier. Since most tryptic digests have a C-terminal lysine or 
arginine this strategy is applicable to many compounds. 
3.4 Reverse cleavage 
The occurrence of c (odd-electron) and z' (even-electron) fragments was first 
reported in the literature by Zubarev et al. [18], and the fragments were rationalised 
by hydrogen atom transfer to an Ca. An alternative explanation consists in the 
attraction of the highly polarisable hydrogen atom by the electric field gradient for 
smaller z fragments [43], resulting in z' and c ions. 
The insert in Figure 3.4 shows the z5 and z5 ' fragments, which are 
separated by a mass difference of 1.00795 Da, corresponding to a hydrogen atom 
difference. Conversely, the mass difference between the z5 ' peak and the '3C 
labelled peak is 1.0033 Da, which is consistent with a heavier isotope peak. By 
analogy, Figure 3.5 shows the c5+,  fragment and a fragment, labelled as c5+.  , which is 
1.017 Da lower in mass, corresponding to a hydrogen atom difference. The 
fragments can be explained in terms of the hot hydrogen re-arrangement mechanism 
due to a 'reverse' alpha-cleavage taking place (see Figure 3.13, scheme B). When a 
'reverse' alpha-cleavage takes place the hydrogen atom would be associated with the 
C-terminal fragment z', thus causing this fragment to be 1 Da higher in mass higher 
than generally expected in ECD, whereas the N-terminal fragment c would be 1 Da 
lower in mass than generally predicted. The 'reverse' mechanism has been put 
forward by Kim Haselmann [44]. 
The observation of radical, as well as even-electron c and z fragments 
supports the view that a hydrogen atom re-arrangement takes place in ECD. 
However, Tureèek and co-workers believe that the appearance of c and z' fragments 
can be explained by the fact that after cleavage of the N-C, bond the c' and Z 
fragments are hydrogen-bonded for long enough to account for an exothermic 
hydrogen atom abstraction from C of the c' fragment to Ca on the z fragment [39], 
resulting in c and z' fragments. 
The observation by O'Connor and co-workers that one electron capture can 
result in two backbone cleavages [45] opens the possibility that odd-electron 
fragment ions can further fragment. Hence, one would expect the most stable odd-
electron fragments to be observed preferentially. 
It is possible that multiple mechanisms are in competition with one another 
(see Chapter 1, section 1.6.2). In this study, the assumption will be made that 
electron capture in these studied peptides predominantly results in one backbone 
alpha-cleavage which can proceed either in the 'normal' direction (Figure 3.13 A) or 
in the 'reverse' direction (Figure 3.13 B). The results in this section will be presented 
in the light of a competition between these two processes. 
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Figure 3.13 (A) Schematic of 'normal' alpha-cleavage on peptide backbone as 
proposed by McLafferty and co-workers [18] resulting in c,' and Zm fragments (see 
Chapter 1, section 1.6.3.1). (B) 'Reverse' alpha-cleavage on peptide backbone, 
resulting in c(fl.1) and Z(m+1)' fragments, where n is the number of residues from N-
terminus, in the number of residues from the C-terminus and (n+m) is the total 
number of residues in the peptide. 
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From Figure 3.13 it can he seen that fragments Zm and Z(m+1)' are due to the 
hydrogen atom being transferred to the same backbone carbonyl. By analogy, 
fragments c' and C(11 l) also result from a hydrogen atom being transferred to the 
same backbone carbonyl. If one assumes that the 'normal' and 'reverse' alpha-
cleavage are in competition with one another, the relative appearance of either alpha-
cleavage mechanism determines the relative abundance of c'/ Zm and c(fl1)/ Z(m+1)'. 
This section is concerned with investigating the trends giving rise to either 
mechanism. It is possible that C(n1) would further dissociate to a(l)  fragments [38], 
however, no such fragments are observed in the present study, with the exception of 
[BK]2 and [AcBK]2 . 
3.4.1 ECD of [LHRH_HR]2 
Figure 3.14 shows the relative abundances of the Zm and z,1 ' fragment ions 
for ECD of [LHRH HR]2 , as observed in the mass spectra. This Figure was made 
by the following procedure: 3 mass spectra (consisting of 100 co-averaged time-
domain transients) were taken at a particular hexapole accumulation time. This was 
repeated for two other hexapole accumulation times, yielding 9 mass spectra in total. 
The relative intensity of each peak in the mass spectrum was calculated by dividing 
its peak intensity by the sum of the intensities of all the z fragments (z3 to z9 , and 
Z3 	to z9 ) , taking into account the heavier isotope peaks of Zm+. . For the 9 spectra 
the mean and standard deviation of each relative fragment abundance was 
determined, which is summarised in Figure 3.14. 
A general observation in Figure 3.14 is that even-electron z' fragments are 
preferentially observed for smaller fragments, while larger z fragments only exist as 
radical f fragments (z8 ' and z9 ' not observed). This has also been reported by 
Zubarev and co-workers [43]. Nevertheless, the trend in Figure 3.14 shows that the 
relative abundance of Zm '  ions is not simply inversely proportional to size, but rather 
shows a maximum at z5 '. 






An alternative way to represent these fragment abundances is in terms of a 
competition between 'normal' and 'reverse' alpha-cleavage. Figure 3.15 shows the 
relative z fragment abundances in terms of this competition and in terms of which 
backbone carbonyl the hydrogen would have to be transferred to for that fragment to 
be observed. Note that in Figure 3.15 the fragment abundance of z3 ' is not 
represented, since the corresponding'normal' alpha-cleavage fragment, Z2,  is not 
observed. Therefore, the abundance of z3 ' is not included in calculating the relative 
fragment abundance in Figure 3.15. 
p-GIu 	His 	Trp 	Ser 	Tyr 	Gly 	Leu 
m: 9 8 7 6 5 4 3 
Figure 3.14 Relative abundances of z111 and z 1' fragment ions for ECD of 
[LHRH_HR]2 as observed in the ECD mass spectra. Error bars represent standard 
deviation obtained for 3 spectra (of 100 time domain transients each) taken at 
hexapole accumulation times of 0.7, 0.8 and 0.9 s. (30 ms electron irradiation). 
The different hexapole accumulation times should account for different 
heating of the ions in the hexapole. A high number of ions in the hexapole causes the 







kinetic energy collisions and therefore more significant heating of the ions [46]. 
Longer accumulation times (> 1.5 s) can give rise to peptide fragmentation (data not 
shown). Figure 3.15 shows that the relative abundance of the fragments does not vary 
significantly over the different hexapole accumulation times, this indicates that the 
temperature of the ions is probably similar over this range of hexapole accumulation 
times. 
D-GIu 	His 	TrD 	Ser 	Tvr 	GIv 	Leu 
m: 9 8 7 6 5 4 3 
Figure 3.15 Relative intensity of Zm and Z(m+I)' fragment ions for ECD of 
[LHRH_HR]2 showing amino acid backbone carbonyl where hydrogen atom would 
have to be transferred to for that fragment to appear. Error bars represent standard 
deviation obtained for 3 spectra (of 100 time domain transients each) taken at 
hexapole accumulation times of 0.7, 0.8 and 0.9 s. (30 ms electron irradiation). 
Electron irradiation was also carried out on [LHRH_HR]2 using the 3 Tesla 
APEX II instrument equipped with the rhenium filament. The relative z fragment 
abundances from these experiments are shown in Figure 3.16 (for raw ECD 
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spectrum, see Appendix 3, Figure A3.1). The procedure to calculate the relative 
abundances of the fragments in this Figure is the same as for Figure 3.15. The 
relative fragmentation pattern in Figure 3.16 is similar, but not identical, to the one in 
i Figure 3.15. The intensity of fragment z6+,  i , n particular, s higher in Figure 3.15 than 
in Figure 3.16. In spite of the fact that the hexapole accumulation times (0.7, 0.8 and 
0.9 s) were the same in both experiments and the analyte concentration was the same 
(20 M pEHWSYGLRPG-OH, MeOH:H20:CH3COOH, 0.495:0.495:0.01) other 
instrumental features are different in both instruments: 
The 3 T APEX II Analytica source probably has a higher transmission 
of ions into the hexapole due to a higher internal diameter (ID) of the 
glass capillary (ID 0.3 mm vs 0.2 mm) (see Chapter 2, section 2.1.1 
and 2.1.2). A higher number of ions in the hexapole results in a more 
significant heating of the ions. 
The ion transmission in the 3 T instrument is probably better due to a 
lower magnetic mirror effect compared to the higher field 9.4 T 
instrument. This is consistent with other findings. 
The electron sources in both instruments are different (see Chapter 2). 
The electron capture efficiency in the 3 T instrument is generally poor 
due to the small diameter of the electron beam from the rhenium 
filament.7 Since only a small proportion of ions capture an electron, 
this also results in higher statistical variation, which can be seen in the 
higher standard deviation in Figure 3.15 compared to Figure 3.14. 
The electron irradiation time in both instruments varies significantly 
(30 ms for high-surface cathode as opposed to 500 ms for electron 
filament). It is conceivable that the gas-phase structure could vary 
over such long experiment times, hence resulting in a different 
fragmentation pattern. 
Intensity of [M+2H]2 for [LHRH_HR]2 remaining after 500 ms electron irradiation using rhenium 
filament compared to sum of intensities of [M+2H] and [M+H] 11 : 1 (see Appendix 3, Figure 
A3.1). Compare this to high-surface cathode results where intensity of [M+2H] 2+  for [LHRH_HR]2+  
remaining after 30 ms electron irradiation relative to sum of intensities of [M+2H]+  and [M+H] 3.5 









p-GIu 	His 	Trp 	Ser 	Tyr 	Gly 	Leu 
m: 9 8 7 6 5 4 3 
Figure 3.16 Relative intensity of z111 and Z(ni+1) fragment ions for ECD of 
[LHRH_HR]2 showing amino acid backbone carbonyl where hydrogen atom would 
have to be transferred to for that fragment to be observed. Error bars represent 
standard deviation obtained for 3 spectra (of 100 time domain transients each) taken 
at hexapole accumulation times of 0.7, 0.8 and 0.9 s. (3 T APEX II, rhenium 
filament, 500 ms electron irradiation). 
In Figures 3.15 and 3.16, the relative occurrence of the 'reverse' alpha-
cleavage decreases as a function of the fragment size. The 'normal' alpha-cleavage 
results in odd-electron z' fragments, whereas the 'reverse' alpha-cleavage results in 
even-electron charged z1 ' fragments. It appears that the odd-electron charged species 
are disfavoured relative to even-electron charged fragments in the vicinity of the 
protonated arginine side-chain. In Figure 3.15 the z 	fragment is particularly 
disfavoured compared to Z5'. Figure 3.17 shows the proposed structures for these 
fragments. The amino acid side-chain adjacent to the radical carbon may play a role 
in stabilising the odd-electron species. Table 3.4 shows the correlation between the 
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amino acid side-chain adjacent to the radical carbon and the preferential appearance 
of the Zm fragment, as opposed to Z(m+j) ', based on Figure 3.15. The charge on the 
fragment would be expected to be located on the arginine amino acid side-chain. 
It appears from Table 3.4 that in particular aromatic amino acid side-chains adjacent 
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CH(CH,)2 
Figure 3.17 Proposed structures (stick structure) of z4+* and z5+,  fragment ions for 
[LHRH_HR] 2+ 
Side-chain Chemical formula Appearance of Zm '  
Arg CH2CH2CH2N}{C(NH2)2 N 
Leu CH2CH(CH3)2 N 
Gly H N 
Tyr CH2C6H60H Y 
Ser CH20H Y 
Trp CH2C7H6N Y 
Table 3.4 Correlation between amino acid side-chain and preferential appearance of 
Zm 	fragment for Figure 3.17. If Zm fragment is preferred (Y), if corresponding 
'reverse' alpha-cleavage Z(m+I)' fragment is preferred (N). 
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3.4.2 ECD of [LHRH_HR_NH2]2 
The relative z fragmentation pattern of the doubly charged peptide 
[LHRH HR NH2]2+  (mammalian type LHRH) is shown in Figure 3.18. The raw 
ECD mass spectrum is shown in Appendix 3, Figure A3.2. The ECD mass spectrum 
of [LHRH_HR_NH2]2 presented by Hâkansson et al. [22] shows a series of z 
fragments (z3 to z7 ) and c9+. The relative fragment abundance is similar, although 
they did not observe z8 and z9 . While in Figure A3.2 (see insert, Appendix 2) the 
0 
peak intensity of z6+* is much higher than for Z6+',  the results presented by Hakansson 
et al. showed equal peak intensities for both [22]. The different experimental 
parameters employed by Hâkansson et al. (8 s accumulation in multipole, 30 s 
irradiation with electron filament) are very different to the ones employed in this 
experiment (< 1 s accumulation, 30 ms electron irradiation with dispenser cathode). 
This shows that different experimental conditions can yield different fragment 
abundances, which could be rationalised by a change in the gas-phase structure. 
[LHRH_HR_NF{2]2 and pEHWSYGLRPG-OH (i.e. [LHRH_HR]2 ) only 
differ by their C-termini and therefore one would expect the relative fragmentation 
patterns to be similar. As far as the relative abundances Of Zm and Z(m+1)' fragments 
are concerned, this seems to be the case. For pEHWSYGLRPG-NH2 the amidated C-
terminus is a competing site of protonation which could account for the slight 
differences in fragmentation compared to [LHRH HR]2 , and this may also affect 


















p-GIu His Tip Ser Tyr Gly Leu 
m: 	9 8 7 6 5 4 3 
Figure 3.18 Relative abundance of 	and Z(n+I)' fragment ions for ECD of 
IILHRH_HR_NH212  showing amino acid backbone carbonyl where hydrogen atom 
would have to be transferred to for that fragment to be observed. Error bars represent 
standard deviation obtained for 3 spectra (of 100 time domain transients each) taken 
at hexapole accumulation times of 0.7, 0.8 and 0.9 s. (30 ms electron irradiation). 
3.4.3 ECD of ILHRH_(1)W12 and (LHRH_(d)W12 
The relative z fragmentation pattern of [LHRH_(l)W]2 is shown in Figure 
3.19. The raw ECD mass spectrum for this peptide is shown in Appendix 3, Figure 
A3.3. The relative occurrence of fragments z5 and z6 ' is reversed in this case 
compared to Figures 3.17 and 3.15. Since in this peptide the glycine residue in 
position 6 is replaced by a tryptophan residue, the structure of the fragment ion is 








NH2 are shown in Figure 3.20. This appears to confirm the assumption that an 
aromatic side-chain group adjacent to the radical carbon stabilises Zm fragments. 
p-GIu 	His 	Trp 	Ser 	Tyr 	Trp 	Leu 
m: 9 8 7 6 5 4 3 
Figure 3.19 Relative intensity of Zm and Z(m+1)' fragment ions for ECD of 
[LHRH_(1)W]2 showing amino acid backbone carbonyl where hydrogen atom 
would have to be transferred to for that fragment to be observed. Error bars represent 
standard deviation obtained for 3 spectra (of 100 time domain transients each) taken 
at hexapole accumulation times of 0.7, 0.8 and 0.9 s. (35 ms electron irradiation). 
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Figure 3.20 Proposed structures (stick structures) for z5 	fragment for (A) 
[LHRHHRNH2]2 and (B) [LHRH (l)W]2 . The site of protonation is assumed to 
be on the arginine side-chain. 
The relative z fragmentation pattern of the doubly charged peptide 
[LHRH(d)W]2 is shown in Figure 3.21. The raw ECD mass spectrum for this 
species is shown in Appendix 3, Figure A3.4. This peptide varies compared to 
[LHRH(1)W]2 only by the fact that the tryptophan residue in position 6 is a (d) 
instead of an (1) stereoisomer. In the case of [LHRH (l)W]2 the z5 fragment is 
more abundant than the corresponding reverse cleavage z6 ' fragment. Whereas the 
ECD mass spectra of the [LHRH_(l)W]2 (Figure A3.3) and [LHRH_(d)W]2 (Figure 
A3.4) look very similar, the inserts show the relative abundances of the z6 ' 
fragment, which is higher for [LHRH_(d)W]2t This finding contradicts the previous 
finding that an aromatic side-chain adjacent to the radical carbon favours odd-
electron Zm ions. The substitution of an (l)W by a (d)W may result in a different 
gas-phase conformation and hence the difference in fragmentation may be related to 















p-Glu 	His 	Trp 	Ser 	Tyr 	(d)Trp 	Leu 
m: 9 8 7 6 5 4 3 
Figure 3.21 Relative abundance of 	and Z(ni+1)' fragment ions for ECD of doubly 
charged [LHRH_(d)W]2 peptide showing amino acid backbone carbonyl where 
hydrogen atom would have to be transferred to for that fragment to be observed. 
Error bars represent standard deviation obtained for 3 spectra (of 100 time domain 
transients each) taken at hexapole accumulation times of 0.7, 0.8 and 0.9 s. (35 ms 
electron irradiation). 
3.4.4 ECD of IBOMB12 
The relative c fragmentation pattern for [BOMB]2+ is shown in Figure 3.22. 
In this case the 'normal' alpha-cleavage results in even-electron c' fragments and 
the 'reverse' cleavage results in corresponding odd-electron c(fl1) '  fragments. The 
'reverse' cleavage is particularly favoured for hydrogen atom transfer to the 
alanine{9} backbone carbonyl, yielding a much higher abundance c8 than the 
corresponding 'normal' alpha-cleavage c9 ' fragment. Figure 3.23 shows the 
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relation to the radical N atom could play a role in stabilising c8+S,  by forming a cyclic 
structure (as shown in Figure 3.23 B), which is resonantly stabilised. 
0.251 pEQRLGNQWAVGHLM-NH2 
p-Glu Gin Arg Leu Gly Asn Gin Trp Ala Val Gly His Leu 
n: 1 234 5678910111213 
Figure 3.22 Relative intensity of 	and c(l) fragment ions for ECD of 
[BOMB]2+  . Error bars represent standard deviation obtained for . spectra (of 100 
time domain transients each) taken at hexapole accumulation times of 0.7, 0.8 and 
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Figure 3.23 Proposed structures (stick structures) for hydrogen atom transfer to 
alanine{9} backbone carbonyl giving rise to 'normal' alpha-cleavage (A) c9 ', and 
'reverse' alpha-cleavage (B) c8+*, which may be able to form a resonantly stabilised 
cyclic structure. 
3.4.5 ECD of [LHRH_RH]2 
The relative fragmentation pattern for ECD of [LHRH_RH]2 is shown in 
Figure 3.24. The fragmentation pattern is dominated by c6 ', which implies NCa 
cleavage on the C-terminal side of tryptophan{6}. One 'reverse' cleavage is seen for 
hydrogen atom transfer to the backbone carbonyl of histidine{8}, yielding abundant 
c7+. However, the corresponding 'normal' alpha-cleavage c8 ' cannot be seen due to 
the presence of proline{9} C-terminal to tryptophan{8}. Hence, the competition 




abundance of c6 ' is somehow surprising, given that the presence of a tryptophan 
side-chain appears to favour c8 in the case of [BOMB]2 . 
pERWSYWLH PG-OH 
p-GIu Arg Trp Ser Tyr Trp Leu His Pro 
n: 1 2 3 4 5 6 7 8 9 
Figure 3.24 Relative abundance of c1 and c(fl 1)"  fragment ions for ECD of doubly 
charged [LHRH_RH]2 peptide showing amino acid backbone carbonyl where 
hydrogen atom would have to be transferred to for that fragment to be observed. No 
error bars are present, since peak intensities only taken from Figure 3.5. 
3.4.6 ECD of ILHRH_HH12 
The relative c and z fragmentation patterns of [LHRH_HH]2 are shown in 
Figures 3.25 and 3.26. Since in this case complementary fragmentation is seen (i.e. N 
and C-terminal fragments), the trends in both can be observed for the same ion. 
Electron capture at the side-chain of histidine{2} would result in C-terminal 
fragments, whereas electron capture at the side-chain of histidine{8} would result in 
N-terminal fragment ions according to the hot hydrogen re-arrangement mechanism. 
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The higher abundances of fragments C6 (Figure 3.28) and z6 ' (Figure 3.29) 
as opposed to their corresponding 'normal' cleavage fragments supports the earlier 
findings that the 'reverse' cleavage takes place in the vicinity of a tryptophan 
residue. The higher abundance of C2 as opposed to c3 ' (Figure 3.27) is odd at first 
sight, since this constitutes a small odd-electron c fragment. Nevertheless, it is 
conceivable that the histidine side-chain could stabilise the electron on the amide 
nitrogen by forming a resonantly stabilised cyclic ring (see Figure 3.27 B), in 
analogy to the tryptophan side-chain in [BOMB]2+ (Figure 3.23 B). In fact, a similar 
ring stabilisation involving the histidine side-chain has also been proposed by 
Wysocki and co-workers to explain the high occurrence of peptide bond cleavage C-
terminal to histidine to yield b fragments [9,10]. 
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p-GIu His Trp Ser Tyr Trp Leu His Pro 
n: 1 2 3 4 5 6 7 8 9 
Figure 3.25 Relative abundances of e' and C(n1)'  fragment ions for ECD of 
[LHRH_HH]2 relative to sum of c and z fragment ions combined. No error bars are 





p-GIu His Trp Ser Tyr Trp Leu His Pro 
m: 9 8 7 6 5 4 3 2 1 
	
Figure 3.26 Relative abundances of 	and Z(m+1)' fragment ions for ECD of 
[LHRH_HH]2 relative to sum of c and z fragment ions combined. No error bars are 
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Figure 3.27 Proposed stick structures for hydrogen capture at tryptophan{3) 
backbone carbonyl, yielding a normal alpha-cleavage (A) c3 ' fragment ion, and 
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Figure 3.28 Proposed stick structures for hydrogen capture at leucine {7} backbone 
carbonyl of [LHRH_HH]2 , yielding a 'normal' alpha-cleavage (A) c7 ' fragment 
ion, and a 'reverse' alpha-cleavage (B) c6 fragment ion, which could again form 
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Figure 3.29 Proposed stick structures for hydrogen capture at tryptophan{6} 
backbone carbonyl of [LHRH HH]2 , yielding a 'normal' alpha-cleavage (A) Z4 
fragment ion, and a 'reverse' alpha-cleavage (B) z5 ' fragment ion. 
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3.4.6 ECD of ILHRH_RR12 
The relative c and z fragment abundances for ECD of [LHRH_RR]2 are 
shown in Figures 3.30 and 3.31. The relative c fragmentation pattern in Figure 3.30 
is similar to the relative c fragmentation pattern for ECD of [LHRH_HH]2 (Figure 
3.25), with c9 ' being the most abundant fragment and c6 more abundant than c7 '. 
This re-confirms the stability of c6 , which can be rationalised by the tryptophan 
side-chain. 
The relative z fragmentation pattern for [LHRH_RR]2 (Figure 3.31) shows a 
striking abundance of Zm' fragments, as opposed to Zm fragments. Even-electron z 
fragments as large as z8 ' and z9 ' are observed for ECD of [LHRH_RR]2 , which is 
not the case for any of the other LHRH variants. The most pronounced 
discrimination, in terms of a competition between 'normal' and 'reverse' alpha-
cleavage, occurs for z5 ' and z6 ', the structures of which are shown in Figure 3.32. 
The low abundance of z5 is surprising, given that the fragment structure is the same 
as for ECD of [LHRH (l)W]2 , for which the abundance of 	is higher (see Figure 
3.19). Nevertheless, the gas-phase structures of [LHRH_RR]2 and [LHRH_(l)W]2 
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p-GIu Arg Trp Ser Tyr Tm Leu Arg Pro 
n: 1 2 3 4 5 6 7 8 9 
Figure 3.30 Relative abundances of c' and C(n J) fragment ions for ECD of 
[LHRFI_RR]2 relative to sum of c and z fragment ions combined. No error bars are 







p-GIu Arg Tip Ser Tyr Trp Leu Arg Pro 
m: 9 8 7 6 5 4 3 2 1 
Figure 3.31 Relative abundances of Zm and z(,,,+,)+' fragment ions for ECD of 
{LHRHRR12 relative to sum of c and z fragment ions combined. No error bars are 
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Figure 3.32 Proposed stick structures for hydrogen capture at tyrosine{5} backbone 
carbonyl of [LHRH_RR]2 , yielding a 'normal' alpha-cleavage (A) z5 fragment ion, 
and a 'reverse' alpha-c1eavag () z6 ' fragment ion. 
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3.4.7 ECD of IBK12 and IAc_BK12 
Finally, the relative c fragment abundances for [BK]2 and [Ac_BK]2 are 
-I shown in Figures 3.33 and 3.34. The patterns look similar, although c8
+, 
 is much 
more abundant for [Ac_BK]2 (see Figure 3.34) than for [BK]2 (see Figure 3.33). 
The higher abundance of c5 relative to c6 ' (which is not observed) can be 
rationalised due to the presence of a proline residue (in position 7) on the C-terminal 
side of serine{6}. These bradykinin peptides have 3 prolinc residues in their 
sequences, which limits the backbone cleavages that can be observed and therefore 
makes these peptides less suitable to study the relative occurrence of radical and 
even-electron c and z fragments. Further, it is not clear how to explain the 
appearance of an a8 fragment, which could be due to further fragmentation from 
Cg, as suggested by Tureek [38], but could also be due to other mechanisms. The 
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n: 1 2 3 4 5 6 7 8 9 
Figure 3.33 Relative abundances of c,,+' and c(.1)+*  fragment ions for ECD of 


















Arg Pro Pro Gly Phe Ser Pro Phe Arg 
n: 1 2 3 4 5 6 7 8 9 
Figure 3.34 Relative abundances of c11 ' and c(lI)'  fragment ions for ECD of 
[Ac_BK]2t Error bars represent standard deviation obtained for 3 spectra (of 100 
time domain transients each) taken at hexapole accumulation times of 0.9 and 1.0 s. 
(30 ms electron irradiation). 
3.4.8 Conclusions 
This study has shown that the relative occurrence of radical and even-electron 
c and z fragments for these peptides could be explained in terms of a competition 
between a 'normal' and 'reverse' alpha-cleavage. The occurrence of even-electron 
Zm '  fragments appears to be favoured for smaller size fragments, whereas larger size 
fragments are more likely to be odd-electron 	fragments. This observation may 
be linked to the vicinity of the radical Ca in z,,, +* to the protonated site; i.e. z,,, +* is 
favoured further away from the protonated group. These results also suggest that the 
amino acid side-chain adjacent to the radical Ca in 	can play a role in stabilising 
-#+ + the fragment (compare abundance of Z5+' for ECD of [LHKI-I_1-Ik_NH2
]2+ and ECD 
of [LHRH_(l)W]2 ) if the gas-phase structure is right (compare abundance of z5 for 
ECD of [LHRH (l)W]2 and ECD of {LHRfl(d)W}2 ). 
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In the case of c fragments, even-electron c' are much more common than 
the corresponding odd-electron c ions for ECD of these peptides. Odd-electron c7 
fragments are observed for larger fragments and there appears to be a correlation 
between the occurrence of 	and the presence of an aromatic hetero-cyclic side- 
chain (i.e. tryptophan and histidine side-chains). It is conceivable that c7 forms a 
cyclic structure with the side-chain as shown for [BOMB]2+ (Figure 3.23 B), 
[LHRH_HH]2 (Figure 3.27 B and 3.28 B) and [LHRH_RR]2t 
Thus, in terms of the discussion above, the relative occurrence of the 
'normal' and 'reverse' alpha-cleavages would be due to a combination of the 
immediate chemical environment of the amino acid side-chains where the hydrogen 
atom is transferred to and the gas-phase conformation of the peptide. In terms of the 
results for [LHRH_(l)W]2 and [LHRH_(d)W]2 the relative fragment abundances in 
ECD may be able to distinguish between amino acid stereoisomers. 
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3.5 Relative fragmentation 
In analogy with the discussion in sections 3.3 and 3.4, in this section I assume 
that the ECD process is fast and that the efficiency of hydrogen atom transfer is 
linked to the ease of abstraction from the protonated site and ease of acceptance from 
the hydrogen atom acceptance site. For the molecule [LHRH_HR]2+ this implies that 
only electron capture at the histidine side-chain gives rise to efficient backbone 
fragmentation, whereas electron capture at the arginine side-chain would merely 
result in neutral loss fragments. For [LHRH_HR]2 the hydrogen affinities of the 
accepting backbone carbonyls are likely to be highly equivalent. Hence, the rate of 
hydrogen atom transfer is probably linked to the relative vicinity of the electron-
capturing protonated site (i.e. H) to the hydrogen-accepting backbone carbonyl. 
Table 3.5 shows the relative occurrences of the different processes in ECD of 
[LHRHHR]2 . Only 1 in 4 electron captures results in hydrogen atom desorption for 
this species (see Table 3.5), which suggests that the intra-molecular hydrogen atom 
transfer is surprisingly efficient. It is therefore conceivable that hydrogen bonding 
plays a role in hydrogen atom transfer. Here, it is put forward that preferential 
hydrogen bonding of the electron-capturing sites to particular backbone carbonyls 
enhances backbone cleavage at those sites. Since the ECD mechanism is assumed to 
be non-ergodic, the structure of the peptide ion before electron capture would 
determine the fragmentation pattern. This will be discussed in terms of modelling 
peptide structures in Chapter 4. 
Process Relative occurrence I % 
Reduced species [M+2H] 8.5 
Hydrogen desorption [M+H] 25 
Sum of neutral losses 13.5 
Sum of ECD backbone fragment ions 53 






3.5.1 ECD of LHRH variants 
Figure 3.35 shows the relative z fragment intensities for [LHRH_HR]2 
associated with respective backbone carbonyls. This Figure was generated by 
summing the relative intensities for Zm
+.  and Z(m+1)
+,  in Figure 3.15. Note that z1 
+. 
and Z(m+1)' are due to hydrogen atom transfer to the same backbone carbonyl, 
according to the 'normal' and 'reverse' alpha-cleavage mechanisms (see Figure 
3.13). Note also that the z3 fragment intensity is not included in this study due to the 
fact that the Z2 does not appear due to the cyclic structure of proline, and that the 
c9 fragment is not included due to the ambiguity with the 59 Da loss (see section 
3.2). 
p-GIu 	His 	Trp 	Ser 	Tyr 	Gly 	Leu 
m: 9 8 7 6 5 4 3 
Figure 3.35 Relative ECD Zm (= Zm + Z(m+1) ') fragment abundances for 
[LHRHHR]2 associated with respective backbone carbonyls. (data taken from 
Figure 3.15) (9.4 T APEX III, dispenser cathode) 
The relative ECD z fragment abundances for [LHRH_HR]2 as determined 
with the electron filament are shown in Figure 3.36. Figures 3.35 and 3.36 show very 
similar patterns, which supports the assumption that the relative fragmentation 
pattern in ECD is reproducible and does not depend on the experimental parameters 









p-GIu 	His 	Trp 	Ser 	Tyr 	Gly 	Leu 
m: 9 8 7 6 5 4 3 
Figure 3.36 Relative ECD Zm (= Zm + Z(rn+1) ) fragment abundances for 
[LHRHHR]2 associated with respective backbone carbonyls. (data taken from 
Figure 3.16) (3 T APEX II, rhenium filament) 
The relative ECD z fragment intensities for [LHRH_HR]2+  
[LHRHHRNB2]2 (data from Figure 3.18), [LHRH(l)W]2 (data from Figure 
3.19) and [LHRH (d)W]2 (data from Figure 3.21) are overlaid in Figure 3.37. The 
relative fragmentation pattern for these peptides is very similar. In terms of the 
efficiency of hydrogen atom transfer this could imply that these peptides have similar 













p-GIu 	His 	Tip 	Ser 	Tyr 	Xxx 	Leu 
m: 9 8 7 6 5 4 3 
Figure 3.37 Relative ECD Zm (= Zm + Z(ffl+) ) fragment abundances for 
[LHRH_HR]2 , [LHRH_HR_NH2]2 , [LHRH_(l)W]2 and [LHRH_(d)W]2 , where 
Xxx denotes the variable amino acid in position 6. 
3.5.2 ECD of [BOMB]2 
The relative ECD c and z fragment intensities for [BOMB]2+ are shown in 
Figure 3.38. The ECD mass spectrum of [BOMB]2+ (Figure 3.7) also includes two z 
fragments (Z12 '  and Z13)  which are included in this analysis. 
The relative cleavage efficiency for [BOMB]2+ in Figure 3.38 is quite 
different to the one for the LHR}T variants in Figure 3.37. One of the higher cleavage 
sites in both systems is on the C-terminal side of tryptophan, which has been reported 
before [12]. Otherwise, the cleavage efficiency over the length of the peptide does 





the backbone carbonyl; whereas backbone cleavage associated with the backbone 
carbonyl of glycine{11} is enhanced, the cleavage associated with glycine{5} is of 
low abundance. 
p-Glu Gin Arg Leu Gly Asn Gin Trp Ala Val Gly His Leu 
1 2 3456 7 8 9 10 11 12 13 
m: 13 12 11 10 9 8 7 6 5 4 3 2 1 
+. Figure 3.38 Relative ECD c11 + (= c,,+ + (c-1)(fll) ) and zz,,+ (= Z +. 	+, + Z(m+I) ) 
fragment abundances for [BOMB]2 . 
The highest fragments are in general not due to hydrogen atom transfer to a 
backbone carbonyl in the immediate vicinity of the histidine side-chain from a stick 
structure point of view. Since the stick structure of the peptide does not give a 
representative idea of the actual vicinity of the histidine side-chain to various 
backbone carbonyls, the gas-phase structures of the above peptides will be modelled 
using mechanical force field modelling (Amber force field [47,48]) in Chapter 4. 
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3.5 Conclusions 
This mechanistic study of ECD of quite well-defined peptide systems has 
shown that the spectra contain much information which can be useful to obtain 
further primary sequence information. In this light, the neutral losses in ECD have 
shown to be of diagnostic value for the presence of some amino acids. The 82 Da 
loss in particular is highly specific and sensitive to the presence of the histidine 
residue. Some other losses (17 Da, 59 Da) are more ambiguous to interpret in these 
peptides and more work needs to be done in that area. The 131 Da loss (isobaric with 
the loss of the tryptophan side-chain plus a hydrogen atom) may be a probe of 
tryptophan protonation. 
The correlation study of linking the gas-phase basicity of the protonated site 
to the occurrence of charged fragments has shown that the most basic site is 
preferentially incorporated in the charged fragment. This is particularly useful in the 
de novo sequencing of tryptic digest peptides, since these often give doubly charged 
peptides in the gas-phase [10] and they generally contain a more basic amino acid on 
the C-terminus (arginine or lysine), therefore resulting in primarily C-terminal 
fragment ions. 
The occurrence of radical and even-electron c and z ions was investigated in 
terms of the 'normal' and 'reverse' alpha-cleavage mechanisms. This study suggests 
that the immediate chemical environment can play a role in stabilising particular 
odd-electron fragments. Further, the differences found for the doubly charged 
peptides of [LHRH(l)W]2 and [LHRH(d)W]2 suggest that the peptide 
conformation may play a role in determining which mechanism is favoured. 
Modelling of peptide ions will be shown in Chapter 4. 
The relative abundances of fragments linked to a particular backbone 
carbonyl show that these do vary significantly over the length of the peptide. For the 
following discussion in Chapter 4, the assumption is made that ECD is based on a 
non-ergodic mechanism and that the transfer efficiency of the radical hydrogen from 
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the protonated site to the backbone carbonyl is related to the vicinity of both groups 
prior to electron capture. 
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Chapter 4 
Molecular mechanics force field 
modelling of peptide gas-phase ions 
4.1 Introduction 
The LHRH (luteinizing hormone releasing hormone) peptides are a family of 
decapeptides that are also known as GnRH (gonadropin-releasing hormone) peptides 
which play a key physiological role as a mediator of neuroendocrine regulation in the 
mammalian reproductive system [1,2]. Fifteen structural variants of GnRH have been 
identified [3]. All GnRH peptides are characterised by the conservation of the N-
terminal residues (pGlu-His-Trp-Ser) and the C-terminal residues (Pro-Gly-N}12) 
with a few exceptions. In mammalian GnRH (mGnRH) (sequence 
pEHWSYGLRPG-NH2, i.e. [LHRHHRNH2]2 is doubly protonated variant of 
mGnRH) residues 5-8 are believed to adopt a 13-11' turn conformation which allows 
interaction with mGnRH type I receptors [4]. The identity of residue 6 plays a 
particular role in determining whether the 13-1I' turn conformation is adopted or not. 
Nuclear magnetic resonance (NMR) studies for mGnRH have shown that a 13-type 
turn is present about Gly{6} (i.e. glycine residue in position 6 from N-terminus) [5]. 
Substitution with a D-amino acid in position 6 increases the receptor binding affinity, 
which is thought to be due to constraining the conformation to a 13-type turn [6]. 
Determining the structure of these peptides is difficult due to their high flexibility 
[7]. Guarnieri et al. [8] have performed solution phase modelling of mGnRH using 
the Amber force field [9,10] and the generalised Bornlsurface area (GB/SA) 
solvation model of water [11]. They probed the conformational space of the peptides 
by Monte Carlo simulated random walks'. They predicted 'families' of GnRH 
structures of which 70% have a 13-type turn involving residues 5-8. A review of the 
Monte Carlo-type simulations involve a stochastic approach based on the use of random numbers 
and probability statistics to investigate a problem. The peptide mGnRH has 35 rotatable torsional 
angles, which makes it impossible to probe the totality of the conformational space that mGnRH has 
available. Hence, Guarnieri et al have used the Monte Carlo approach where the value of a torsional 
angles are set to particular values by the 'roll of a die'. This approach allows for a statistical 
evaluation of the different conformations that mGnRH can adopt. 
140 
structural dependence of GnRH peptides and their interaction with the GnRH 
receptor has been published by Millar and co-workers [12]. 
So far, no gas-phase structure modelling has been published on GnRH 
peptides. Since the dielectric constant of the vacuum (Evacuuni=  1) is more similar to 
the immediate environment of the GnRH type I receptor (Epeptide/protein = 4) than for 
water (Ewater = 80), the gas-phase is an appropriate 'medium' to study the structures 
of these systems. Further, hydrogen bonding between e.g. pGlu(1) and Gly-NH2(10) 
is believed to play a role in stabilising the -turu conformation [6] and can be studied 
more readily in the absence of water. 
In this Chapter modelling of the GnRH/LHRH peptides investigated in 
Chapter 3 [LHRHHR]2 , [LHRHHRNH2]2 , [LHRH(l)W]2 and 
[LHRH_(d)W]2 (see Figure 3.35) will be attempted in vacuo (i.e. the gas-phase) 
using the AMBER  suite of programs [13]. A correlation is drawn between the 
relative ECD fragmentation pattern in Chapter 3 (section 3.5) and preferential 
hydrogen bonding (Hbond) of the protonated sites to particular backbone carbonyls 
as predicted by modelling. For the sake of simplicity this is referred to as the 
ECD/Hbond correlation study. In the light of the ECD mechanism, the assumption is 
made that the ECD mechanism is non-ergodic and hence the gas-phase structure 
pjpr to electron capture determines the dissociation pattern. In particular, 
preferential hydrogen bonding of the protonated site to particular backbone carbonyls 
may enhance hydrogen atom transfer to those carbonyls resulting in higher backbone 
cleavage at those sites. Thus, the applicability of ECD as a tool to study gas-phase 
structure will be investigated. 
The approach to perform force field modelling in this study is outlined in 
section 4.2. The modelling results for the peptides in this study are presented 
thereafter [LHRHHR]2 (section 4.3), [LHRHHRNIH2]2 (section 4.4), and 
[LHRH(l)W]2 and [LHRH (d)W]2 (section 4.5). Gas-phase structure modelling is 
also carried out for the larger peptide [BOMB]2+ (section 4.6) (for amino acid 
sequences, see Table 3.1 Chapter 3). 
2  Note that AMBER refers to the computer modelling package, whereas Amber refers to the 
mechanical force field that is used in this modelling package. 
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4.2 Approach to force field modelling 
4.2.1 Making new residues 
Molecular modelling of peptides in this study has been carried out using 
Amber7 [13] based on the 1999 force field (ff99) [14]. The atom types are mostly 
those developed by Cornell et al. in the 1994 force field [15], however, changes have 
been made in many torsional parameters.3 Standard amino acid residues are available 
in the AMBER suite of programs to build polypeptide chains [15]. These residues are 
suited for solution phase modelling and hence the standard residues have protonation 
sites reflected by the basicities of amino acids in solution (i.e. pKa values, see 
Chapter 1 section 1.4.2). As discussed in Chapter 1, the order of basicities of the 
amino acids in the gas-phase is different to the one in solution. When carrying out 
modelling in the gas-phase, it is often necessary to make new residues that reflect the 
protonation sites in the gas-phase. 
Figure 4.1 shows the flow chart for the procedure to make new residues in 
AMBER that was used in this work. The procedure involves using the program LeAP 
(imbedded in the AMBER suite of programs) which allows visualisation of the 
residue and saving of the residue as a coordinate file; e.g. pdb file (Protein Data Bank 
file). Initial electrostatic potential (ESP) charge fitting on the atoms for new amino 
acid residues is derived from Gaussian 98 [17] single point calculations at HF/6-
31 G*  level of theory. The basic idea underlying the ESP charge fitting procedure is 
to produce a set of atom-centred point-charges meant to accurately describe the 
electrostatic potential of the molecule at given multiples of the Van der Waals radii 
(1.4, 1.6, 1.8 and 2.0). The restrained electrostatic potential (RESP) [18] fitting 
procedure is then carried out in antechamber (part of AMBER suite of programs) in 
order to minimise high charges on embedded atoms and differences in charges on 
equivalent atoms. The charges obtained from the ESP charge fitting procedure in 
Note that the 2002 force field (ff02) is a polarisable variant of ff99, where the charges were 
determined at the B3LYP/cc pVTZ//HF/631G* level [16]. In the ff02 force field the atomic charges 
are more similar to 'gas-phase' charges, whereas the charges derived by Cornell et al. exaggerate the 
dipole moment by 10-20 % thereby accounting for the polarisation in an aqueous environment. At the 
time of modelling these peptides, I was not aware of this new force field (ff02) and hence the 'newest' 
known variant was used (i.e. 09). 
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Gaussian are not equivalent for a static molecule, however, in a dynamic molecule 
where free bond rotation takes place these charges should be equivalent. Apart from 
new atomic charges, sometimes also new bond and torsion angles are required when 
making new residues. The structures of the modified residues as well as the atomic 
charges are shown in Appendix 4: pyro-glutamic acid (Figure A4.1), neutral C-
terminal glycine (Figure A4.2), neutral amidated C-terminal glycine (Figure A4.3), 
protonated amidated C-terminal glycine (Figure A4.4), neutral amidated C-terminal 
methionine (Figure A4.5) and protonated amidated C-terminal methionine (Figure 
A4.6). The atoms in these residues are represented using CPK4 with colour-coding of 
the atoms: C = green, H = white, 0 = red, N = blue and S = yellow. This convention 
of colour-coding of the atoms will also be employed for other structures shown in 
this Chapter. The (d) isomer of tryptophan was made by changing the order of atoms 
in the (I) tryptophan residue and hence did not require new charges to be made. 





charge fitting from 
GAUSSIAN 
Perform RE SP 
charge fitting in 
antechamber 
Build residue 
again in LeAP 
and add charges 
Update bond and 
torsion angles 
Name residue 
and add to library 
Figure 4.1 Schematic flow chart for procedure to make new amino acid residue in 
the AMBER suite of programs. 
"All graphical representations of structures were effected using the VMD software (Visual Molecular 
Dynamics) available on website: http://www.ks.uiuc.edulResearchlvmdl 
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4.2.2 Simulated annealing and molecular dynamics 
Figure 4.2 shows the flow chart outlining the procedure used in investigating 
the gas-phase structures. The polypeptides in this study are subjected to a simulated 
annealing procedure involving heating to 800 K5 followed by controlled cooling to 0 
K to give a minimised structure (see Figure 4.3). This minimised structure then 
serves as a seed structure for the next annealing cycle. In total 100 candidate 
structures are generated with this procedure, which is thought to give a reasonable 
probing of the potential energy surface of the possible structures .6 Since the 
temperature reflects the velocities of atoms in the molecule, the cooling cycle causes 
the molecule to minimise its potential energy (i.e. fall into a minimum on the 
potential energy surface). 
A 0 K structure represents a structure where no atomic movement takes place 
and therefore it needs to be interrogated by molecular dynamics at a higher 
temperature (e.g. 300 K) to determine its gas-phase stability at higher internal 
energies. The temperature 300 K represents a reasonable internal energy to probe the 
secondary structure of peptides [19] using the Amber force field. The hydrogen 
bonding interactions of the protonated site of lower gas-phase basicity than arginine 
(i.e. histidine side-chain or C-terminal protonated amide) to backbone carbonyls are 
determined for the lowest energy structures and these are investigated at higher 
internal energies with dynamics. Hydrogen bonding in this analysis refers to an 
atomic distance of< 3 A for the heavy atom distance N ... 0 and an angle N-H ... 0> 
1500, where 180° refers to linear alignment of N-H ... 0. The cut-offs employed for 
hydrogen bonding differ among research groups. Whereas Kurz et al. [20] used 
distance N ... 0 < 3.5 A and angle N-H ... 0 > 120°, McDonald et al. [21] used 
distance N-H ... 0 < 2.5 A and angle N-H ... 0 > 120°. The reasons for using the 
stringent definition for hydrogen bonding, as employed in this study, is explained in 
section 4.3.1. The fundamental time-step in these dynamics calculations is 1 Es 
As explained in Chapter 1 (section 1.5), the temperature expresses the kinetic energy (K.E.) of the 
atoms. K.E. = '/2 m v2 = Nf k T/2, where m = mass of atom, v = velocity of atom, Nf = degrees of 
freedom (Nf = 3, for perfect gas), k = Boltzmann constant and T = temperature. 
This procedure has been developed by the group of Prof Michael Bowers in Santa Barbara, 
California, USA. 
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(femto second = 1015 s), however, the structures of the molecular dynamics 
simulations will be extracted only every 1000 fs (i.e. 1 ps). 
Build polypeptide in 
LeAP 
Make coordinate 
(.crd) and topology 
(.top) files 
Run annealing script 
(set T and limit) 
Obtain relative 
energy of structures 
Investigate low- 





dynamics (e.g. 300 
K) to see if structure 
is stable 
Figure 4.2 Schematic flow chart showing procedure for analysis of gas-phase 
structures. 
T / K 	Molecular dynamics at 800 K 








over 10 steps (1 step 
= 1 ps dynamics at 
lower temperature) 
I 0 	10 	20 	30 	40\ Time / PS Minimised structure Minimised structure (cycle n) 
(cycle n+1) 
Figure 4.3 Schematic for simulated annealing procedure (cycle n+1) showing 
heating of the minimised structure from the previous cycle (cycle n) to 800 K and 





4.3 Modelling of [LHRH_HR]2 
4.3.1 Minimised structures 
The peptide [LHRH HR]2 (sequence: pEHWSYGLRPG-0H) was built by 
protonating the side-chains of histidine and arginine. This peptide was chosen due to 
the relative unambiguous assignment of the protonation sites. Figure 4.4 shows the 
relative energies of the 100 minimised candidate structures from the annealing 
procedure which have been normalised with respect to the strain energy of the lowest 
energy structure Es[LHRH_HR]2{min73} = -128.06 kcal mol. 
-51 	 I 	 I 	• 	I 	 I 	 I 
0 	20 40 60 80 100 
Minimised structure number 
Figure 4.4 Relative energies of minimised structures for [LHRH_HR]2 obtained 
from the simulated annealing procedure, normalised with respect to 
Es[LHRHHR]2{min73} = -128.06 kcal rnoF1 . The horizontal line indicates the cut-
off for the 10 lowest energy structures. 
An analysis of the hydrogen bonding interactions using the hydrogen bonding 
definition as used by Kurz et al. [20] (i.e. bond distance N ... 0 < 3.5 A and bond 
angle N-H ... 0> 120°) showed hydrogen bonding for [{2}(His)N-H ... 0=C(His){2}] 
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for 50 of the 100 minimised structures. Hydrogen bonding of the histidine side-chain 
to other backbone carbonyls was found to be much reduced (i.e. 	20 candidate 
minimised structures for each backbone carbonyl). Since the hydrogen atom is 
believed to be desorbed from the protonated site as a hot hydrogen H (-j 6 eV) [22] 
it is reasonable to argue that the angle for N-H ... 0 should be more linear and hence 
the cut-off angle for a hydrogen bonding interaction was chosen to be a more 
conservative N-H ... 0 > 150°. Moreover, the bond distance N ... 0 was chosen as 
N ... 0 <3 A. Calculated equilibrium hydrogen bonding distances for bond distance 
N ... 0 by Kim et al. using quantum chemical calculations were 3 A [23]. Quantum 
chemical calculations by Huang et al. gave bond distances for N ... 0 < 3 A and angle 
N-H...0 	1800 for the minimum interaction geometries of hydrogen bonded 
biological complexes [24]. As noted by McDonald et al. the hydrogen bond 
Populations predicted by modelling vary with definition stringency for a hydrogen 
bonding interaction [21]. Nevertheless, constraints for hydrogen bonding interactions 
must be established in order to analyse the modelled structures even if this approach 
is somewhat arbitrary. 
Table 4.1 shows which of the 100 minimised structures for [LHRHHR]2+  
have hydrogen bonding interactions (length < 3 A, angle > 150°) with particular 
backbone carbonyls. The number of minimised structures showing hydrogen bonding 
of the histidine side-chain N-H's to a particular backbone carbonyl is summarised in 
Figure 4.5. No structures are found showing hydrogen bonding for [{2}(His)N-
H ... 0=C(pGlu){1}] and only 3 structures are found to show hydrogen bonding for 
[{2}(His)N-H ... 0=C(His){2}]. This is in agreement with the relative ECD 
fragmentation pattern for [LHRH_HR]2 (Chapter 3, Figure 3.35), which shows low 
abundances for z fragments associated with the backbone carbonyls of pGlu{1 } and 
His{2}. However, the relative distribution for the number of minimised structures 
showing hydrogen bonding to any of the other backbone carbonyls does not match 
the relative abundances of ECD fragments linked with particular backbone carbonyls 
(see Chapter 3, Figure 3.35). This shows that the statistical distribution of minimised 
structures predicting hydrogen bonding to particular backbone carbonyls for this 
annealing procedure does not correlate with the statistical distribution of ECD 
fragments linked to particular backbone carbonyls in Figure 3.35. Conversely, the 
lWA 
modelling studies by Guarnieri et al. involved a Monte Carlo-type approach [8], 
which allows for a statistical assessment of gas-phase structures, which would be 
more appropriate for this study. 
Backbone carbonyl Structure number Relative energy to min73 / kcal moE' 
pGlu{l} none NA 
His{2} rnin2l 14.79 
His{2} min72 5.71 
His{2} rnin9l 15.43 
His{2}  Average: 11.98 ±5.44 
Trp{3}  min 15 17.53 
Trp{3} min l6 6.39 
Trp{3}  min27 18.85 
Trp{3}  min28 12.37 
Trp{3}  min29 8.92 
Trp{3}  min35 21.66 
Trp{3}  min45 11.32 
Trp{3}  min47 11.16 
Trp{3}  niin48 29.45 
Trp{3}  rnin56 18.13 
Trp{3}  min66 16.25 
Trp{3}  min69 21.27 
Trp{3}  niin73 0 
Trp{3}  min85 17.97 
Trp{3}  min94 11.60 
Trp{3}  minIOO 8.74 
Trp{3} Average: 14.88 ± 7.05 
Ser{4} minlO 0.84 
Ser{4} min32 19.03 
Ser{4} min49 7.43 
Ser{4} rnin60 21.20 
Ser{4} m1n74 18.71 
Ser{4} min93 7.90 
Ser{4} min95 24.52 
Ser{4} min96 19.50 
Ser{4} min98 18.16 
Ser{4} min99 6.93 
Ser{4} Average: 14.42 ± 7.88 
Tyr{5} niin4 9.58 
Tyr{ 5} min6 14.98 
Tyr{5} min7 17.53 
Tyr {5} min30 23.67 
Tyr{5} min3l 13.16 
Tyr{5} rnin36 19.15 
Tyr{5} min43 16.91 
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Tyr{5} rnin78 17.27 
Tyr{5} rnin79 15.56 
Tyr{5} rnin89 16.95 
Tyr(5) Average: 16.48 ± 3.69 
Gly{6} min 12 9.58 
GIy{6} min 14 14.98 
Gly{6} rnin29 8.92 
Gly{6} min40 19.82 
Gly{6} min57 20.26 
Gly{6} rnin64 31.69 
Gly{6} min75 9.55 
Gly{6} min8l 23.24 
Gly{6} min84 21.69 
Gly{6} Average: 1775±7,67 
Leu{7} mini 7.92 
Leu{7} min2 0.84 
Leu{7} min9 7.92 
Leu{7} miniS 17.53 
Leu{7} III ini6  6.39 
Leu{7} min20 12.42 
Leu{7} rnin37 12.99 
Leu{7} min44 19.82 
Leu{7} rnin45 11.32 
Leu{7} min46  7.20 
Leu{7} min47 11.16 
Leu{7} rnin55  6.84 
Leu{7} min65 18.96 
Leu{7} min67 15.52 
Leu{7} min69 21.27 
Leu{7} rnin70 17.53 
Leu{7} rnin8O 27.20 
Leu{7} min85 17.97 
Leu{7} rnin88 3.44 
Leu{7} Average: 12.85±6.82 
laNe 4.1 lable sunirnarising hydrogen bonding interactions of histidine side-chain 
with backbone carbonyls for 100 minimised structures of [LHRHHR]2+  . The 
average energy of the structures that show hydrogen bonding to a particular 





















p-GIu 	His 	Trp 	Ser 	Tyr 	Gly 	Leu 
Figure 4.5 Number of minimised structures for [LHRI-I_FIR]2 showing hydrogen 
bonding (Hbond) to particular backbone carbonyls. 
An alternative way to look at the modelled results is to consider the lowest 
energy structures only, since the ions may exist in low-energy conformations. Figure 
4.6 shows the 10 lowest energy structures. For the sake of clarity only the side-chains 
of histidine and one other amino acid are shown. The backbone of the peptide 
structures is represented as a ribbon, with the N-terminus on the left-hand-side and 
the C-terminus on the right-hand-side. 5 of the minimised structures (min2, minlO, 
rnin17, min52 and min73, Figure 4.5 A, B, C, G and I) can be classified as 'loop' 
structures involving a 13-turn in the middle of the molecule and both termini close in 
space. Other minimised structures have backbones that vary more significantly, 
despite an energy difference of merely < 6 kcal mol'. This compares to calculated 
energy stabilisation of biologically relevant hydrogen bonds by ab initio calculations 

























Figure 4.6 10 lowest energy structures for simulated annealing of [LHRH_HR]2 , 
showing backbone ribbon, the side-chain of histidine and the backbone carbonyl that 
histidine nitrogen-bound hydrogens are in hydrogen bonding contact with (indicated 
by blue lines). (A) min2, (B) minlO, (C) minl7, (D) minl8, (E) min50, (F) min5l, 
(G) min52, (H) min72, (I) min73 and (J) min88. COXXX{X} refers to backbone 
carbonyl of amino acid residue Xxx in position {X} from N-terminus. 
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An analysis of the 10 lowest energy structures reveals that six of thern show 
hydrogen bonding of one of the nitrogen-bound hydrogens (N-H's) on the histidine 
side-chain to backbone carbonyls (see Figure 4.6). Structure minl7 (Figure 4.6 C) 
shows a hydrogen bonding interaction of the histidine side-chain to the C-terminal 
backbone CO (carbonyl). The other five show hydrogen bonding of the histidine 
side-chain to the backbone carbonyls of histidine{2} (Figure 4.6 H), tryptophan{3} 
(Figure 4.6 I), serine{4} (Figure 4.6 B) and leucine{7} (Figure 4.6 A and J). 
The three lowest energy structures predicted from this annealing procedure 
are min2 (Figure 4.6 A), minlO (Figure 4.6 B) and min73 (Figure 4.6 1), which show 
hydrogen bonding to the backbone carbonyls of leucine{7}, serine{4} and 
tryptophan{3}. In the study of the relative z fragment abundances for [LHRHHR]2 
(see Figure 3.35, Chapter 3), the fragmentation associated with the backbone 
carbonyls of tryptophan{3}, serine{4}, glycine{6} and leucine{7} were found to be 
enhanced. Hence, the hydrogen bonding pattern of the histidine side-chain to 
backbone carbonyls as predicted by the lowest energy minimised structures has 
confirmed 3 of the 4 enhanced ECD cleavage sites in Figure 3.35 (Chapter 3). 
Figure 4.7 shows the detail of the lowest energy structure min73, where the 
side-chain of histidine is in hydrogen bonding contact with the backbone carbonyl of 
tryptophan [{2}(His)N-H ... O=C(Trp){3}]7, resulting in enhanced hydrogen atom 
transfer to that carbonyl followed by higher backbone cleavage. Ab initio 
calculations by Tureëek and co-workers also showed that the activation barrier for 
such a one-step transfer of the hydrogen atom to a backbone carbonyl is very low and 
would be preferred over the two-step process (hydrogen atom desorption followed by 
re-capture) [25]. The predicted rate constants for this one-step process were as high 
as 1012 s-i, which approaches non-ergodic behaviour. It should be noted that no 
hydrogen bonding was found in these modelling studies to arnide nitrogens and it is 
well known that hydrogen bonding to oxygen is stronger than to nitrogen due to the 
four lone pair electrons on oxygen. 
Note that [XJ(Xxx)N-H ... O=C(Yyy)Y}] refers to the atomic distance between the nitrogen-bound 
hydrogen on the side-chain of amino acid residue Xxx in position {XI (from N-terminus) to the 
oxygen atom on the backbone carbonyl belonging to the amino acid residue Yyy in position {Y) 
(from N-terminus). 
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Figure 4.7 Detail of minimised structure min73, showing hydrogen bond between 
histidine N-H to backbone carbonyl of tryptophan [{2}(His)N-H ... O=C(Trp){3}J. 
Schematic exemplifies that electron capture at histidine side-chain results in 
enhanced hydrogen atom transfer to the backbone carbonyl of tryptophan and 
therefore higher cleavage at that site (indicated by red line). (The 'normal' a-
cleavage is shown, see Chapter 3 Figure 3.13. Note that arrows refer to single 
electron movement.) 
4.3.2 Molecular dynamics of min73 
Molecular dynamics of the lowest energy structure (min73) at 300 K shows 
that the hydrogen bonding interaction for [{2}(His)N-H ... O=C(Trp){3}] is 
conserved at higher internal energies (see Figure 4. 8).8  Despite an initial increase in 
the interatomic distance, the structure quickly (< 30 ps) stabilises to within a 
hydrogen bonding interaction distance for [{2}(His)N-H ... O=C(Trp){3}J. Molecular 
dynamics of the structure 300K.1000ps9 at 500 K shows that both hydrogens of the 
histidine side-chain are alternately in hydrogen bonding contact, suggesting a 
flipping of the histidine side-chain (see Figure 4.9). The higher temperature of the 
8  Note that the SHAKE algorithm 26J is used in these simulations. This restricts the movement of the 
hydrogen atoms. 
For the sake of simplicity the gas-phase structures of dynamic simulations will be referred to as 
XK.Yps, where X is the temperature of the simulation in Kelvin and Y is the number of pico seconds 
of simulation. Hence 300K.1000ps refers to the structure obtained after 1000 ps molecular dynamics 
at 300 K. 
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molecule represents a higher velocity of the atoms, manifesting itself in side-chain 
flipping. The higher temperature can also be understood as a speeding up of the 
simulation and hence 1000 Ps at 300 K is equivalent to a time frame of < 1000 Ps 
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Figure 4.8 Atomic distance [{2}(His)N-H ... O=C(Trp){3}J (in Angstrom) for 
molecular dynamics of [LHRH_HR]2+ min73 at 300 K. 
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Figure 4.9 (A) Atomic distances [{2}(His)N-HD1 . . .0C(Trp){3}] and (B) 
[{2}(His)N-HE2 ... O=C(Trp){3}I for molecular dynamics of [LHRHHRJ2 min73 
at 500 K. (C) Structure (stick structure) of protonated histidine side-chain showing 
delocalisation of positive charge and two different nitrogen-bound hydrogens (HE2 
and HD I) on histidine side-chain. Curvy arrow indicates rotation of side-chain. 
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Figure 4.10 shows the root-mean-square (RMS) deviation of the 500 K 
molecular dynamics simulation. In Figure 4.10 RMS refers to the average spatial 
deviation of each heavy backbone atom (i.e. N, Ca, C and 0) for 500K.Yps (where Y 
is number of ps of simulation) compared to the reference structure 500K.lps. This 
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Figure 4.10 RMS deviation of peptide backbone (atoms N, Ca, C and 0) for inin 73 
of [LHRH_HR]2 at dynamics of 500 K for reference = 500K. 1 Ps. 
Figure 4.11 shows the gas-phase structure of min73 at 500 K after 50 Ps of 
simulation (500K.50ps). The 13-turn centred at residues 4-6 can clearly be seen. 
Given the high internal energy of the molecule, the similarity of this structure to the 
minimised structure of rnin73 (Figure 4.6 I) implies a significant thermodynamic 










Figure 4.11 Ribbon gas-phase structure of min73 of [LHRH_HR]2 at dynamics of 
500 K after 50 ps simulation (500K.50ps) showing pyro-glutamic acid N-terminus 
and secondary structure (p-sheet - brown, f3-turn - cyan). Insert shows detail of I-
turn for residues 4-6 (serine, tyrosine and glycine). 
The interaction of the arginine side-chain N-H's with the backbone carbonyls 
of [LHRH_HR]2+  for the 300 K dynamics run is shown in Figure 4.12. Three of the 5 
nitrogen-bound hydrogens (N-H's) are in hydrogen bonding contact to the backbone 
carbonyls of leucine and tyrosine. Figure 4.13 shows a representative ribbon 
backbone structure for this simulation and the hydrogen bonding interactions for the 
arginine side-chain. If preferred hydrogen bonding of the charged site hydrogens to 
particular backbone carbonyls results in enhanced backbone cleavage next to those 
carbonyls, one would expect c5 and c7 fragments. As discussed in Chapter 3, in 
ECD of [LHRH_HR]2 no such fragments are observed. In terms of the hot hydrogen 
re-arrangement mechanism these modelling results suggest that the poor transfer of 
hydrogen atoms from the arginine side-chain to the backbone (resulting in backbone 
cleavage) is not due to an inability of the arginine side-chain to solvate backbone 
carbonyls (see discussion on 'ease of hydrogen atom transfer from protonated site', 
section 3.3, Chapter 3). 
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Figure 4.12 (A) Atomic distances of arginine side-chain N-HA, N-HB and N-HC to 
backbone carbonyls of tyrosine {5} and Icucine{7} for dynamics of min73 at 300 K. 
(B) Schematic structure (stick structure) of arginine residue showing 5 N-H on side-
chain: HA, HB, HC, HD and HE. Positive charge (+) nominally located on C, but in 




Figure 4.13 Ribbon structure of min73 at molecular dynamics of 300 K showing 
hydrogen bonding of N-H's to backbone carbonyls of tyrosine{5} and leucine{7}. 
Structure 300K.l00ps. 
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4.3.4 Molecular dynamics of minlO 
Molecular dynamics at 100 K of the minimised structure [LHRH_HR]2 
minlO maintains {2}(His)N-HD1 . . .O=C(Ser){4}J in a hydrogen bonding 
interaction (Figure 4.14 A). However, at higher internal energies of 300 K (Figure 
4.14 B), this hydrogen bond is broken. Figure 4.15 shows the RMS deviations for the 
molecular dynamics simulation at 300 K, comparing the following structures in the 
dynamics simulation to the initial structure or the structure obtained after 30 ps. The 
peptide backbone is shown to readily adopt a 13-turn conformation around residues 4-
6, similarly to min73 (see Figure 4.11). This structure can be described as a 'loop' 
structure with a 13-turn involving residues 4-6 and both N and C-termini close 
together. Nevertheless, neither of the two histidine side-chain N-H's are found to be 
in hydrogen bonding to backbone carbonyls. 
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100 Kdynamics 
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Figure 4.14 Atomic distance [{2}(His)N-H ... 0C(Ser){4}J for [LHRHHR]2 
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Structure 300 K.Yps 
Figure 4.15 RMS deviation for [LHRH_HR]2 minlO (A) structures 300K.2ps - 
300K.1000ps in 300 K dynamics simulation compared to reference 300K.lps (B) 
structures 300K.31ps - 300K.1000ps in 300 K dynamics simulation compared to 
reference 300K.30ps (C) ribbon structure for 300K.30ps (D) ribbon structure for 
300K.500ps. 3-turn is shown for both structures. 
4.3.5 Molecular dynamics of min2 
Molecular dynamics at 300 K of [LHRHHR]2 min2 shows that this 
structure falls apart to an elongated structure (Figure 4.16) and that the hydrogen 
bond for [{2}(His)N-HE2 ... O=C(Leu){7fl is broken (Figure 4.17 A). Instead, N-
HE2 of the bistidine side-chain is found to be in hydrogen bonding contact with the 
backbone carbonyl of tyrosine. This structure is fairly dynamic and hence the 
hydrogen bonding interaction of the atomic distance [{2}(His)N-
HE2 ... O=C(Tyr){5}] is broken at times (Figure 4.17 B). In the relative ECD 
fragmentation study of [LHRH_HR] 2+  (see Chapter 3, Figure 3.35) the z 





Histidine{2} side-chain 	COtyrosine{5} 
Figure 4.16 Molecular dynamics ribbon structure of [LHRH_HR]2 min2 at 300 K. 
Structure 300K.200ps. 
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Time / PS 
Figure 4.17 Atomic distances for dynamics of [LHRH_HR]2 min2 at 300 K (A) 
12 } (His)N-HE2. . . 0C(Leu) {7 }] and (B) [{2 } (His)N-HE2. . . O=C(Tyr) { 5 }]. 
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4.3.6 Conclusions for LLHRH_HR12 
In summary, an analysis of the three lowest energy structures of 
[LHRH_HR]2 obtained by simulated annealing has shown that hydrogen bonding of 
the histidine side-chain N-H's to backbone carbonyls correlates with high ECD 
backbone fragmentation associated with those carbonyls. Hydrogen bonding to the 
backbone carbonyl of glycine{6} was not predicted from the lowest energy 
structures. Molecular dynamics at low energy (100 K) appears to conserve the 
hydrogen bonding interaction (Figure 4.14 A), however higher energy (300 K) 
dynamics changes the gas-phase conformation for minlO and min2 (Figure 4.14 B 
and 4.17 A). This could be explained by the fact that the ions in the ECD 
experiments of [LHRHHR]2+  have low internal energies. The loop structure 
involving a f3-turn conformation at residues 4-6 was independently found for 
different minimised structures and found to be stable at higher internal energies (with 
the exception of rnin 2, see Figure 4.16). 
4.4 Modelling of C-terminal amidated LHRH 
4.4.1 Modelling of [LHRH_HR_NH2]2 
4.4.1.1 Minimised structures 
In order to assess the comparability of the simulated annealing procedure, the 
peptide [LHRH_HR_NH2]2 (mGnRH, sequence: pEHWSYGLRPG-NH2, 
protonation sites: side-chains of arginine and histidine) was modelled using the same 
approach as for [LHRH HR]2 . Both peptides differ merely by their C-termini and 
hence the annealing procedure is expected to yield low-energy structures that are 
similar. 
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Figure 4.18 Relative energies of 100 minimised structures obtained by simulated 
annealing of LHRH_HR_NH2]2 , normalised with respect to 
Es[LHRH HR NH21 {min48} = -184.17 kcal mol. 
Figure 4.18 shows the relative energies of the 100 minimised candidate 
structures. The energy spread from the lowest (min48) to the highest energy structure 
(minl6) is 37.5 kcal rnol 1 , which is comparable to the simulated annealing for 
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[LHRHHR]2 (difference = 31.8 kcal moF, see Figure 4.4). Table 4.2 shows which 
of the 100 minimised structures for [LHRH HRNH2]2* have hydrogen bonding 
interactions (length < 3 A, angle < 30°) with particular backbone carbonyls. The 
number of minimised structures showing hydrogen bonding of the histidine side-
chain N-H's to a particular backbone carbonyl is summarised in Figure 4.19. The 
relative distribution of structures showing hydrogen bonding in Figure 4.19 does not 
correlate with the relative ECD fragmentation pattern for [LHRH_HR_NH2I2 
(Chapter 3, Figure 3.37). 
Backbone carbonyl Structure number Relative energy to min48 / kcal moF1 
pGlu{1} rnin42 24.44 
pGlu{1} rnin7l 14.94 
pGlu{1} minlOO 30.30 
pGlu{1} Average: 23.23 ±7.75 
His{2} min] 14.90 
His{2} rnin9 27.76 
His{2} mmli 18.28 
His2} min12 11.86 
His{2} minl5 31.01 
His{2} min69 2.17 
l-Iis{2} min70 18.41 
His{2} min88 25.33 
His(2) Average: 18.72±9.35 
Trp{3} min l3 21.68 
Trp{3} minl6 37.55 
Trp{3} III inl9 33.08 
Trp{3} min2l 35.00 
Trp{3} m1n32 25.34 
Trp{3} min33 29.49 
Trp{3} min34 26.67 
Trp{3} min40 21.54 
Trp{3} min73 22.35 
Trp{3} m1n74 19.01 
Trp{3} m1n92 20.97 
Trp{3} min97 27.45 
Average: 26.678 ± 6.03 
Ser{4} min2 22.97 
Ser{4} min5 33.88 
Ser{4} min30 32.52 
Ser{4} min39 34.31 
Average: 30.92 ± 5.35 
Tyr{5} min14 15.83 
Tyr{5} min20 34.54 
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Tyr {5} min25 31.73 
Tyr {5} rnin27 26.05 
Tyr{5} min28 16.68 
Tyr {5} rnin29 16.47 
Tyr{5} rnin58 1.20 
Tyr{5} niin59 15.71 
Tyr{5} m1n93 17.18 
Tyr{5} min95 27.08 
Tyr{5} Average: 20.25 ± 9.75 
Gly{6} rnin36 26.67 
Leu{7} minlO 30.48 
Leu{7} n1in54 22.12 
Leu{7} rnin55 13.76 
Leu{7} rnin6l 9.06 
Leu{7} min62 7.34 
Leu{7} niin79 17.02 
Leu{7} Average: 16.63 ±8.65 
Table 4.2 Table summarising hydrogen bonding interactions of histidine side-chain 




















p-Glu 	His 	Trp 	Ser 	Tyr 	Gly 	Leu 
Figure 4.19 Number of minirnised structures for [LHRH_HR_NH2]2 confirming 
hydrogen bonding (Hbond) to particular backbone carbonyls. 
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Figure 4.20 shows the ribbon structures of the 10 lowest energy minimised 
structures for the simulated annealing of [LHRH _HR_NH2]2 . One 'family' of 
structures includes rnin48, min49, min50 and min52 (Figure 4.20 A, B, C and D), 
which all show hydrogen bonding of (His)N-HD1 to the backbone carbonyl of 
arginine{8}. Two other structures predict hydrogen bonding of (His)N-HD1 to the 
backbone carbonyl of leucine{7} (min6l and min62, Figure 4.20 F and G), whereas 
min63 and min69 (Figure 4.20 H and I) predict hydrogen bonding of(His)N-HDI to 
the C-terminal glycine{ I 0} carbonyl. This means that none of the low-energy 
structures for [LHRH_HR_NH2]2 predict hydrogen bonding of the histidine side-
chain N-H's to backbone carbonyls with enhanced ECD fragmentation (see Chapter 
3, Figure 3.37). 
on 
Histidine{2} 













Histidine{2} 	C-terminal glycine{1 O} 	Histidine{2} 













Figure 4.20 Low-energy ribbon structures for annealing of [LHRH _HRNH2]2 
showing histidine side-chain and hydrogen bonding interaction with backbone 
carbonyl if present (A) min48, (B) min49, (C) min50, (D) min52, (E) min58, (F) 
min6l, (G) min62, (H) min63, (I) min69 and (J) min9l. 
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4.4.1.2 Molecular dynamics of min48 
The lowest energy structure min48 was subjected to molecular dynamics at 
300 K. Figure 4.21 shows the atomic distances of N-HDI on the histidine side-chain 
to the backbone carbonyls of arginine{8}, proline{9} and leucine{10}, all of which 
are in hydrogen bonding distance. Figure 4.22 shows the ribbon backbone structure 
of the peptide after 500 Ps dynamics at 300 K (300K.500ps). Once again, the N-H's 
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Figure 4.21 Atomic distances (in Angstrom) for molecular dynamics at 300 K of 
[LHRH NH2 HR]2 min48 (A) [12}(His)N-HDI .. .O=C(Arg){8}], (B) [{2}(His)N-








Figure 4.22 Representative ribbon structure of molecular dynamics at 300 K of 
[LHRH _HR_NH2]2 min48. Structure 300K.500ps. 
4.4.1.3 Molecular dynamics of min6l 
The minimised structure min6l (Figure 4.20 F) was also subjected to 
dynamics at 300 K. The atomic distances for (His)N-HD1 to various backbone 
carbonyls are shown in Figure 4.23. A representative structure of the dynamics 
simulation is shown in Figure 4.24. Enhanced hydrogen atom transfer from the 
histidine side-chain to the backbone carbonyls of arginine could explain the high 
abundance of the z3 ' fragment in the ECD mass spectra of all LHRH compounds. 
The presence of the proline residue in position 9 prevents the corresponding normal 
alpha-cleavage Z2 respectively cg fragment to be seen. Hydrogen atom transfer to 
the backbone carbonyl of proline could explain the high abundance of the c9 
fragment (once again the c8 fragment could not be observed in this case, due to the 
presence of proline). 
The atomic distances of (His)N-HE2 with backbone carbonyls for this 
dynamics simulation are shown in Figure 4.25. Whereas, the hydrogen bond to the 
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C-terminal 
glycine{10} Histid ine{2} 
side-cF - 
backbone carbonyl of leucine can be rationalised (see Chapter 3, Figure 3.37), the 
hydrogen bond to the backbone carbonyl of tyrosine cannot be rationalised with the 
relative ECD z fragment intensities for [LHRH_HR_NH2]2 . 
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Time / PS 
Figure 4.23 Atomic distances for molecular dynamics at 300 of [LHRH 
—HR _NH2]2 min6l (A) [{2}(His)N-HD1 . . .0C(Arg){8}], (B) [121(I-lis)N-
HD1 .. .0C(Pro){9}] and (C) [{2}(His)N-HD1 . . .0C(Gly){ 10}]. 
Figure 4.24 Representative ribbon structure of molecular dynamics at 300 K of 
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Figure 4.25 Atomic distances for molecular dynamics at 300 K of 
[LHRH NH2 l-1R]2 	rnin6l (A) [{2}(His)N-HE2 ... O=C(Leu){7}] and (B) 
[{2}(His)N-HE2 ... O=C(Tyr){5}]. 
4.4.1.4 Conclusions for [LHRH HRNH2 J 2 
In summary, the 10 lowest energy structures of [LHRH _HR_NH2]2 have 
not confirmed hydrogen bonding of the histidine N-H's to backbone carbonyls that 
show enhanced ECD backbone fragmentation and in particular not to COser ine{4}, 
which shows the highest ECD fragmentation (Chapter 3, Figure 3.37). Nevertheless, 
the loop' structure was again found to be adopted for the molecular dynamics of 
both m1n48 and niin6l. 
4.4.2 Modelling of [LHRH_HRNH3]2 
4.4.2.1 Minimised structures 
A possible competitive protonation site in amidated LHRH peptides is the C-
terminal amide NH2 group instead of the histidine side-chain. The gas-phase basicity 
of this amide group is likely to be similar to the gas-phase basicity of asparagine or 
glutamine (see Appendix 2, Table A2.2), which is lower than the gas-phase basicity 
of histidine and even lower than other residues in the molecule (i.e. proline and 
tryptophan). Since all naturally occurring LHRH peptides are amidated at the C-
terminus, is was deemed to be interesting to determine how the modelled structures 
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change when this site is protonated instead of the histidine side-chain. The 
[LHRH_HR_NH3]2 (sequence pEHWSYGLRPG-NH2; protonation sites: side-chain 
of arginine and amidated C-terminus) peptide was built in LeAP and the 
conformational space was probed using the annealing procedure. 
The relative energies of the 100 lowest energy structures are shown in Figure 
4.26. Of these, structures min47, min76 and min89 are lowest in energy. The strain 
energy for the lowest energy conformer, as derived by AMBER, is 
Es[LHRH_HR_NH3]2 {min89} = —214.64 kcal moF1 , which is energetically more 
favourable to the strain energy determined for the corresponding lowest energy 
structure for {LHRH HRNH2I2 (Es[LHRH HRNH2]2 { min48 } = -184.17 kcal 
mold ). Since [LHRH HRNH2]2 and [LHRH HRNH3]2 are structural isomers, 
their relative energies can in principle be compared. The difference in gas-phase 
basicity of histidine (GBli ist idine = 223.7 kcal mor1 ) and the C-terminal amide group 
(GBasparag i ne = 214.2 kcal mol') is approximately 10 kcal mol', whereas the strain 
energy difference for the structural conformers [LHRHHRNH2]2 min48 and 
[LHRHHRNH3]2 min89 is approximately 30 kcal mol'. Hence, these results 
suggest that protonation of the amidated C-terminus is in fact energetically 
favourable to protonation at the histidine side-chain. The ribbon structures, as well as 
the hydrogen bonding interactions of the C-terminal NH3 group (if present) are 
shown in Figure 4.27. Whereas, min47 and min76 (Figure 4.26 A and B) have a 
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Figure 4.26 Relative energies of minimised structures obtained from simulated 
annealing of [LHRHHRNH3]2 , normalised with respect to 





Figure 4.27 Ribbon structures of minimised structures for {LHRH HR NH3]2 (A) 
min47, (B) min76 and (C) min89. f3-turn represented in cyan. 
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4.4.2.2 Molecular dynamics of min89 
Min89 was subjected to molecular dynamics at 300 K (see Figure 4.28). The 
initial structure changes due to the higher internal energy, but stabilises after about 
300 ps dynamics (Figure 4.28 B). The 13-turn around residues 4-6 for the 300 K 
dynamics is reproduced, although the N-terminus of the molecule still points away 
thus causing a 'non-loop' type structure. 
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Figure 4.28 RMS deviation of molecular dynamics simulation at 300 K of 
[LHRH_HR_NH3]2 min89 for backbone N, Ca, C and 0 for (A) reference = 
300K.lps and (B) reference = 300K.300ps. (C) Representative structure for 
simulation (300K.300ps). 
4.4.2.3 Conclusions for ILHRH_HR_NH312 
Protonation of the C-terminal amide group renders the analysis of hydrogen 
bonding interactions of this group with backbone carbonyls more complicated, since 
no preferential hydrogen bonding exists. While a 13-turn involving residues 4-6 is 
found for min89 at higher internal energies, the termini of the molecule are not close 
in space (i.e. non-loop type structure), showing that different protonation of the 
peptide yields different minimised gas-phase structures. Nevertheless, protonation of 
the amidated C-terminus may only represent a small proportion of ions in the gas-
phase due to the higher gas-phase basicity of histidine. Moreover, basicity of amides 
in solution is very low [27] and since ions are made by electrospray ionisation (ESI) 
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the solution phase structure may need to be taken into account. On the other hand, 
ions are held in an accumulation hexapole for 600-1000 ms, which will cause heating 
to the ions and hence gas-phase conformations of the ions should be favoured. 
4.5 Modelling of ILHRH_(1)W12 and ILHRH_(d)W12 
4.5.1 Minimised structures 
LHRH peptides with a tryptophan residue in position 6 were modelled. The 
lowest energy structures for [LHRH_(l)W]2 (sequence pEHWSY(l)WLRPG-NH2; 
protonation sites at the side-chains of arginine and histidine) and [LHRH_(d)W]2 
(sequence pEHWSY(d)WLRPG-NH2; protonation sites at the side-chains of arginine 
and histidine) are shown in Figure 4.29. While these structures are quite dissimilar, 
the calculated strain energies Es for both are very similar. 
Figure 4.29 Lowest energy structures of (A) [LHRH_(l)W]2 min23 Es = -172.78 
kcal moi' and (B) [LHRH (d)W]2 min47 Es = -169.79 kcal mol' from simulated 
annealing. Purple colour indicates cc-helix and cyan colour indicates n-turn. Note that 
VMD does not recognise (d)Trp as a residue to show ribbon structure. 
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4.5.2 Molecular dynamics 
Molecular dynamics was carried out on both these structures at 300 K. 
Figures 4.30 and 4.31 show representative gas-phase conformations of both these 
peptide ions for the dynamics simulation. 
The lowest energy structure for [LHRH_(l)Trp]2 (Figure 4.29 A) shows an 
a-helix around residues 4-6 (Ser-Tyr-Trp), which is conserved at higher internal 
energies (Figure 4.30). This structure resembles a 'twist' and is very different to the 
'loop" type structure found for the lowest energy structure of [LHRH_(d)Trp]2 
(Figure 4.29 B). The 'loop' structure is conserved for [LHRH_(d)Trp]2 at higher 
internal energies (Figure 4.31). For [LHRH_HR]2 (Figure 4.11) and 
[LHRH_HR_NH2]2+  (Figure 4.22) the loop structure was also found to be stable at 
higher internal energies. Whereas, ECD of [LHRH HR]2 , [LHRH HRNH2]2 and 
[LHRH_(d)Trp]2+  had shownthat the abundance of Z6
+, 
 > Z5+* (Chapter 3, Figures 
3.15, 3.18 and 3.21), the opposite is the case for [LHRH_(l)Trp]2+ (Chapter 3, Figure 
3.19). These modelling results seem to indicate that the competition between 
normal' and reverse alpha-cleavage could be affected by the gas-phase 




/ 	 COleucine{7} 
Histidine side-chain 
Figure 4.30 Molecular dynamics structure for [LHRH(l)W]2+  min23 300K.300ps. 
Structure resembles a 'twist'. 
°°tyrosine{5} 	
Histidine side-chain 
(d)Tryptophan{6} 	 °°glycine{10} 
side-chain 	 °°Ieucine{7} 
Figure 4.31 Molecular dynamics structure for [LHRH_(d)W]2 min47 300K.300ps. 
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4.5.3 Conclusions for LHRH variants 
In summary, modelling of these LHRH variants in vacuo has shown that a 
loop' structure involving a 13-turn is energetically favourable for the variants with 
protonation sites on the arginine and histidine side-chain, which therefore confirms 
solution phase modelling results by Guanieri [8]. The exception to this rule seems to 
be [LHRH (l)Trp]2 , which has also been confirmed by NMR structure results [5]. In 
terms of the correlation between hydrogen bonding of the protonated site to 
backbone carbonyls and enhanced cleavage at those carbonyls, results for 
[LHRH_HR]2+  suggest good correlation for the lowest energy minimised structures, 
whereas results for [LHRH HR NI-I2]2+ show no such agreement. 
The relative ECD fragmentation patterns for these LHRH variants (Chapter 3, 
Figure 3.37) are similar, which could be explained by similar gas-phase structures. If 
[LHRH_(l)Trp]2 has a different gas-phase conformation to the other LHRH variants, 
but gives a similar ECD fragmentation pattern, this would show that the secondary 
structure of the peptide does not influence the fragmentation pattern significantly. 
This could, however, rationalise whether the relative ECD fragment abundances for 
Z6+' and 	are related to the gas-phase conformation. 
4.6 Modelling of bombesin 
4.6.1 Modelling of IBOMB_NH21 2 
4.6.1.1 Minimised structures 
Since hydrogen bonding in small' peptide such as the LHRH variants may 
not be as robust, the larger peptide bombesin was also modelled using the AMBER 
force field. The doubly protonated bombesin peptide (sequence: 
pEQRLGNQWAVGHLM-NH2) was first attempted with protonation of the side-
chains of arginine and histidine - [BOMB _NH2]2 . The relative energies of the 100 









30- 	 U 	 U.  U 
. 	 U 
L() 	 U . 
LO •  • 	 U • . •.. ... 	• • 
20- 	 . 	 . 	 . . U 	
• 
> 	 U •:... . U 
	
U 
2' . 	 •U •.I 
ca 
 • U •• • U 	• U 	 •. . . 
U 	 . 
. 	U 
0::: 	 • 'dI•• • 
0 	20 	40 	60 	80 	100 
Minimised structure number 
Figure 4.32 Relative energies of minimised structures obtained from simulated 
annealing of [BOMB NH212 , normalised with respect to Es[BOMB  NH2I 2 { min5 5 } 
=-409.74 kcal moF t .  
The ribbon structures of the 10 lowest energy minimised structures are shown 
in Figure 4.33. An analysis of the hydrogen bonding interactions of the histidine 
side-chain N-H's with backbone carbonyls for the 10 lowest energy structures is 
summarised in Table 4.3. 
Hydrogen bonding of the histidine side-chain N-H's to the backbone carbonyl 
of tryptophan{8} is predicted for 2 minimised structures, whereas hydrogen bonding 
to the backbone carbonyl of alanine{9} is predicted for 3 minimised structures. 
Experimentally, these backbone carbonyls show higher ECD cleavage (see Chapter 
3, Figure 3.38). On the other hand, 3 of the lowest energy structures predict 
[{12}(His)N-H ... O=C(Asn){6}] to be hydrogen bonded, which however does not 
























pGlu{1}  0 
Gln{2}  y y  2 
Arg{3}  0 
Leu{4}  0 
Gly{5}  0 
Asn{6} y  Y  Y  3 
Gln{7}  Y  1 
Trp{8}  Y  Y 2 
Ala{9}  Y Y  Y  3 
Val -1101  0 
G!y{11}  0 
His{ 12} ____ ____ ____ ____ ____ ____ 0 
Leu{13}  y  1 
Met{ 14} y 1 
Table 4.3 Table summarising hydrogen bonding interactions of histidine side-chain 
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Figure 4.33 Low-energy ribbon structures for annealing of [BOMB_NH2
]
2 showing 
histidine side-chain and hydrogen bonding interaction with backbone carbonyl if 
present (A) min7, (B) min22, (C) min46, (D) min54, (E) min55, (F) min57, (G) 







4.6.1.2 Molecular dynamics of min22 
Molecular dynamics at 300 K are shown for three of these structures: min22, 
min55 and min6l. Figure 4.34 shows the RMS deviation of the backbone of min22 
during the 300 K simulation. The structure seems to stabilise after 50 Ps dynamics. 
(Figure 4.34 B). A representative 300 K dynamics structure (shown in Figure 4.34 C) 
shows that hydrogen bonding of the histidine N-H's to the backbone carbonyls of 
tryptophan{8} and leucine{13} is conserved (compare to Figure 4.33 B). Figure 4.35 
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Figure 4.34 RMS deviation for molecular dynamics at 300 K of backbone atoms for 
[BOMB _NH2]2 min22 for (A) reference = 300K. ips, (B) reference = 300K.50ps. 
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Figure 4.35 Atomic distances for molecular dynamics at 300 of [BOMB NI-T2]2 
min22 	(A) 	[{11}(His)N-HD1 ... O=C(Leu){13}] 	and 	(B) 	[{1I}(His)N- 
HE2. . .O=C(Trp){8}I. 
4.6.1.3 Molecular dynamics of min55 
The backbone RMS deviation for the molecular dynamics simulation of 
min55 is shown in Figure 4.36. The structure stabilises after 50 ps dynamics and a 
representative structure is shown in Figure 4.36 C. This structure is very similar to 
the minimised structure min57 (see Figure 4.33 F), showing hydrogen bonding of the 
histidine N-H's to COalanineJ91  and the side-chain of glutamine{7}. Figure 4.37 
supports the stability of the hydrogen bonding interactions for [{12}(His)N-
HDI .. .O=C(Ala){9}] at 300 K. Dynamics at 500 K, however, lead to a break-up of 
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Figure 4.36 RMS deviation for molecular dynamics at 300 K of backbone atoms for 
[BOMB NH2]2 min55 for (A) reference = 300K.lps, (B) reference = 300K.50ps. 
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Figure 4.37 Atomic distance for molecular dynamics at 300 of [BOMB_NH2]2 
min55 [{12}(His)N-HD1 ... 0C(Ala){9}]. 
4.6.1.4 Molecular dynamics of min6l 
Figure 4.38 shows the backbone RMS deviation for min6l at 300 K 
dynamics, which deviates significantly from the initial structure (300K.lps). A 
representative stabilised structure (300K.50ps) for the remainder of this dynamics 
simulation is shown in Figure 4.38 C. For this structure hydrogen bonding is 
observed 	for 	[{ 1 2} (His)N-HD 1 . . . 0C(p-Glu) { 1 }] 	and 	[{ 12 }  (His)N- 
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backbone carbonyls of glutamine{2} and asparagine{6} in min6l are broken in 
favour of new hydrogen bonding to the backbone carbonyls of pyro-glutamic 
acid{1 } and glutamine{7} (see Figure 4.39). Note that these hydrogen bonds 
correlate with higher ECD cleavage associated with the backbone carbonyls of pyro-
glutamic acid{ 1 } and glutamine{7} (see Chapter 3, Figure 3.38). 
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Figure 4.38 RMS deviation for molecular dynamics at 300 K of backbone atoms for 
[BOMB _NH2]2 min6l for (A) reference = 300K.lps, (B) reference = 300K.50ps. 
(C) Ribbon structure 300K.50ps showing hydrogen bonding of histidine side-chain. 
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Figure 4.39 Atomic distances for [BOMB _NH2]2 min6l dynamics at 300 K: (A) 
[{ 12}(His)N-HE2 ... O=C(Gln){7}], (B) [{ 12}(His)N-HD1 . . .0C(pGlu){ 1 }], (C) 
112 1 (His)N-HE2 . . .O=C(Asn){6}J and (D) [{ 12}(His)N-HD1 . . .O=rC(Gln){2}]. 
184 
4.6.1.5 Conclusions for [BOMB_NH2]2 
In summary, these results seem to indicate that hydrogen bonding of the 
histidine side-chain to the backbone carbonyls of alanine{9} and tryptophan{8} is 
predicted for low-energy structures and remains conserved at higher internal energies 
of 300 K. Hydrogen bonding of the histidine side-chain to the backbone carbonyl of 
asparagine{6} was also predicted for low-energy structures, however, at higher 
internal energies this hydrogen bond is not stable and is replaced by hydrogen 
bonding to glutamine{7}. These results correlate well with the relative ECD cleavage 
of[BOMB]2 in Figure 3.38 (Chapter 3). 
4.6.2 Modelling of [BOMB_NH3 I 2 
4.6.2.1 Minimised structures 
A competing site of protonation in the bombesin peptide is the amidated C-
terminus. The peptide [BUM B_N H3]2 (sequence: pEQRLGNQWAVGLM-N H2, 
protonation on the side-chain of arginine and the amidated C-terminus) was built in 
LeAP. The relative energies of the structures obtained from the simulated annealing 
are shown in Figure 4.40. Once again, in analogy to [LHRH_HR_NH2]2 and 
[LHRHHRNH3I2 , the strain energy for the lowest energy structure for 
[BOMB NH3]2 (Es[BOMBNH3]2 {min55} = —491.59 kcal moll) is more 
favourable than in the case of [BOMB NH2]2 (Es[BOMBNH2]2 1rnin551 = 
409.74 kcal moM). The ribbon backbone structures of the 10 lowest energy 
structures are shown in Figure 4.41. 
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Figure 4.40 Relative energies of minimised structures of [BOMB _NH3J2 generated 
by simulated annealing, normalised with respect to Es[BOMB NH3]2 {min55} = - 
491.59 kcal mor. 
The minimised structures obtained form the simulated annealing of 
[BOMB—NH3 12  are very different to the ones obtained for [BOMB_NH2]2 . This 
shows that the protonation site plays a significant role in determining the gas-phase 
structure. The hydrogen bonding interactions of the C-terminal NH3 group with 
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Figure 4.41 Low-energy ribbon structures for annealing of [BOMB _NH3]2 showing 
histidine side-chain and hydrogen bonding interaction with backbone carbonyl if 
present (A) minlO, (B) min32, (C) min44, (D) min5l, (E) min54, (F) min55, (G) 


























pGlu{1}  Y  1 
Gln{2}  0 
Arg{3}  0 
Leu{4}  0 
Gly{5}  Y  1 
Asn{6}  y 
Gln{7}  y 1 
Trp{8}  Y  Y 2 
Ala{9} V  1 
Val{ 10}  y y 2 
Gly{11}  Y  1 
His {12}  Y  1 
Leu{13}  0 
Met{ 14}  0 
Table 4.4 Summary of hydrogen bonding interactions of C-terminal NH3 group 
with backbone carbonyls (CO) for 10 lowest energy structures in Figure 4.41. 
4.6.2.2 Molecular dynamics and conclusions 
C-terminal methionine{14} 
-'0pyro-gIutamic acid{1} 
Figure 4.42 Dynamics of [BOMB _NH3 ]2 min55 at 300 K (A) 300K.100ps and (B) 
300K.200ps. 
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Dynamics of min55 (lowest energy structure) shows that the C-terminal NH3  
group enters into hydrogen bonding contact with many backbone carbonyls (see 
Figure 4.42) and hence preferential hydrogen bonding is much more difficult to 
establish. In terms of an ED/Hbond correlation study protonation of the C-terminal 
amide is less useful than protonation of the histidine side-chain. As argued before 
(section 4.4.2.3), the second protonation site in this molecule (first protonation site is 
arginine side-chain) is a matter of controversy. 
4.7 Conclusions and further work 
Molecular modelling of the doubly protonated LHRH variants 
[LHRHHR]2 , [LHRH_HR_NH2]2 and [LHRH_(d)W]2 gives rise to low-energy 
loop' structures involving a 13-turn around residues 4-6, which are stable at higher 
internal energies. For [LHRH(l)W]2 a different lowest-energy structure is 
predicted. This correlates with a difference in the relative abundances of ECD 
fragments z5
+. 
 and Z6+, 
	 2+ 
for [LHRH_(l)W] as opposed to the other three LHRH 
variants. More studies on structural LHRH variants should be conducted to see 
whether the preference for ECD fragments z5 over z6 	is related to the 
conformation of the peptide. 
The results of the ECD/Hbond correlation study are ambiguous. Whereas, the 
lowest energy minimised structures for [LHRH_HR]2+  and [BOMB_NH2]2+  and 
molecular dynamics show that such a correlation seems to exist, the results for 
[LHRH_HRNH2]2 do not support these findings. Further, the second protonation 
site in the C-terminal arnidated peptides is more controversial. Whereas, the higher 
gas-phase basicity of histidine should favour protonation of the histidine side-chain, 
calculated strain energies for the low-energy structures of mGnRH and bombesin 
show that protonation of the C-terminal amide is energetically favourable. 
Protonation of the C-terminal amide group in favour of the histidine side-
chain results in modelling results with no preferential hydrogen bonding pattern. In 
terms of using ECD as a tool to study the gas-phase structure the protonation of this 
group is of less diagnostic value. 
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Modelling of these peptides has shown that the arginine side-chain N-H's do 
engage in hydrogen bonding interactions with backbone carbonyls even at higher 
internal energies. In terms of the hot hydrogen re-arrangement mechanism the low 
transfer of hydrogen atoms from the arginine side-chain to the backbone is therefore 
not due to lower hydrogen bonding interactions than is the case for the histidine side-
chain N-H's. 
The gas-phase structures of these peptides should be investigated by ion 
mobility measurements. The collision cross-sections of the 'loop' structure 
([LHRHRH]2 , [LHRH HRNH2]2 and [LHRH (d)W]2 ) and the 'twist' structure 
([LHRH(l)W] 2+ ) should be different enough to differentiate them. If the gas-phase 
structures of the studied LHRH variants, with the exception of [LHRH(l)W]2+  
confirm the'loop' structure, this could explain the differences in relative abundances 
of ECD fragments z5 and z6 '. Conversely, this would also imply that the 
ECD/Hbond correlation does not always hold, since it would be difficult to explain 
why different gas-phase conformations give rise to very similar fragmentation 
patterns. 
The accuracy of hydrogen bonding interactions as predicted by force field 
modelling (i.e. electrostatic models) has been seriously questioned by Marten et al. 
and Kim etal. due [23,24,281. Kim etal. suggested the use of polarisable force fields 
to improve the accuracy of hydrogen bonding interactions [23]. 
The newer force field in AMBER, ff02, is a polarisable variant of ff99 which 
is more suited for gas-phase modelling. The LHRH peptides in this study should be 
modelled using ff02; it would be interesting to see if the 'loop' structure is again 
predicted as a stable low-energy structure and what preferential hydrogen bonding 
interactions are predicted. Further, a Monte-Carlo type approach to modelling these 
peptide structures (as employed by Guarnieri ci' al. [8]) could establish the relative 
proportion of families of gas-phase structures and hence add a quantitative dimension 
to the modelling studies. 
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Chapter 5 
Zn isotope exchange in the 
metallothionein Zn4SmtA 
5.1 Background 
Zinc is an important metal in biological systems due principally to its role in 
zinc fingers [1], which regulate DNA expression, and metallothioneins [2,3]. The 
interaction of the protein with the metal, and in particular the metal-ligand cluster, 
determines the thermodynamic and kinetic properties of these metals [4], including 
their redox potentials [5,6] and transfer rates [7,8]. Whereas mammalian 
metallothioneins contain two types of clusters: Zn3Cys9 and Zn4Cysi1 [9], bacterial 
metallothioneins possess only one type of cluster [10], Zn4Cys9His2 for the case of 
cyanobacterial Zn4SmtA (Figure 5.1) [11]. 
Figure 5.1 (A) 3D structure of Zn4SmtA (PDB 1JJD). The Zn atoms are shown in 
purple, whereas the sulphur atoms are in yellow. The secondary structure shown 
includes an a-helix (red) and beta sheet (blue arrows). (B) Representation of 
Zn4Cys9His2 cluster, showing Zn sites A-D and ligands binding to metals. 
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Mass spectrometry has been used to examine rnetalloproteins in conjunction 
with electrospray ionisation given the 'softness' of the ionisation [12-15]. Solvent 
conditions must be selected carefully to ionise the metal-protein complex without 
losing the metals in the process. In practical terms, this means that the solution pH 
must be buffered with, for example, ammonium acetate. FT-ICR MS is ideally suited 
to investigate these systems given its high mass resolution and accuracy [16]. When 
unit resolution is achieved the isotope distribution of the metal:protein complex can 
be fitted to the theoretical isotope distribution [17-20]. 
5.2 Materials and methods 
The Zn4SmtA protein is expressed in Echerichia coli BL21(DE3) cells and 
purified as described by Sadler and co-workers [11]. Samples for mass spectrometry 
were exchanged into 10 mM ammonium acetate (at pH 7.4) using pDlO gel filtration 
columns (Pharmacia), and were concentrated by ultrafiltration using Amicon YM3 
filters (MW cutoff 3 kDa). 
Apo-SmtA (i.e. not containing Zn) was prepared according to a literature 
procedure for mammalian nietallothionein [21] by decreasing the pH to 1 and thus 
removing the zinc from the protein by gel filtration at pH 2 (0.01 M HCI) on a 
Pharmacia pDlO column under nitrogen. The protein was re-constituted as 
67Zn4SmtA by adding a slight excess of a 0.1 M 67ZnCl2 solution (prepared from 
67ZnO by dissolving in a minimum amount of 1 M HCI), and carefully raising the p1-I 
to 7.4 with I M NH3. Samples were subsequently washed with 10 mM NH4Ac (pH 
7.4) using Am icon filters to remove excess zinc and chloride. 
For the Zn exchange study, Zn4SmtA with a natural Zn isotope distribution' 
(200 tM, in 10 mM NH4Ac) was incubated at 310 K with a 10-fold molar excess (8 
mM) of 67ZnC12 (prepared from ZnO, 93.11 % isotopic purity). An aliquot (20 or 40 
jiL) was taken after various time intervals. The aliquot was diluted to 2.5 ml and 
Natural abundances of stable Zn isotopes: 64  Zn 48.6(3)%, "Zn 27.9(2)%, 67Zn 4.1(1)%, "'Zn 
l8.8(3)%. 70Zn 0.6(1)%, taken from [22]. 
2 	67 Zn isotopic purity = 93.11% ± 0.05. 14  Zn = 1.37 ± 0.02, 66  Zn = 2.58 ± 0.02. 68Zn = 2.89 ± 0.02 
and 70Zn = 0.05 ± 0 (Oak Ridge National Laboratory, TN). 
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applied to a Pharrnacia pDlO column, which had been equilibrated with 25 ml 10 
mM NH4Ac (for desalting). The total separation time was less than 3 mm. The eluate 
(3.5 mL) was concentrated employing Amicon YM3 filters achieving a final 
concentration of about 20 pLM protein in 10 mM NH4Ac and 10% MeOH, and 
samples were analyzed by FT-ICR MS. 
5.3 Preliminary results 
In order to test the solution conditions necessary to study Zn4SmtA by mass 
spectrometry, Zn4SmtA was prepared with bovine ubiquitin (MW 8564.9, Sigma 
Aldrich) (4:1. Zn4SmtA:ubiquitin) at a total concentration of 15 VtM (1:1:0.12, 
MeOH:H20:CH3COOH) and ionised by electrospray ionisation on the 3 Tesla FT-
ICR MS instrument. Figure 5.2 shows the mass spectrum obtained by averaging 12 
time-domain transients (5 12k). The mass spectrum was internally calibrated with the 
.7+ 	 9-j- ubiquitin peaks (Ubi , Ubi -'-  , Ubi 	and Ubi.11+  .). 
The ionisation efficiency of bovine ubiquitin is found to be higher than for 
Zn4SmtA in these conditions. The 5+ charge state of Zn4SmtA, [M]5+  l, is observed to 
be the most abundant charge state for this species. Nevertheless, some losses do 
occur, such as the loss of threonine ([M-Thr]5 ) and, more importantly, the loss of Zn 
from the metalloprotein ([M+7H-4Zn]7 , [M+6H-4Zn]6 ), giving rise to the 
apoprotein. The loss of threonine can be rationalised from the SmntA sequence', 
which would imply that the N-terminal threonine (T) is lost upon ionisation or in the 
transfer to the ICR cell. The loss of Zn takes place when the pH of the solution is too 
acidic or the solvent conditions too organic, both resulting in an unfolding of the 
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Figure 5.2 Raw ESI mass spectrum of Zn4SmtA [M] and bovine ubiquitin (Ubi) 
(4:1, total concentration 15 jtM) sprayed from MeOH/H20/CH3COOI-I (1:1:0.12). 
The base peak in the mass spectrum is Ubi8t The insert shows the isotopic 
distribution of [M]; arrow indicates the centre peak. The pH was not measured. 
The insert in Figure 5.2 shows the isotopic distribution for [M]t The mass 
resolution on the centre peaks is measured to be >25000, amply sufficient for unit 
resolution, however, the intensity of the centre peak (marked with an arrow) clearly 
is suppressed. The theoretical value for this centre peak was also calculated using the 
isotope distribution' facility in the XmassTM  software, developed by Van Orden 
based upon work by Rockwood et al. [23]. The exact masses in this program are 
taken from Audi and Wapstra [24] and the relative abundances of the isotopes are 
taken from the CRC Handbook of Chemistry and Physics [22]. The elemental 
composition of Zn4SmtA4 is determined using GPMAWTM.5  A comparison of the 
Elemental composition for neutral Zn4 SmtA: C225H348N70080S9Zn4 
experimental (m/z 1173.62) and the theoretical (m/z 1173.61) value of the centre 
peak of the isotope distribution of [M] 5+  yields a mass error of < 5 ppm. Internal 
calibration of the Zn4SmtA peaks with the bovine ubiquitin peaks can give good 
mass accuracy. Nevertheless, a distortion in the isotope distribution seen in the 
example of a suppressed centre peak for [M]5"can result in a misallocation of the 
mass by 1 Da. The relatively low magnetic field of 3 Tesla has a low tolerance of 
space charge effects in the cell and hence more precautions must be taken to 
minimise these effects. 
5.4 Re-constituted 67Zn4SmtA 
Solution conditions were optimised to render the electrospray ionisation 
process less destructive. Zn4SmtA was examined at a concentration of 10 LM 
together with bovine ubiquitin at a concentration of 5 gM in a 5 mM NH4Ac 
water/methanol/formic acid (70:30:0.05, v/v/v) throughout these experiments. The 
ESI generated ions were accumulated in the hexapole for 2000-3000 ins and then 
transferred to the ICR cell. Initial trapping of the ions was effected at 3 V (rear 
trapping plate, PV2) and 2 V (front trapping plate, PVI), followed by dynamic 
ramping to 0.1 V on both trapping plates. These very low trapping plate voltages 
enable the ion cloud to occupy a larger space in the direction of the magnetic field (z 
direction), thereby reducing space charge effects in the cell. Conversely, the previous 
experiment (5.3 Preliminary Results) was conducted using static trapping potentials 
of 0.8 V. The population of ions in the cell was limited, again for the purpose of 
minimising space charge effects. 30 time-domain transients were co-averaged in 
order to reduce distortions in the isotope distribution due to statistical variations in 
the isotope abundances. 
Figure 5.3 shows a mass spectrum of Zn4SmtA spiked with ubiquitin standard 
run under the above solution conditions. Ionisation conditions appear to be gentle 
enough, since no losses were observed. The charge state distribution here (Figure 
5.3) is narrower than previously (Figure 5.2) and additionally the species appear at 
lower charge states. The 4+ charge state, [M]4 (at m/z 1467), is the most abundant, 
http://welcome.to!gpmaw 
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which perhaps reflects the natural charge state of Zn4SmtA in solution. At pH 5.5 
(measured), the conditions were only mildly acidic compared to natural pH 
conditions (pH 7.4). 
The 6+ charge state of ubiquitin, Ubi6 , appearing at m/z 1428 was chosen as 
a suitable standard for calibration of [M]4 . Care was taken to have similar peak 
intensities for Ubi6 and [M]4 in the mass spectra (i.e. intensity of Ubi6 < 3 times 
the intensity of [M]4 ), thereby achieving the best mass accuracy. If required, the 
ratio of Zn4SmtA to bovine ubiquitin concentration was modified to account for this 
discrepancy. 
1000 	 1500 	 2000 
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Figure 5.3 Raw ESI mass spectrum of Zn4SmtA (10 jtM) and bovine ubiquitin (5 
tM) in 5 mM NH4Ac water/methanol/formic acid (70:30:0.05. v/v/v). No losses are 
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Figure 5.4 Isotopic distribution of the 6+ charge state of bovine ubiquitin, Ubi6 , 
centred around m/z 1428. The theoretical isotope distribution calculated using the 
XmassTM software is shown as red dots. The good fit between experiment and model 
validates the use of Ubi6 as a suitable standard for [M]4 . 
The theoretical isotope distribution of Ubi6 was again calculated using the 
XmassTM software, as described previously, based on the elemental composition of 
bovine ubiquitin.6 The isotopic distribution of Ubi6 in Figure 5.4 shows little 
distortion, on the more intense isotope peaks. This confirms that Ubi6 is an 
appropriate standard to check that no isotope distortion is present in the mass 
spectrum. 
For the purpose of determining the mass increase that occurs when 
substituting the natural Zn isotope abundances in Zn4SmtA with 67Zn (93 % 
enriched), the mass raw spectra were deconvoluted to the neutral charge mass 
spectra. This was carried out with the deconvolution algorithm [25] in the XmassTM 
software. The deconvolution algorithm assumes that charges on a protein are due to 
protonation (for cations) and to deprotonation (for anions). In a metalloprotein 
charge is also carried by the metal centres. The oxidation state of some metals (e.g. 
Fe) can vary, thus making the interpretation of their mass spectra more complicated 
[20]. In the example of Fe, the algorithm would underestimate the neutral charge 
6 Elemental composition of neutral bovine ubiquitin: C5781-1629N1060118S1 
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mass for a Fe 3+  containing metalloprotein by the mass of 3 protons, whereas for a 
Fe 2+  containing protein the neutral mass would be underestimated by the mass of 2 
protons, even if the protein itself is the same. In order to be consistent, Johnson et al. 
therefore defined the 'apparent mass' as the mass determined by the deconvolution 
algorithm, which then needs to be corrected by the charge carried by the metal 
centres (i.e. increased by the number of protons that the charge on the metal centres 
equals to). For Zn there is no ambiguity concerning the oxidation state, which is 
always Zn2 . Hence there is no need to correct for the fact that charge is carried by 
the metal centres. In fact, in order to obtain the neutral charge species of Zn4SmtA 
from for example [M]4+, the mass of 4 protons is substracted, which is exactly what 
the deconvolution algorithm does. It is for this reason that the 4+ charge state is 
labelled [M]4 and not [M+4H]4t The neutral elemental composition for Zn4SrntA4 
is determined from the amino acid sequence of SmtA (with the acidic groups 
protonated and the basic groups deprotonated - i.e. neutral); the mass of 4 Zn atoms 
is added and 8 hydrogens are removed since Zn (Zn 2 ) is the charge carrier. 
The deconvoluted neutral mass spectra for Zn4SmtA with a natural isotope 
distribution (Figure 5.5 A) and the reconstituted 67 Zn4SmtA (Figure 5.5 B) show that 
the most intense isotope peak increases from 5862.95 Da (Figure 5.5 A) to 5868.81 
Da (Figure 5.5 B). This compares to calculated theoretical values of 5863.00 Da and 
5869.00 Da, deviations of 8.5 and 32 ppm respectively. The substitution of all 4 Zn 
by 67  Zn (93% enriched) causes a mass increase of the most intense peak by 6 Da and 
the isotope distribution becomes more narrow, due to a decrease in the abundances of 
the various Zn isotopes. The theoretical isotope distributions are in fairly good 
agreement with the experimental ones. The most intense peaks derived 
experimentally and from the model match. Some distortion in the isotope distribution 
is observed and deviation from model to experiment is generally more pronounced 
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Figure 5.5 Deconvoluted neutral charge mass ESI mass spectra and modelled 
isotope distributions (red circles) of (A) natural abundance Zn4SmtA and (B) 93% 
enriched 67  Zn4SmtA. 
5.5 Zn isotope exchange 
Given that the exchange of all 4 Zn atoms in Zn4SmtA gives rise to such a 
pronounced mass increase, it should be possible to determine the number of Zn 
atoms exchanged at any point in between 0 and 4 and hence to investigate the kinetic 
exchange of Zn in this protein. Zn4SmtA was incubated with 67ZnC12 (93% "Zn 
enriched) for different time intervals (at 310 K) and to then determine which of the 
modelled isotope envelopes for Zn 67ZnSmtA (x = 1-4, in 0.25 intervals) fitted the 
experimental data best (see publication, Appendix 5). 
When comparing the experimental to the theoretical isotope distribution, one 
could compare the most intense isotope peaks, as was done above for [M]5 in Figure 
5.2. However, there is a substantial risk that a distortion in the isotope envelope 
could lead to a mislabelling of the mass. This would especially be the case for higher 
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mass compounds (> 1 5 kDa), where the isotope envelopes are much wider and the 
most abundant isotope peak is not readily identifiable. instead, Senko et al. proposed 
the chi squared test', which takes the whole isotope distribution into account and 
statistically compares it to the theoretical one [17]. He et al. proposed a method 
which uses the standard deviation as measure of how well the experimental and 
theoretical isotope distributions match [19]. The standard deviation method' has the 
advantage that it is easier to compare the quality of fits for different charge states. 
Here the standard deviation method' is used as well, since it is easy to 
implement and allows a simple comparison between different fits. By statistically 
fitting the experimental to the theoretical isotope distributions, the number of 67  Zn 
exchanged on average can be determined much more accurately. To maximise the 
accuracy of this fitting, only the 7 most abundant isotope peaks are included in this 
analysis, since lower intensity isotope peaks are more likely to deviate from the 
model and would thus give rise to distortions. The 4+ charge state of Z114SmtA, 
4+ [M] is chosen as the model system, given that it is the most abundant charge state 
in the soft' ionisation conditions used and therefore probably the best representation 
.6 of the charge state in solution. As stated, the internal standard Ubi +  is very close in 
mass-to-charge and hence one can assume that if little isotope distribution distortion 
is observed for Ubi6 , the same would hold true for [M]4t 
The procedure for calculating the relative isotope abundances for a different 
number of x in Zn4 67ZnSmtA, which is the number of Zn atoms that have 
exchanged on average, is shown in Table 5.1. In this procedure the assumption is 
made that only 67  Zn from the 10-fold excess 67ZnC12 exchanges for Zn atoms in the 
metal loth ionein, since for example the exchange of 64  Zn from the solution for any 
other isotope in the protein is negligible. The relative abundance of each Zn isotope 
for different values of x is then used to generate a theoretical isotope distribution. 
The most abundant isotope peak of the experimental data and of the theoretical 
distribution are normalised to 1. Standard deviations of the 7 most intense isotope 
peaks are calculated for various Zn4 67ZnSmtA possibilities (in x=0.25 intervals) 
(see Figure 5.6). A least squares second order polynomial fitting is carried out to 
determine the minimum standard deviation which was retained as the best fit. Figure 
5.7 shows the isotope distributions of [M]4 for different time points and the 
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corresponding best fits (nearest by 0.25 67 Z intervals) as determined by the 
'standard deviation method'. 
A B 0.15 f(X) =0.43557-0.42915 X+0.14217 
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Figure 5.6 Fitting of the number of 67 Z exchanged on average (x) for different time 
points using the 'standard deviation method'. (A) 1 hour, (B) 7.5 hours, (C) 99 hours 
and (D) 168 hours. The theoretical isotope distribution for different values of x in 
Zn 67ZnSmtA (in x=0.25 intervals) was compared to the experimental isotope 
distribution measured at a particular time point of incubation by calculating the 
standard deviation for the 7 most intense isotope peaks. A least squares second order 
polynomial fit was performed to determine the point of 67 Z exchanged where the 
standard deviation is minimised for each time point. The expression of each 














1 64 0.486 0.11312865 0.00837135 0.3645 0.37287135 
66 0.279 0.064944225 0.004805775 0.20925 0.214055775 
67 0.041 0.009543775 0.000706225 0.03075 0.264231225 
68 0.188 0.0437617 0.0032383 0.141 0.1442383 
70 1 	0.006 1 	0.00139665 1 0.00010335 0.0045 1 0.00460335 
sum 1 0.232775 1 check 1 	1 
Table 5.1 Screen-shot of MS ExcelTM  script used to calculate Zn isotope abundances 
for value of x equal to I in Zn4 67ZnSrntA. The heading 'Normal Zn distribution' 
shows the natural abundance of each isotope. In the heading 'Zn exchanged', of the 1 
Zn out of 4 that is exchanged on average, the amount of each isotope that is 
exchanged for 67  Zn is calculated (e.g. for 64  Zn: (114)*0.486*0.931 1=0.113). The sum 
of all Zn that has exchanged for 67  Zn is calculated. In the heading Zn not 
exchanged', the amount of Zn (of the I Zn out of 4 on average) that has not 
exchaned for 67  Zn is calculated (e.g. for 64  Zn: (1 /4)*0.4860.  113=0.008) (This arises 
since 6  Zn is only enriched to 93.11%, not 100%). In the heading Zn site not 
exchanging', the amount of each Zn isotope that is not involved in 67  Zn exchange is 
calculated (e.g. for 64  Zn: (1(1/4))*0.486=0.3645). In the heading 'Zn isotope 
abundances', the relative amount of each isotope is given for any value of x. For 
64 Zn, this means summing the values in columns 'Zn not exchanged' and 'Zn site not 
exchanging'. For 67  Zn these two columns are summed, as well as the total amount of 
Zn that has exchanged for 67  Zn (sum = 0.233). The check box should always have the 
value of 1 to indicate that the relative amounts of Zn isotopes add up correctly. 
For the time points of 1 hour (Figure 5.7 A) and especially for 7.5 hours 
incubation (Figure 5.7 B) the best fits are not centred around the experimental 
isotope distribution. It appears that the 'standard deviation method' has not given the 
best fit for these distributions. Visually fitting the isotope distributions could have led 
to a more accurate result! The reason for this poor fitting using the 'standard 
deviation method' is that the abundances of the isotope peaks in the experimental 
isotope distribution are suppressed relative to the most intense isotope peak; this is 
particularly the case for Figure 5.7 B. As a result of this, the sum of the differences 
squared, which is calculated in the 'standard deviation method', can be minimised, 
even though the theoretical isotope distribution is not symmetrically centred around 
the experimental one. 
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Figure 5.7 Isotope distributions of [M]4 for different time points, and corresponding 
nearest best theoretical fits (by 0.25 67 Z interval) determined by 'standard deviation 
method' for (A) 1 hour, (B) 7.5 hours, (C) 99 hours and (D) 168 hours. 
Hence, it was decided to employ a different method of statistical fitting, the 
'statistical deviation method' which is a measure of the degree of symmetry between 
the experimental and theoretical isotope distributions (see Figure 5.8). The minimum 
'symmetry deviation' was again determined by a least squares second order 
polynomial fitting procedure. The nearest best fits (by 0.25 67 Z intervals) as 
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Figure 5.8 Fitting of the number of 67 Z exchanged on average (x) for different time 
points using the 'symmetry deviation method'. (A) 1 hour, (B) 7.5 hours, (C) 99 
hours and (D) 168 hours. The theoretical isotope distribution for different values of x 
in Zn 67ZnSmtA (in 0.25 intervals) was compared to the experimental isotope 
distribution measured at a particular time point of incubation by calculating the 
symmetry deviation for the 7 most intense isotope peaks. The symmetry deviation 
consists in the fo1lowin expression for the 7 most intense peaks: CTS = [(Imodel,1 - 
Jexp,i) - (Imodel.7 - Iexp,7)] + [(imodel.2 - Iexp2) - (Imodel,6 - Iexp.6)] + [(Imodel3 - Iexp.3) - 
(Imodel,5 - Texp,)]2 + [(Imodel,4 - Iexp4) 
]2, where 'model,l is the normalised intensity of 
peak number 1 of the modelled isotope distribution and 'exp,I is the normalised 
intensity of peak number 1 in the experimental isotope distribution. When the 
symmetry deviation is minimised the theoretical fit is centred around the 
experimental isotope distribution. A least squares second order polynomial fit was 
carried out to determine the minimum symmetry deviation. 
Not surprisingly, the theoretical fits in Figure 5.9 are centred around the 
experimental isotope distributions completely symmetrically. The advantage of the 
'statistical deviation method', as opposed to the 'standard deviation method', is that a 
distortion in the isotope distribution such as a suppression of the lower isotope peaks 
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. 	Model 1.75 °'Zn exchanged 
is less likely to result in an inaccurate fitting. For lower magnetic fields, such as our 
3 Tesla magnet, distortions in the isotope distributions are much more common than 
for high-field magnets (> 7 T). Distortions in the isotope distribution were minimal 
for the work by He et al. on their 9.4 Tesla instrument [19]. The fitting for 168 hours 
incubation (Figure 5.7 D) gave a best fit of 2.25 67 Z exchanged. The most intense 
isotope peaks of experiment and model do not coincide, which may be due to a 
suppression of the isotope peaks on the right-hand side of the isotope envelope. 
Given the possibility of such a suppression effect, this implies that the extent of 67 Z 
exchanged at any time point can only be determined to an accuracy of about ± 0.25 
67Zn. 
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Figure 5.9 Isotope distributions of [M]4 for different time points, and corresponding 
nearest best theoretical fits (by 0.25 67 Z interval) determined by asymmetry 
deviation method' for (A) 1 hour, (B) 7.5 hours, (C) 99 hours and (D) 168 hours. 
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The best exact fits for the different time points as determined by the 
symmetry deviation method' are summarised in Figure 5.10. Following an initial 
fast exchange of about 1.35 Zn after 1 hour, the exchange kinetics progressively 
decrease. A maximum incorporation of 2.73 
67 
 Zn is observed after 99 hours and no 
further increase occurs after this (value for 168 hours lower, but within experimental 
error). In terms of the kinetics of the four zinc sites, this means that one of the Zn 
atoms exchanges quickly (< 1 hour) and a second Zn is exchanged over a period of -S 
10 hours. A third Zn atom is exchanged much more slowly (100 hours), whereas the 
fourth Zn atom does not exchange over the period of one week. The reason for the 
lower measured incorporation of 
67 
 Zn for 168 hours incorporation probably also has 
to do with the unusually large extent of Na adduct formation in the mass spectrum 
(see Figure 5.11). Possibly, the Na concentration in solution increased over time, 
thereby affecting the Zn exchange study. Given that the 93% enriched 
67 
 Zn medium 
is at a 10-fold excess, the maximum number of Zn atoms that can exchange when 3 
of the Zn sites exchange is a value of x=2.7. Hence, it appears that at maximum 3 of 
the 4 Zn sites are able to exchange for Zn in solution, suggesting that one of Zn sites 
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Figure 5.10 Time course of the reaction of Zn4SmtA with a 10-fold excess of 
67ZnC12 showing the number of 
67 
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Figure 5.11 Raw ESI mass spectrum for Zn4SmtA incubated for 168 hours showing 
high extent of Na adduct formation. 
Previous NMR experiments of the reaction of 111Cd2 with Zn4SmtA had 
shown that Zn site A is kinetically inert [11]. The space-filling representation in 
Figure 5.12 shows that whereas site B-D are surface accessible, site A is completely 
buried inside the molecule. 
Figure 5.12 Space-filling model showing availability of Zn sites B, C and D. Site A 
(not shown) is buried inside the molecule. 
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It appears that the elements of secondary structure surrounding site A render 
it unavailable for exchange. This occurs in spite of the fact that site A is bound to 4 
cysteines; in most cases, all cysteine binding sites exhibit a much stronger binding to 
Cd 21  than Zn2 , and complete substitution occurs [26,27]. This Zn isotope exchange 
study has confirmed that one of the Zn sites is kinetically inert. Importantly, FT-ICR 
MS allows direct determination of the metal-protein ratio, while at the same time 
conserving the metal —protein complex intact. Alternative techniques, such as 
radioisotope exchange require a separate detection of the metal and protein. Zinc as 
an element is not readily detected by other techniques. The d'° electronic 
configuration of Zn 2+  precludes d-d excitations and therefore makes electronic 
spectroscopy of Zn 2+  less informative. Since all electrons are paired, EPR cannot be 
used to investigate Zn2 . The NMR spectroscopic properties of zinc are highly 
unfavourable: low magnetic moment, implying low sensitivity, modest resonance 
frequency and a nuclear spin of 5/2, implying a high quadrupole moment. Usually, 
zinc metalloproteins have been studied by substituting Zn for a 'spin-spy' (typically 
13Cd) with more favourable spectroscopic properties [28,29]. It is important to note 
that NMR cannot directly observe the native Zn metalloproteins. Hence, the 
contribution of mass spectrometry in the study of Zn metalloproteins should not be 
underestimated. 
Given the wide range of transition metal isotopes, this metal exchange study 
could be extended to a variety of other metal-protein systems. The high mass 
resolution and accuracy of FT-ICR MS enable an accurate determination of the 
extent of isotope exchange. Higher field magnets, where distortion of the isotope 
distribution is less of a problem, can play an important role in metal exchange studies 
of proteins. Further, the rapidity of mass spectrometric analysis would allow the 
kinetic study of this exchange on a much faster time scale (i.e. minutes), thus 
approaching faster biological time scales. 
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Chapter 6 
Further avenues in the study of the 
ECD mechanism 
6.1 Introduction 
The study of electron capture dissociation in Chapter 3 limited itself to 
particular aspects such as neutral side-chain losses, the ease of hydrogen atom 
transfer from the protonated site, normal' alpha-cleavage and 'reverse' alpha-
cleavage of the backbone and the relative abundances of c and z fragments. These 
results were attempted to be rationalised in terms of a non-ergodic mechanism in 
ECD and the proposed hoe hydrogen re-arrangrnent mechanism [I]. Chapter 4 
showed putative gas-phase structures of some of the peptides dissociated with ECD, 
which were modelled using the Amber molecular mechanics force field [2,3]. In 
some cases ([LHRH HR]2 , [BOMB NH2]2 ) a correlation seemed to exist between 
preferential hydrogen bonding of the electron-capturing hydrogen to a particular 
backbone carbonyl (as predicted by the low-energy structures) and higher ECD 
cleavage adjacent to that carbonyl. Conversely, for [LHRH HRNH2]2 no such 
correlation was found for the low-energy structures. 
In this Chapter. ECD mass spectra of some synthetic peptides1 are shown, 
which were generated on a 9.4 T APEX III FT-ICR mass spectrometer equipped with 
an indirectly heated dispenser cathode (see Chapter 2, section 2.3.3). In this light the 
neutral losses will be re-visited (section 6.2.1). The link between the fixation of the 
charge and the resulting fragments is further studied: a truly 'fixed' charge group 
peptide is subjected to ECD (section 6.2.2) and a small peptide with no arginine 
residues is irradiated with electrons (section 6.2.3). 
The second part of this Chapter (section 6.3) assumes a much slower time-
scale of the ECD mechanism. In Chapter 4 the assumption was made that the ECD 
mechanism is ultra-fast (< ps) and that therefore the gas-phase structure of the ion 
These peptides were obtained from the group of Prof. Vicki Wysocki from the University of Arizona 
(Tucson. Arizona. USA). 
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prior to electron capture determines the dissociation pattern. While electron capture 
itself is likely to be a very fast process (< ps), the intra-molecular hydrogen atom 
transfer could take place on a much slower time-scale. The gas-phase structure of an 
ion that has captured an electron on the arginine side-chain is attempted using the 
Amber molecular mechanics force field (section 6.3). 
6.2 ECD of synthetic peptides 
6.2.1 Another look at neutral losses 
The doubly protonated form of the peptide RVYIH(Bz)PF (for structure of 
l-1(Bz) see Figure 6.1) was irradiated with electrons giving the mass spectrum in 
Figure 6.2. The insert in Figure 6.2 shows a high neutral loss of 91.053 Da from the 
reduced species [M+2H]+ , which matches the mass of C7H7 (mass 91.054 Da). 
The loss of this group can be associated with the benzyl group on the histidine side-
chain. The neutral fragment C7H7 does not have a hydrogen atom incorporated. The 
loss of the whole histidine(Bz) side-chain (masstieoretjcaj = 173.108 Da, massobse - ed = 
173.121 Da) is of low abundance. Further, the loss of 44 Da linked with the arginine 
side-chain is of low abundance. These results suggest that: 
either the hydrogen atom is transferred to N on the histidine side-
chain giving rise to radical cleavage of the benzyl group (see Figure 
6.3) 
or that N is already protonated 
or that this radical cleavage occurs without hydrogen atom re-
arrangement 
The first hypothesis could be tested by determining the hydrogen atom 
affinity of the nitrogen atom on the histidine side-chain by ab initio calculations. If 
the hydrogen atom affinity of N is high, then the mechanism shown in Figure 6.3 is 
possible. The abundant loss of C7H7 is likely to be due to resonance stabilisation of 
this fragment (see Figure 6.3). 
Another feature in this mass spectrum is the appearance of an a5 fragment 
ion. The corresponding c5 fragment cannot be observed due to the proline residue C- 
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terminal to H(Bz). No other a fragments are seen in this spectrum. Thus, it appears as 
if the molecule somehow 'knew' that it had to cleave the CaC bond (to give a 
fragment) as opposed to the NC,,, bond (to give c fragment) to result in backbone 
fragments. The labelled (a5-17) peak could correspond to an a5 fragment that has 
lost its N-terminal NH3. This suggests that two cleavages result from one electron 
capture, an observation that has also been made by O'Connor and co-workers [4]. 
Histidine 





Figure 6.1 Structure (stick structure) of histidine(Bz) residue, showing N and N1, 
which carries an additional benzyl group. 
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Figure 6.2 ECD mass spectrum of doubly protonated peptide RVYIH(Bz)PF. (200 









Figure 6.3 Schematic of proposed mechanism of hydrogen atom transfer to N on the 
histidine side-chain, inducing radical cleavage of benzyl group. This fragment is 
likely to be energetically favoured due to resonance stabilisation (Note that arrows 
refer to single-electron movement). 
6.2.2 ECD of peptide with fixed charge group 
The doubly charged (but only singly protonated) peptide 3PCH2C(0)-
VYIHPF (for structure of fixed charge group 3PCH2C(0)- see Figure 6.4) was 
irradiated with electrons to give the ECD mass spectrum in Figure 6.5. As expected, 
all charged backbone fragments include the 3PCH2C(0)- fixed charge group, 
which was also observed in collisionally-induced dissociation (CID) of this peptide 
[5]. The most likely site of protonation is the side-chain of histidine, which is further 
supported by abundant loss of 82 Da. 
OMe 
1
0Me—C4+ —c  
OMe 
Figure 6.4 Structure (stick structure) of 3PCH2C(0)- group, showing (nominal) 
positive charge on phosphorous atom. 
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Figure 6.5 ECD mass spectrum of the doubly protonated peptide t 3PCI-12C(0)-
VYII-IPF. (200 time-domain transients, hexapole accumulation = 0.6 sec, electron 
irradiation = 30 ms). 
The peaks labelled 533.191 Da and 590.212 Da are lower in mass than the 
fragment ion a1 1 . One would assume that the fixed charge group is included in both 
of these fragments. In this light the elemental formula matches for these are 
C27H3409P1 (monoisotopic mass = 533.1935 Da) and C29H37010N1 P1 
(monoisotopic mass = 590.2150 Da). For the fragment at m/z 533.191 this implies 
hydrogen atom incorporation into the fragment. Figure 6.6 shows a possible 
mechanism that could explain hydrogen atom incorporation into this fragment. The 
fact that the peak at m/z 533.191 Dais by far the highest abundance fragment implies 
that hydrogen atom transfer to this group is particularly efficient. To test this 
assumption the hydrogen atom affinity of P would need to be calculated. 
The peak at m/z 590.212 can be rationalised by hydrogen atom transfer to the 















These results show that for a fixed charge group in a doubly charged peptide 
all charged ECD fragments include the fixed charge group. The very high abundance 
of the fragment at m/z 533.191 can be rationalised by hydrogen atom to the 
phosphorous atom on the fixed charge group as shown in Figure 6.6. These results 
appear to imply that hydrogen atom re-arrangement in the ECD mechanism does 
take place, since it would be difficult to explain the incorporation of a hydrogen atom 
into this fragment otherwise. 
OMe 
Figure 6.6 Schematic for hydrogen atom capture at p  causing radical cleavage. 
(Note that arrows refer to single-electron movement). 
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6.2.2 Peptide without arginine residue 
Figure 6.7 shows the ECD mass spectrum of the doubly protonated peptide 
with sequence VYIHPF. The fragmentation pattern is very unpredictable and 
multiple processes seem to be taking place. Many of the fragment peaks are 
unidentified and may be due to internal fragments2. The occurrence of b fragments 
are likely to be due to vibrational excitation processes. Since VYIHPF is a small 
peptide and the proton affinity of the least basic site is low, the resulting 
recombination energy from electron capture is particularly large (see Figure 1.13, 
Chapter 1). Hence, ECD may result in highly energetic fragments that further 
fragment by vibrational excitation dissociation resulting in b and y fragments, as well 
as internal fragments. 
All identified fragments (apart from xi and b2 ) include the most basic 
residue in the molecule, namely histidine. This once again confirms the correlation 
between the higher gas-phase basicity of the protonated residue and the probability 
that this residue is included in a charged ECD fragment. The insert in Figure 6.7 
shows the detail of the 'reduced' species and hydrogen atom desorption. The 
reduced' species ([M+2H]) is not present in this case since hydrogen atom 
desorption (peak labelled [M+H]) is much more prominent. The high hydrogen 
atom desorption may be due to the lower gas-phase basicities of the protonated sites 
in this molecule. Surprisingly, no neutral side-chain losses are observed in this 
spectrum. 
From this result it appears that non-specific protonation (i.e. more protonated 
sites than basic sites) leads to more unpredictable fragmentation. Conversely, the 
presence of two basic sites in a doubly protonated molecule, and in particular one 
higher gas-phase basicity site such as arginine, leads to more predictable ECD 
spectra. These results are analogous to the work by Wysocki and co-workers on 
surface-induced dissociation (SID) [6], who showed that the number of ionising 
protons relative to basic sites influences the dissociation behaviour of the peptide [7]. 
2  An internal fragment is due to two backbone cleavages, one N-terminal and one C-terminal, thus 
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Figure 6.7 ECD mass spectrum of doubly protonated peptide VYIHPF. (200 time-
domain transients, hexapole accumulation = 0.6 sec, electron irradiation = 30 rns). 
6.3 Slow hydrogen atom transfer 
The previous results have shown that the arginine residue may play an 
important part in ECD by making ECD spectra more predictable. An arginine residue 
that should resemble a neutralised protonated arginine side-chain (i.e. a protonated 
arginine side-chain that has captured an electron) was built using the procedure in 
Chapter 4 (section 4.2.1). The RESP fit charges for this residue (ARE) are shown in 
Figure 6.8. The ESP charge fitting procedure was performed on the trimer p-Glu-
Arg-Gly-OH, since charged termini (protonated N-terminus, de-protonated C-
terminus) gave rise to a distortion of the charges (data not shown). The RESP derived 
charges for the protonated arginine residue (ARG) contained in AMBER 7 [8] are 
- 
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shown for reference in Figure 6.9. While the backbone charges (N, Ca, C and 0) are 
not identical for both residues, they do not differ significantly. The sum of the 
charges for ARE ctiarges = 0.016, which is close an approximation to zero. 
Comparing the charges for both residues on the guanidine group (-NH-C-(NH2)2) 
(ARE charges = -0.181 and ARG charges = 0.6898) shows that most of the charge of 
the electron is delocalised over this group. 
The assumption is made here that electron capture at the guanidine group of 
the protonated arginine side-chain could effectively result in keeping the electron 
localised at this site for a period of time. Since the guanidine group has a high degree 
of charge delocalisation (which explains the high proton affinity of this group) it is 
conceivable that the additional electron density to the ion resulting from electron 
capture could be mainly localised over the guanidine group. 
The peptide [LHRH HR] 	was built in LeAP and a topology file was 
generated. The coordinate file for [LHRH I-IR]2 min73 for the molecular dynamics 
simulation at 300 K (structure 300K.I000ps) was taken as the coordinate input file 
for the molecular dynamics of [LHRH_HR] at 300 K and 500 K. Figure 6.10 shows 
the interatomic distance [{2}(His)N-HDI . . .N(Arg){8}] at 300 K and 500 K 
dynamics, where (His)N-HDI is a nitrogen-bound hydrogen on the histidine side-
chain and N(Arg) is one of the amino nitrogens on the arginine side-chain. 
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Figure 6.8 RESP fit charges on protonated arginine residue that has captured 
electron on side-chain (ARE). chargcs = 0.0 16; charges(guanidine) = -0.181. 
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Figure 6.9 RESP fit charges on protonated arginine residue (ARG) contained in 
LeAP (AMBER program). charges = 1; Echarges(guanidine) = 0.6898. Charges from 
Cornell et al. [9]. 
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Figure 6.10 Interatomic distance [{2 } (His)N-HE2. . .N(Arg) { 8 }] for molecular 
dynamics of [LHRH_l-IR] at (A) 300 K and (B) 500 K. 
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Figure 6.11 RMS (in Angstrom) for backbone (N, Ca, C, and 0) of [LHRHHR] 






Figure 6.12 Representative structures of [LHRH_HR]' for dynamics at 500 K (A) 
500K.50ps and (B) 500K.100ps. 3-turn for residues 4-6 represented in cyan and j3-
sheet represented in yellow. 
Modelling of this peptide has shown that the side-chains of histidine and 
arginine enter into hydrogen bonding contact after 100 ps dynamics at 500 K and that 
they remain in this state for the remainder of the simulation (see Figure 6.11). The 
increase in temperature from 300 to 500 K could be rationalised by the fact that 
electron capture is an exothermic process (releasing 4-7 eV energy). Importantly, the 
backbone structure of the peptide changes little over the length of this simulation (see 
RMS deviation Figure 6.11). A comparison to the RMS deviation for the 500 K 
dynamics simulation of [LHRHHR]2 (see Figure 4.10, Chapter 4) shows little 
difference to the RMS deviation for the 500 K dynamics simulation of 
[LHRH_HR] (see Figure 6.11). Hence, the interaction between the histidine and 
arginine (plus electron) side-chains arises mainly due to the difference in atomic 
charges on the guanidine group for ARE as opposed to ARG. Figure 6.12 shows 
representative gas-phase structures of [LHRH_HR]' for simulations at 500 K after 




This result suggests that if the captured electron remains localised on the 
arginine side-chain the histidine and arginine side-chains interact. This could explain 
proton transfer from the less basic (i.e. histidine side-chain) to the more basic site 
(i.e. arginine side-chain) prior to or during backbone cleavage. In fact, this result 
could be interpreted in terms of a 'concerted' mechanism, where hydrogen atom 
transfer from the arginine side-chain to the backbone is concerted with proton 
transfer from the histidine side-chain to arginine (see Figure 6.13). This mechanism 
is consistent with the observation that in doubly protonated peptides the charged 







Figure 6.13 'Concerted' mechanism for [LHRH_HR]' where electron is captured 
on the arginine side-chain: 1. hydrogen atom transfer from arginine side-chain to 
backbone carbonyl, 2. proton transfer from histidine to arginine side-chain and 3. 
cleavage of backbone (for 'normal' backbone alpha-cleavage). 
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6.4 Summary and final conclusions 
The ECD results in this thesis suggest that a hydrogen atom re-arrangement 
can take place in the ECD mechanism. The highest fragment peak in the peptide with 
the fixed charge group (Figure 6.5, section 6.2.2) can only be explained as due to the 
incorporation of a hydrogen atom. The occurrence of c fragments without 
incorporation of a hydrogen atom and z fragments which include an additional 
hydrogen atom, referred to as c and z' fragment ions, can be explained by a 
'reverse' alpha-cleavage mechanism (see section 3.4, Chapter 3). Trends influencing 
the occurrence of the normal' and the 'reverse' cleavage are not yet clear. 
Nevertheless, these results seem to indicate that the location of charge on the 
precursor ion and the gas-phase conformation of the peptide may play a role. 
This work has also shown that in a peptide with relatively unambiguous 
assignment of the protonation sites the most basic site is preferentially included in 
the charged fragments. Comparing the ECD spectra of [RVYIH(Bz)PF]2 (Figure 
6.2) and [VYIHPF]2 (Figure 6.7), ECD of the latter is less clear. The trend for the 
studied peptides in this thesis is that the presence of an arginine residue and a residue 
of lower gas-phase basicity (such as histidine) gives the most predictable ECD 
spectra. In terms of the non-ergodic mechanism in ECD and the proposed hot 
hydrogen re-arrangement mechanism this could be explained by less efficient 
transfer of the hydrogen atom from the arginine residue to the backbone. In other 
words, the hydrogen atom from the arginine side-chain is less mobile' than the 
hydrogen atom from the histidine side-chain, in analogy to the mobile proton model 
by Wysocki and co-workers [10]. 
The ECD/Hbond correlation study (Chapters 3 and 4) for [LHRH_HR]2 and 
[BOMB]2+ seemed to show agreement between preferential hydrogen bonding of the 
histidine side-chain to particular backbone carbonyls (as predicted by low-energy 
structures) and enhanced ECD cleavage at those sites. Conversely, no such 
correlation was found in the case of [LHRHHRNH2]2 . 
The ECD results for [Ac_BK]2 are not easily explained in terms of the hot 
hydrogen re-arrangement mechanism. Nevertheless, the observation that the most 
basic site is preferentially included in the charged fragments is conserved. The fact 
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that the most basic residue is preferentially included in charged fragments implies 
that the mechanism here is not non-ergodic. 
Whereas, electron capture is likely to be a very fast process (< ps), the 
mechanism involving hydrogen atom re-arrangement in the molecule culminating in 
backbone cleavage may take place on a slower time-scale (i.e. ps or ns). The 
modelling results of [LHRH HR] (section 6.3) are not robust, since molecular 
mechanics models are not accurate for radical species. Further, the electron is 
thought to be captured in a Rydberg state initially [11], which is not represented in 
the model. Nevertheless, the possibility of proton and hydrogen atom re-arrangement 
taking place before the molecule is broken apart may need to be taken into account. 
Given the very long time-scale of FT-ICR experiments (100's ms) relative to 
the time-scale of the dissociation, it is difficult to say whether the mechanism really 
is non-ergodic or not. The estimated energy released from electron capture (4-7 eV, 
equivalent to approximately 400-700 ki mol1) is easily sufficient to cause backbone 
cleavage. Recent ab initio calculations by Tureëek have shown that it may be 
unnecessary to invoke the hypothesis of a non-ergodic mechanism [12]. 
The debate about the mechanism in electron capture dissociation will 
generate controversy for some time to come until a spectroscopic technique can 
prove that the mechanism is not non-ergodic (proving the opposite would be harder). 
Some of the work in this thesis may be of benefit for predicting ECD spectra, 
especially in relation to the sequencing of tryptic digest peptides. This thesis has 
raised many questions about the ECD mechanism. The crucial question on whether 
the gas-phase structure plays an important role in determining the relative 
fragmentation still remains to be answered. Hence, the applicability (and limitations) 
of electron capture dissociation as a tool to investigate the gas-phase structures of 
ions is yet to be verified. Hopefully, this thesis may provoke some discussion which 
will bring us closer to solving this scientific puzzle. 
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6.5 Further work 
Some of the peptides in this study, and particularly the LHRH variants, 
should be characterised using ion mobility measurements. Such experiments should 
establish the preferential gas-phase conformations of these peptides. If the nature of 
the amino acid in position 6 for doubly charged LHRH peptides also changes the 
gas-phase conformation, this may give clues to the differences in 'normal' and 
reverse' alpha-cleavage for ECD of [LHRH_(l)W]2 and [LHRH_(d)W]2 in 
particular. Such a result would also imply that the relative ECD fragmentation 
pattern is not significantly affected by the gas-phase conformation. 
Molecular mechanics modelling of some of these peptides could be carried 
out using the newer 2002 force field (ff02) in AMBER. This could show whether the 
loop' structure involving a n-turn is predicted by ff02 as a stable low-energy 
conformation for LHRH peptides in the gas-phase. In other words, the accuracy of 
the newer force field ff02 for predicting gas-phase conformation could be tested. 
Molecular mechanics modelling of [LHRH HR]+* (Figure 6.12 B) could be 
taken as a starting geometry for ab initio calculations to determine whether effective 
proton and hydrogen atom transfer could take place under these conditions. 
Ab initio calculations should also be performed to determine the hydrogen 
atom affinity of the phosphorous atom in the fixed charge group (Figure 6.4). If the 
hydrogen atom affinity of this site was found to be exceptionally high, this would 
explain the high cleavage at that site. This would also add more weight to proving 
that the hot hydrogen re-arrangement mechanism takes place in ECD. 
Finally, the protonation sites of peptides in the gas-phase made by 
electrospray ionisation need to be characterised. Higher gas-phase basicity sites are 
not necessarily protonated in favour of less basic sites if the alternative structures are 
more energetically favourable overall. In fact, protons may be 'mobile' in the ion, 
depending on the internal energy of the ion. Hence, a direct probe of protonation 
sites is required, which is most readily achieved with infrared spectroscopy. I hope to 
investigate some of these problems at the FOM institute (Rijnhuizen, Netherlands) 
using the free electron laser facility (FELIX). 
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Appendix 1 
Potential energy surface 
Since the fundamentals of the SIMION program have been explained by 
David Dahl elsewhere (see literature referred to in section 1.3.3, Chapter 1), this 
appendix will only give a brief explanation of SIMION. Electrostatic fields can be 
modelled as boundary problem solutions of an elliptical differential equation called 
the Laplace equation: 
DEL2V = DELxE = dExldx + dEy/dy + dEz/dz = 0 	Equation A1.1 
In the Laplace equation a zero charge volume density assumption is made, 
which means that it does not allow for space charge effects. Conversely, Poisson's 
equation does allow for such space charge effects to be taken into account. This is a 
limitation to SIMION, which needs to be taken into account especially when carrying 
out simulations on high density ion beams. Furthermore, given the limited space 
charge capacity of an ICR cell, such considerations should not be neglected. 
In SIMION the Laplace equation is solved for each grid unit by using a finite 
difference technique called over-relaxation. In a 3D array, as was used in the 
practical simulations in this work, each array point has 6 nearest neighbours. Thus, 
each array point is calculated as the average of its nearest neighbours: 
V = (Pl+P2+P3+P4+P5+P6)16 	 Equation A1.2 
The software performs this by undertaking a number of iterations on each 
point until the value of each point reaches a set convergence limit. 
Ion trajectory calculations 
SIMION calculates the forces acting on a charged particle in each grid unit 
and expresses them in the form of volts per grid unit in the case of electrostatic fields 
and Gauss in the case of magnetic fields. The resulting acceleration on the particle is 
then added to the velocity that the ion has when entering the particular grid unit. The 
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position and velocity of the ion are calculated for each time increment. However, in 
order to minimise computing requirements, SIMION uses a self-adjusting time step 
method, which is a standard fourth order Runge-Kutta method. Hence in regions 
where the voltage gradient is almost linear, larger time steps are used, whereas 
smaller time steps are used in regions where steeper voltage gradients are present. 
User programs 
SIMION offers a very powerful tool to model ion traps, quadrupoles, 
collision cells and a range of other devices that rely on changing conditions (i.e. 
voltages, pressure) over time. Such user programs are contained in ASCII files with 
the extension .PRG and are based on a RPN (reverse Polish notation) software 
language. The user program can dynamically change electrode voltages at each time 
increment and hence significantly extend the capabilities of SIMION. In the light of 
ICR cells the applicability of user programs can be used to model the dipoar 
excitation of ions before detection, quadrupolar excitation axialisation (QEA), as 
well as sustained off-resonance excitation collisionally anduced dissociation (SORI 
CAD). Given the complex trajectories of ions in the ICR cell in such conditions, 
SIMION can provide a very powerful visualisation tool. 
ICR open-ended cell 
The ICR cell used in these simulations (see Figures AI.I and AI.2) is 
modelled on a capacitively coupled open-ended cell, which refers to a detection cell 
where the dipolar excitation is also applied to the excitation trapping plates (i.e. 
electrodes 1, 4, 9 and 11). The cell consists of 3 elements, which are made of 4 sub-
elements each. The cell entity is enclosed by an electrode box held at 0 V (i.e. 
ground). The reason for the outer electrode box is to prevent a distortion in the 
electrostatic energy surface, due to an infinite boundary problem. Whereas in Figure 
A1.1 this outer electrode is shown, Figure AI.2 shows the same instance without the 
outer box electrode and also the direction of the magnetic field as defined by the 
magnetic instance. The dimensions of the electrostatic array are x=67, y=67 and 
z=201, resulting in> 900000 grid units (I grid unit = I mm3). A magnetic instance 
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(x=7, y=7, z=26) is scaled to overlapped with the electrostatic instance (1 grid unit = 
1,000 min 3). 




5-8 I E 	 9-12". 
Electrodes 
Figure A1.2 Electrostatic instance showing ICR cell with 12 electrodes. Insert shows 
xy cross-section of cell, indicating 4 electrodes, which consist of oppositely placed 
excitation electrodes (E) and detection electrodes (I)). 
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Appendix 2 
Amino Acid One-letter Three-letter Structure of R group Residue mass 
code code (Da) 
Glycine G Gly -H 57.02 
Alanine A Ala -CH3 71.04 
Serine S Ser -CH20H 87.03 
Proline# P Pro 97.05 
COOH 
Valine V Val 99.07 
—c!-I 
CH3 
Threonine T Thr OH 101.05 
-CHCH3 
Cysteine C Cys -CH2SH 103.01 
Leucine L Leu ,CH3 113.08 —c—c 
H2  H'CH 
Isoleucine I lie CH3 113.08 
—CHCH2CH3  
Asparagine N Asn 0 114.04 
—C—CNH2 
H2 
Aspartate D Asp 0 115.03 
-C-COH 
H2 
Glutamine Q Gin 0 11 128.06 -C-C-CNH 2 H2 H2 
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Lysine K Lys -CH2CH2CH2CH2NH2 128.09 





Methionine M Met -CH2CH2SCH3  131.04 
Histidine H His 137.06 
I-IH2 	H 
Phenylalanine F Phe 147.07 




Tyrosine Y Tyr 163.06 
C----OH 
Tryptophan W Trp / 186.08 
H2 	NH 
# In case of proline, the whole amino acid structure is shown. 
Table A2.1: Genetically encoded amino acids with structures and residue masses 





O 	 H 0  
Figure A2.1 Formation of pyro-glutamic acid (pE) through elimination of water. 
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Amino acid GB (kcal mol ) 
1 PA (kcal mol ) a 
pKa 
Side-chain 
Gly 202.7 210.5 
Cys 206.2 214.0 8.37 (suithydril) 
Ala 206.4 214.2 
Ser 207.6 215.2 
Asp 208.6 216.4 3.90 (J3-COOH) 
Vat 208.7 216.5 
Leu 209.6 217.4 
lie 210.8 218.6 
Thr 211.7 219.5 
Phe 212.1 219.9 
Asn 212.8 220.6 (223.6)  
Tyr 213.1 220.9 10.46 (phenol) 
Met 213.3 221.1 (224.1)  
Gin 214.2 222.0 (225.0)  
Pro 214.3 222.1 
Glu 215.6 223.4 (226.4) 4.07 ('y-COOH) 
Trp 216.1 223.9 (226.9)  
Lys 221.8 235.6 10.54 (E-NH3 ) 
His 223.7 231.5 (234.5) 6.04 (imidazole) 
Arg 237.0 244.8 (247.8) 12.48 (guanidine) 
Table A2.2 Evaluated gas-phase basicities (GB) and proton affinities (PA) (taken 
from Harrison, A. G. Mass Spectrom. Rev. 1997, 16, 201-217) and side-chain pKa 
values, where applicable, (taken from Dawson, R. M. C.; Elliott, D. C.; Elliott, W. 
H.; Jones, K. M. In Data for Biochemical Research (3rd Ed.); Oxford Science 
Publications, 1986; pp  1-3 1). 
a Proton affinities estimated assuming AS°rot= 0 except 
for lysine (Lys). Values in parantheses assume AS°r0t = -10 cal mol K 1 due to 
intramolecular hydrogen bonding. 
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Figure A3.4 ECD mass spectrum of doubly protonated pEHWSY(d)WLRPG-NH2. 















Figure A4.1 Structure of pyro-glutamic acid residue with annotated RESP derived 









Figure A4.2 Structure of neutral C-terminal glycine with annotated RESP derived 
charges. charges = 0.082.1  












Figure A4.3 Structure of neutral amidated C-terminal glycine with annotated RESP 








Figure A4.4 Structure of protonated amidated C-terminal glycine with annotated 
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Figure A4.5 Structure of neutral amidated C-terminal methionine with annotated 
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Figure A4.6 Structure of protonated amidated C-terminal methionine with annotated 
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Electron capture dissociation (ECD) of polypeptides has been demonstrated using a commercially 
available 3 Tesla Fourier transform ion cyclotron resonance (FTICR) instrument. A conventional 
rhenium filament, designed for high-energy electron impact ionisation, was used to effect ECD of 
substance F, bee venom melittin and bovine insulin, oxidised B chain. A retarding field analysis of 
the effective electron kinetic energy distribution entering the ICR cell suggests that one of the most 
important parameters governing ECD for this particular instrument is the need to employ low 
trapping plate voltages. This is shown to maximise the abundance of low-energy electrons. The 
demonstration of ECD at this relatively low magnetic field strength could offer the prospect of more 
routine ECD analysis for the wider research community, given the reduced cost of such magnets and 
(at least theoretically) the greater ease of electron/ion cloud overlap at lower field. Copyright c, 2002 
John Wiley & Sons, Ltd. 
Electron capture dissociation (ECD)1 has proven to be a 
valuable research tool for polypeptide sequencing and the 
localisation of post-translational modifications. 2-' This frag-
mentation technique is complementary to the more estab-
lished heating techniques, such as collisionally-activated 
dissociation (CAD)' and infrared multi-photon dissociation 
(IRMPD).8 In combination with these other dissociation 
techniques, ECD can play an important role in de novo 
sequencing, where complete sequence coverage is required. 
To date ECD has only been applied on Fourier transform 
ion cyclotron resonance mass spectrometers equipped with 
super-conducting magnets of 4.7 Tesla, or higher, field 
strength. The obvious advantages of higher field strength, B, 
are higher mass resolution (proportional to B) and the ability 
to trap more ions (proportional to B2). However, at higher 
magnetic field, the ions and electrons are more tightly 
focused, potentially making their efficient overlap more 
difficult. The advantages of lower field magnets are reduced 
cost and greater magnetic field stability. The use of FTICR 
mass spectrometers equipped with lower field magnets 
could enable ECD mass spectra to be obtained more cost-
effectively for lower mass compounds, such as tryptic 
digests of proteins, where high mass resolution is not as 
essential. 
*Correspondence to: P. R. R. Langridge-Smith, Department of 
Chemistry, The University of Edinburgh, King's Building, West 
Main Road, Edinburgh EH9 3JJ, Scotland, UK. 
E-mail: prrls@ed.ac.uk 
Since the electron capture cross-section increases with the 
charge squared (z2) of the cationic species of interest, a 
requirement for ECD is an ionisation technique capable of 
generating multiply charged cations, such as electrospray 
ionisation (ESI). In order to increase the probability of 
electron capture, low-energy electrons (<0.2 eV) are also 
required.' This contrasts with the usual function of standard 
filament-based electron sources, which are designed for 
ionisation of neutral molecules by high-energy (e.g. 70 eV) 
electron impact. 
A number of approaches have been proposed in order to 
improve ECD. McLafferty and co-workers9 have used a 
design of ICR cell, consisting of an open-ended cylindrical 
cell with additional flat trapping plate electrodes, 'the nested 
ion cell geometry', which has enabled the simultaneous 
trapping of positively charged ions and electrons. They have 
reported ECD mass spectra for bovine ubiquitin showing 
extensive sequence coverage. However, the use of multiple 
electron irradiation (3 s) and storage (6 s) cycles (overall 
10 x 9 s) increases the overall experimental time and can 
preclude the use of ECD in conjunction with on-line liquid 
chromatographic (LC) separation techniques. 
In contrast, Tsybin et al.'° and Haselmarin et 01.11  have used 
indirectly heated high-surface area dispenser cathodes, in 
the former case fitted with a tungsten sponge impregnated 
with Ba-Ca aluminate, and in the latter a low work function 
BaO surface. Both groups have reported substantially 
reduced electron irradiation times, as short as I ms electron 
Copyright c 2002 John Wiley & Sons, Ltd. 
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Figure 1. EGO mass spectrum of substance P in the 2+ charge state (40 scans). Electron irradiation time = 1 5. 
Asterisk denotes artefact peaks. The insert shows the electron current measured on the ion optic FOCL2, the rear 
element of the last Einzel lens that the ions pass through prior to entering the ICR cell, as a function of filament 
voltage U. 
irradiation, '(),11  which are more compatible with those 
required for on-line LC. 
The use of dispenser cathodes has been shown to 
markedly improve the rate of ECD. Primarily, this is due 
to the higher emission current and the larger emitting 
surface area, which result in emission of electrons with a 
larger beam diameter. This not only increases overlap of the 
electron beam with the ion cloud, but it has also been 
suggested lo that the electron beam itself is large enough to 
confine the ion cloud, thereby creating a potential well that 
traps the ions in the radial direction in conjunction with the 
magnetic field. Nevertheless, these dispenser cathodes do 
present practical problems, such as increased blackbody 
radiation, which can lead to increased pressure within the 
ICR cell, as well as concerns regarding the possibility of 
contamination of the ICR cell with Ba sputtered from the 
cathode surface. 
These different approaches to ECD have only been 
demonstrated by a select few research groups and are not 
generally available to the wider research community. Most 
commercially available FTICR instruments already are 
equipped with standard tungsten or rhenium filaments, 
which in principle should allow ECD to be performed. In this 
paper we report results on ECD experiments which were 
carried out on a commercial FTICR mass spectrometer 
(Bruker Daltonics APEX II) equipped with a 3 Tesia super-
conducting magnet and a standard rhenium filament as the 
electron source. Characterisation of the electron kinetic energy 
distribution from the rhenium filament was carried out in an 
attempt to optimise the efficiency of the ECD process. 
EXPERIMENTAL 
The polypeptides studied in this work were substance P 
(MW 1347.6), bee venom mehttin (MW 2846.5), bovine 
insulin, oxidised B chain (MW 3495.9), and bovine ubiquitin 
(MW 8564.9), which were all obtained from Sigma and used 
without further purification. The compounds were dis-
solved in a water/methanol/acetic acid solution (49:49:2, 
v/v/v) to concentrations of between 10-100 pM. Electro-
spray ionisation (ESI) mass spectra were generated using an 
Analytica loll source (Branford, CT, USA), which is 
equipped with a standard glass capillary (end-caps metal-
hsed) and a storage hexapole. The solutions were infused 
using a syringe pump (Cole Parmer, IL, USA), at flow rates 
of between 80-120 pL/h. Mass spectra were recorded using 
a passively shielded 3 Tesia FTICR instrument (APEX II) 
manufactured by Bruker Daltonics (Billerica, MA, USA). 
The cations produced by ESI were accumulated for 500-
1000 ms in the hexapole of the ion source before being 
injected into the InfinityC ICR cell. The ions were trapped at 
low trapping plate voltages, typically 0.5 V, which were 
maintained during the entire experiment. No Sidekick+  or 
pulsed gas was used to assist trapping of the ions. Precursor 
ion isolation was achieved using a correlated sweep 
isolation of the most intense charge state. In the case of 
substance P. the doubly protonated precursor ion was 
isolated, whereas for both mehttm and B chain insulin the 
quadruply protonated precursor ion was isolated. For 
ubiquitin no isolation was carried out. In order to induce 
ECD inside the ICR cell the cations were irradiated, for a 
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Figure 2. ECD mass spectrum of melittin in the 4± charge state (100 scans). Electron irradiation time = 1.5 a. The 
insert shows an expansion of the m/z 950 region of the reduced species [M + 4H]3 '. Asterisk denotes artefact peaks. 
period of 1-5 s, by low-energy electrons from a heated 
rhenium filament located 13 cm behind the ICR cell, 
The rhenium filament (Ca. 5 mm long Re ribbon, 
0.038 x 0.51 mm, resistance 0.09959 Ohm/cm) was operated 
at a current of 3 A. During electron irradiation a voltage U 
(range —0.48 to -1-0.65 V) was applied to one side of the 
filament. As a consequence of the potential drop across the 
filament, a voltage U' (U± = U + 2 V) was measured on the 
other side of the filament. The emitted electron current was 
measured by using a picoammeter (model 610C; Keithley 
Instruments, Munich, Germany) at the Einzel lens element 
closest to the ICR cell (FOCL2). In the case of this particular 
instrument the filament voltage U at which no electron 
emission occurred was found to be +3.5 V. Detection of the 
precursor ions and their fragments was carried out in 
broadband mode using 512 K data points. No apodisation or 
extra zero-fill processing was carried out prior to fast Fourier 
transformation of the data. For all ECD mass spectra 
presented, between 40 and 200 scans were accumulated, 
unless otherwise stated. 
RESULTS AND DISCUSSION 
A prerequisite for ECD is good overlap of the ion cloud, 
trapped in the ICR cell, and the irradiating electron beam. 
The electron beam, however, has a small radius due to the 
effect of the magnetic field present and the limited surface 
area of the filament. For this design of ICR cell the trapping 
plates have small annular apertures (6 mm dia.). Trapping of 
ions on or very close to the centreline axis of the cell is 
therefore crucial. In order to trap ions at 0.5 V without 
Sidekick trapping or the use of a pulsed gas, the ion source 
and tuning parameters of the ion transfer optics had to be 
very carefully adjusted. The precursor ion magnitude had 
first to be maximised since electron irradiation was found to 
reduce the initial ion abundance by approximately two-
thirds. Larger precursor ion magnitudes could be achieved 
by using higher trapping voltages. However, it was found 
that ECD was markedly reduced. The reason for this is 
discussed later. 
The insert in Fig. 1 shows the current measured on the last 
Einzel lens element (FOCL2) that the ions pass through prior 
to entering the ICR cell, as a function of the filament voltage 
U. For experimentally favourable ECD conditions the 
optimum filament voltage U was found to be near +0.5 V; 
this corresponds to the onset of the steep rise in the emitted 
current. Another important parameter is the electron 
irradiation time. This must be long enough to permit 
sufficient electrons to enter the ICR cell, but not to lengthen 
excessively the acquisition time or to cause significant ion 
loss. Irradiation times of between I and 5 s were found to be 
sufficient. Since the ECD fragments are of low abundance the 
accumulation of several scans (S) is essential, thereby 
increasing the signal-to-noise (S/N) ratio by a factor of \/S. 
This is a further reason for keeping the acquisition time for 
each single scan as short as possible. In the case of substance 
P. for example, 40 scans were found to be sufficient to 
generate ECD mass spectra with adequate sequence cover-
age. 
ECD mass spectra 
The ECD mass spectrum of the neuromodulator substance P 
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Figure 3. ECD mass spectrum of bovine insulin, oxidised B-chain, in the 4+ charge state (200 scans). Electron 
irradiation time = 5 s. Asterisk denotes artefact peaks. 
is shown in Fig. 1. A 1-s electron irradiation time was used 
and 40 time-domain transients were accumulated. The N-
terminal c-ion fragments starting from c to cso+  are visible 
in the mass spectrum. The c fragment is of lowest 
abundance, with a S/N ratio of 10. This mass spectrum is 
representative of previously reported ECD mass spectra for 
this compound.9 In the mass spectrum shown in Fig. 1, two 
b-ions are present, suggesting that other activation mechan-
isms, as well as electron capture, took place. Vibrational 
excitation due to blackbody infrared irradiation from the 
heated filament could explain such fragment peaks. In 
addition, two odd electron n-ions can also be seen in the 
mass spectrum. 
For ECD of bee venom melittin, isolation of the quadruply 
protonated precursor ion was performed. The electron 
irradiation time was increased to 1.5 s. The optimum 
filament voltage U, where the reduced triply protonated 
species was just visible in a single scan, was found to be 
+0.65 V. The optimum filament voltage will probably vary 
from instrument to instrument, since the filament position, 
the ICR cell geometry and, most importantly the filament 
itself, will be different. 
The ECD mass spectrum obtained for melittin is shown in 
Fig. 2. In this case, 100 scans were accumulated and a total of 
17 ion fragments were observed, including four c-ions, eight 
z-ions, one a-ions, three y-ions and one x-ion. Fragment 
peaks arising from the triply protonated reduced species 
([M + 4H]3 at 949.59 Th) due to the typical small neutral 
losses expected in ECD, such as hydrogen desorption,  
ammonia and arginine side-chain losses, can also be seen. 
The mass resolution on the quadruply protonated precursor 
ion peak was approximately 18000. The individual peaks in 
the isotopic distribution had a symmetrical shape and were 
fully baseline resolved. For the reduced species the mass 
resolution dropped to 8000 and the peak shapes deteriorated 
slightly. Nevertheless, the mass resolving power of this 3 
Tesla instrument was adequate since all the fragment peaks 
could be isotopically resolved. 
In other experiments the 5+ charge state of melittin was 
isolated and subjected to ECD. However, no further 
structural information was gained. This was rather surpris-
ing, since the efficiency of electron capture increases with the 
square of the charge (z2). The most likely explanation is due 
to the fact that the initial signal magnitude, after isolation, of 
the 5+ charge state of the precursor ion was only half that of 
the 4+ charge state. Addition of in-nitrobenzyl alcohol (m-
NBA) was tried, in order to increase the signal magnitude at 
higher charge states,9 but, although the relative abundance 
was shifted towards these higher charge states, the overall 
signal magnitude was suppressed. 
SORI-CAD and IRMPD mass spectra were also recorded 
for the 4+ charge state of melittin. The typical b- and y-ion 
fragment pattern was observed (data not shown), which is 
complementary to the ECD fragmentation pattern. By 
combining the fragmentation data from the ECD mass 
spectrum as well as the SORT-CAD and IRMPD mass 
spectra, a total of 21 out of a possible 25 backbone bond 
cleavages could be identified. 
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Figure 4. ECD fragment efficiency for substance P as a function of filament voltage U-. The ECD fragment 
efficiency was calculated by adding the abundance of the ECD fragment peaks, c4 to c30 , and normalising 
with respect to the mass spectrum with the highest ECD fragment efficiency. 
The ECD mass spectrum for the 4+ charge state of bovine 
insulin, oxidised B chain, is shown in Fig. 3. This mass 
spectrum was generated by averaging 200 time-domain 
transients and employing a 5-s electron irradiation time. This 
translates into a total spectral accumulation time of slightly 
over 23 mm, which is about 5 times longer than for melittin. 
The backbone bond cleavage was reduced to 13 out of a 
possible 29 bonds, equivalent to 45% sequence coverage. The 
B chain of insulin is modified by oxidation of the two cystein 
residues at position 7 and 19, resulting in an overall mass 
increase of 95.97 Da. However, no ambiguities were en-
counted in assigning the peaks nor did any loss of 
modification occur. In spite of the 5-s electron irradiation 
time employed, the mass resolution on the precursor ion 
peak was almost 40000, indicating that the electron flux 
could be further increased without compromising the mass 
resolution or peak shapes. 
Not surprisingly, the interresidue bond cleavage efficiency 
was observed to decrease, from substance P to bovine 
insulin, with increasing molecular weight due to the higher 
number of decomposition pathways and the larger degree of 
tertiary structure. Isolation of the 5+ charge state of bovine 
insulin, oxidised B-chain, was also attempted, but the signal 
magnitude was insufficient for assigning fragment ions. 
To explore the limits of this 3 Tesla instrument, ECD was 
also attempted on bovine ubiquitin. In this case no mass 
isolation was carried out. The charge state distribution for 
this compound extended over the range 8+ to 13+. Despite 
averaging 200 time-domain transients, the resulting ECD  
mass spectrum only showed very limited fragmentation 
(data not shown). The reduced species, charge state 7+, was 
visible, as well as a number of fragment ions, including c, 
3+ 	.3+ 	4+ 	2+ 	3+ 	4~ 	3± 	4+ 
C24 , C27 , C37 , Z17 , Z17 , Z26 , 
Y782+, 
 Y24 	an 
b. Furthermore, peaks due the expected small neutral losses 
accompanying ECD were also seen in the mass spectrum. 
Whilst some degree of ECD seemed to have occurred, full 
interpretation of the mass spectrum is not possible due to 
insufficient mass resolving power to enable all of the 
fragment ions to be identified. Therefore, this size of peptide 
appears to be beyond the capability of this particular 3 Tesla 
FTICRMS instrument. 
Characterisation of the rhenium filament 
In order to gain a better understanding of the ECD process, 
measurements of the ECD fragment efficiency as well as the 
effective kinetic energy distribution of the electrons when 
entering the ICR cell as a function of the filament voltage U 
were carried out. The ECD efficiency was measured for 
substance P. The fragment efficiency was obtained by 
adding the abundance of the ECD fragment peaks c to 
CJQ in each spectrum (of 40 scans). The data were then 
normalised with respect to the mass spectrum with highest 
fragment efficiency. The initial, non-fragmented, precursor 
ion magnitude was approximately the same in all spectra. 
Figure 4 shows the ECD fragment efficiency for the 2+ 
charge state of substance P as a function of the filament 
voltage U, confirming that maximum electron capture is 
observed at a filament voltage U just above +0.5 V. A third- 
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Figure 5. (A) Schematic diagram of the rhenium filament, ICR cell and the Einzel 
lens elements FOCL2, PL9 and FOCL1 on the APEX II instrument. The diagram 
is not drawn to scale. (B) The effective electron kinetic energy distribution at the 
rear trapping plate PV2 (held at ±0.5 V during ECD experiments) for different 
filament voltages U. In the case of the distribution shown for a filament voltage 
U = ±1,5 V. the y-axis intensity has been multiplied by a factor of 10 for clarity. 
order polynomial expression was fitted to the data to 
estimate the voltage corresponding to maximum electron 
capture (+0.52V). When the filament was turned on in 
advance and allowed sufficient time to reach operating 
temperature, this parameter (the voltage corresponding to 
maximum electron capture) was observed to be highly 
reproducible (±0.1 V). Furthermore, baking out the ICR cell 
with the filament on at regular intervals maintained the 
reproducibility. 
The use of low trapping plate voltages (+0.5 V) on this 
particular instrument was observed to increase ECD. 
Conversely, increasing the voltage on the trapping plates 
gave rise to a reduction in ECD; for example, no ECD was 
observed at trapping plate voltages of 1 V. This could be due 
to a combination of factors, including higher on-axis 
velocities of both the ions and electrons, as well as increased 
magnetron motion of the ions. Another possible reason 
could be higher loss of electrons to the rear trapping plate 
(PV2), when more positive trapping plate voltages are 
applied. Experimentally, however, the emitted electron 
current measured on PV2 was found to be very low (<50 
pA), indicating that the electron beam was tightly focused 
and that few electrons were lost to this trapping plate. 
Furthermore, when measuring the emission current at the 
Einzel lens element FOCL2, higher currents were observed  
at higher trapping plate voltages, suggesting higher extrac-
tion efficiency of the electrons. 
One of the most important parameters for ECD is to 
employ low-energy electrons (<0.2 eV), which increases the 
electron capture cross-section. Since there is a potential 
energy difference between the filament, where the electrons 
are emitted, and the rear trapping plate, 14 this could be used 
as a means to alter the kinetic energy of the electrons entering 
the ICR cell in order to effect ECD. 
Figure 5(A) shows a schematic diagram of the salient 
details of the APEX II instrument used in this work, showing 
the rhenium filament, ICR cell and the Einzel lens 
components FOCL2, PL9 and FOCL1. One side of the 
filament is held at a voltage U as well as the repeller plate. 
As a consequence of the potential drop across the filament, a 
voltage U' is measured on the other side of the filament, 
which is 2 V higher than U. The repeller plate is, therefore, 
negatively biased relative to U. Some of the emitted 
electrons travel in the z-direction (the same direction as the 
magnetic field B) through the ICR cell to the Einzel lens 
shown. The filament and the ICR cell are in the bore of the 
superconducting magnet, while the Einzel lens is situated 
outside the bore, in the fringing magnetic field. The magnetic 
field lines diverge substantially in the fringing field region, 
enabling the emitted electrons to be detected on the Einzel 
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lens. Experimentally, an electron current could only be 
measured on the element FOCL2 of the Einzel lens. An 
attempt was made to increase the number of electrons 
striking the element FOCL2 by employing a 'reverse' 
Sidekick. However, this had no effect on the measured 
electron current. This would imply that most of the emitted 
electrons from the filament that passed through the ICR cell 
could be reliably detected at the element FOCL2. 
Since it was the aim of this study to gain an understanding 
of the energetics of the electrons involved in ECD, only those 
electrons that passed through the ICR cell were of interest. 
Therefore, only the velocity component of the emitted 
electrons in the z-direction is of interest. While it is known 
that electrons are emitted in a range of angles from a 
thermionic electron emitter, 15  the resulting x- or y-velocity 
components of the electrons are likely to be small due to 
axialisation in the strong magnetic field. No attempt was 
made in this work to measure the actual emitted electron 
kinetic energy profile from the filament. Since ECD takes 
place in the ICR cell, it is only the kinetic energy distribution 
of the electrons entering the ICR cell that is of relevance for 
electron capture. 
The effective kinetic energy distributions of the electrons 
entering the cell are shown in Fig. 5(B). These distributions 
were obtained by measuring the total electron current 
detected on the Einzel lens element FOCL2, which was held 
at ground potential, whilst varying the potential difference 
between the filament and the trapping plate PV2 (the 
trapping plate closest to the filament). This potential energy 
ramp provided a means of 'retarding field' analysis. For 
these measurements, the voltage on the trapping plate PV2 
was initially set to a sufficiently negative value. At this 
voltage there was no transmission of emitted electrons 
through the ICR cell to the Einzel lens element FOCL2. The 
trapping plate voltage was then incrementally increased to 
o v, and then to positive values until there was no further 
increase in the measured electron current. For a filament 
voltage U of —0.5 V, a voltage of —2.4 V on the rear trapping 
plate PV2 was found to be just sufficient to retard the 
electrons sufficiently so that no current was observed. This 
implies that even the most energetic electrons had an 
effective kinetic energy at PV2 of 0 eV. When using a voltage 
of +0.5 V on the trapping plate PV2, as during an ECD 
experiment, such an electron would have an effective kinetic 
energy of 2.9 eV [0.5 -(-2.4)] when entering the ICR cell. The 
experimentally measured current profiles, 11'0CL2  versus the 
retarding field voltage, were differentiated. The data from 
these differentiated current profiles was then plotted as a 
function of the effective kinetic energy of the electrons at 
PV2. This kinetic energy is the difference between the 
voltage applied to the rear trapping plate PV2 for the 
retarding analysis and the actual voltage applied to the 
trapping plate during an ECD experiment (+0.5 V). Figure 
5(B) shows effective kinetic energy distributions for different 
values of U, and hence U. 
As can be seen in Fig. 5(B), at a filament voltage U of 
—0.5 V the most abundant electrons have an effective kinetic 
energy of 1.3 eV and, at a filament voltage U of ±0.5 V, the 
most abundant electrons have an effective kinetic energy of 
0.9 eV. The effective kinetic energy of the most abundant  
electrons is higher when lower (i.e. more negative) filament 
voltages are used. Whilst the total emitted electron current is 
much larger at a filament voltage U of —0.5 V, compared to 
that at U = +0.5 V, the proportion of low-energy electrons is 
much greater for the kinetic energy distribution correspond-
ing to a filament voltage of U = +0.5 V. 
Currently, the abundance of the electrons in the low-
energy tail of the kinetic energy distribution is not fully 
optimised. The only way to generate more low-energy 
electrons with the current approach is to reduce the trapping 
plate voltage, so that the kinetic energy of the electrons is 
effectively lowered since the retarding field is greater. Given 
that low trapping plate voltages were already employed (i.e. 
+0.5 V), there is not much scope left to further reducing the 
voltage on the trapping plates without compromising 
trapping of the ions. 
CONCLUSIONS AND FUTURE WORK 
It has been shown that a commercial 3 Tesla FTICR 
instrument (Bruker Daltonics APEX II) equipped with a 
conventional electron filament is capable of performing ECD 
on peptides with molecular weights up to 3.5 kDa. It has also 
been shown that in order to achieve ECD using this 
instrument one of the most important parameters is to 
employ low trapping plate voltages. The current electron 
source design, which is optimised for high-energy electron 
impact ionisation, limits the efficiency of ECD that can be 
achieved. 
In future work the use of a modified filament design, 
incorporating a thorium coating, will be investigated. This 
should permit increased emitted electron flux from the 
filament at lower operating temperatures, which should 
decrease the achievable average electron kinetic energy. 
With this modified design it should be feasible, even on a 3 
Tesla FTICR instrument, to generate sufficient ECD sequence 
information on peptides with molecular masses as high as 
5 kDa. This would permit studies of post-translational 
modifications on most tryptic digest fragments, without 
the need to employ FTICR instruments equipped with 
larger, and more expensive, superconducting magnets. 
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It is well known that proteins control the local environment of 
bound metal ions,1 and hence their thermodynamic and kinetic 
properties, for example, redox potentials23 and transfer rates .4 
Metal loth ioneins (MTs) appear to play an important role in Zn 
homeostasis and the zinc buffer/distribution system.5 Mammalian 
MTs contain Zn3Cys9 and Zn4Cys,1  clusters ,6 and metal exchange 
reactions for MTs are usually fast.' Bacterial MTs possess only a 
single zinc cluster,' Zn.1Cys9His2 in the case of the cyanobacterial 
MT SmtA (Figure l).'° We have investigated Zn exchange 
reactions of Zn4-SmtA by a new method using stable isotope 
labeling combined with Fourier transform ion cyclotron resonance 
mass spectrometry (FT-ICR-MS). We show that the Zn4 cluster of 
SrntA, in contrast to the structurally analogous cluster of mammalian 
MT, contains a kinetically inert Zn site, a feature which can be 
related to its secondary and tertiary structure, and which is of 
potential importance to its biological function. 
Gentle ionization by electrospray (ESI) has previously been 
exploited for MTs,'' and in combination with FT-ICR-MS 2 it is a 
powerful tool for the analysis of metalloproteins.'3 Deconvoluted 
ESI-FT-ICR spectra of Zn.,-SmtA containing Zn isotopes in natural 
and with 93% enrichment 15  with 67Zn are compared 
in Figure 2. The observed experimental masses of the most intense 
isotopic peaks in Figure 2A and B (5862.95 and 5868.81 Da, 
respectively) are in good agreement with calculated values (5863.00 
and 5869.00 Da: deviations of 8.5 and 32 ppm, respectively). 
The effects of isotope enrichment are pronounced. Exchange of 
all four Zn atoms causes an increase in mass of the most abundant 
peak by 6 Da, and the isotopic envelope becomes much narrower 
(Figure 213). 
To investigate Zn exchange behavior, we incubated natural 
abundance Zn4-SmtA with 67ZnCI, for various time intervals at 310 
K, removed unbound Zn 2' by rapid gel filtration (Ca. 3 mm), and 
analyzed the product by FT-ICR-MS." The amount of exchanged 
Zn at each time point was determined by comparing the experi-
mental data to modeled isotope envelopes for Zn_467Zn,SmtA 
(x = 1-4, in 0.25 Zn intervals), taking into account the isotopic 
compositions of both natural abundance Zn and the 67Zn-enriched 
67ZnC12 used 14,11  (see Figure S2). 
Crucially, the FT-ICR-MS measurements allow direct determi-
nation of the metal:protein ratio, without the need for separate 
measurements of metal and protein concentrations, as is necessary 
in radioisotope studies, while simultaneously confirming the identity 
of the intact metal—protein complex. 
We find that initial Zn exchange is fast (Ca. 1.4 Zn exchanged 
after 1 h, see Figure S3) as expected for meta1lothioneins,7 but 
most interesting is the extent of 67  Zn incorporation at equilibrium. 
If exchange occurred at all four Zn sites, the maximum achievable 
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Figure 1. (A) 3D structure of Zn4-SmtA (PDB IJJD) showing elements 
of secondary structure around site A. The amide proton of Cys32 forms an 
H-bond to the sulfur of Cys9, which accounts for the extraordinary low-
field shift of its 'H resonance (10.01 ppm). The tertiary arrangement of the 
helix and sheet is further stabilized by the CH-2r interaction between A1a37 
and Tyr3 I. (B) The Zn4C'ys1)His2 cluster of Zn4-SmtA. 
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Figure 2. Deconvoluted ESI-FT-ICR mass spectra and modeled mass 
envelopes (red circles) of (A) natural abundance Zn.,-SmtA (first model 
circle is I Da below monoisotopic peak). (B) 93%-enriched 67Zn.4-SmtA, 
and (C) Zn4-SmtA reacted with a 10-fold molar excess (with respect to 
Zn) of 67ZnCl2 for 99 hat 310 K, and model for exchange of 2.75 Zn. 
incorporation of 67Zn with a 10-fold excess of 93% enriched 17  Zn 
would be 3.6 17  Zn per ntol SmtA. We observed a maximum 
incorporation of 2.75 67 Zn (Figure 2C) after 99 h of incubation, 
close to the value of 2.7 67Zn calculated for exchange at only three 
sites. This implies that one of the four sites in the Zn4 cluster (Figure 
1 B) is inert to exchange, a result consistent with our previous I "Cd 
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Figure 3. Space-filling models showing accessibility of the tenninal Cys 
and His ligands in sites B, C, and D (Cys S yellow, N blue, 0 red, C white, 
H cyan). Site A is completely buried. 
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Figure 4. Low-field region (NH peaks) of the 'II NMR spectrum of Zn4-
SmtA, and 30 and 60 min after reaction with ca. 6 mid equiv of EDTA, 
and 2 days after reaction with a further It) isol equiv of EDTA. Zn removal 
was indicated by the decrease in intensity of the ethylene singlet of free 
EDTA (6 = 3.256) and appearance of the analogous singlet for [Zn(EDTA)]2 
(6 = 2.873; Figure S5). 
NMR observations' of reactions of I Cd21 with Zn4-SmtA, in which 
Zn(A) is inert. The formation of Cd3Zn-SmtA is substantiated by 
ICP-AES and ESI-MS data (Figure S4). Normally, all-cysteine sites 
are thermodynamically stronger binding sites for Cd2 as compared 
to Z112 (e.g., 102 x stronger for Cys4 zinc fingers,' 7 and 104 x 
stronger for mammalian MTs"), and Zn2+  replacement by Cd2+  in 
MTs is fast and stoichiometric.19 
Zn exchange is likely to involve attack of 57Zn21  on an accessible 
ligand atom: S of Cys or N of His. It can be seen in Figure 3A 
and B that the terminal sulfurs in sites B, C, and D are accessible 
from the protein surface, but this is not the case for site A, for 
which all of the ligands (Cys 9, 14, 32, and 36) are buried. 
Site A is surrounded by elements of secondary structure, an 
a-helix and two short antiparallel fl-sheets, structural features which 
are not found in mammalian MTs, and these give rise to an H-bond 
between the S of Cys9, a ligand in site A, and the backbone NH of 
Cys32, a ligand in sites A and C (Figure IA). Such an arrangement 
probably prevents intramolecular metal exchange into site A. The 
secondary structure around Zn(A) appears to be maintained during 
removal of Zn2 from Zn4SmtA by EDTA,2° as indicated by the 
behavior of the low-field shifted NH resonances of Cys32 and Val 18 
(Figure 4; see also Figure IA). It seems likely therefore that Zn-
(B,C,D) are removed by EDTA more rapidly than Zn(A). 
These findings show that the Z114  cluster in bacterial metallothio-
nein confers novel properties on the protein. Site A and the 
surrounding secondary structure constitute a zinc finger fold of the 
kind found in GATA2' and L1M22 proteins which recognize other 
zinc finger proteins and DNA. Metal exchange and transfer reactions 
of proteins423 are currently presenting important and challenging 
questions, and it is clear that FT-ICR-MS can make a major 
contribution to studies of both their thermodynamics and exchange 
dynamics. 
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